{"id": "282_565_1_382", "text": "DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB.", "text_with_entity_marker": "DJ-1 enhances cell survival through the binding of [E1]Cezanne[/E1][E2]DJ-1[/E2] enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cezanne", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "DJ-1", "entity_2_idx": [[0, 4]], "entity_2_idx_in_text_with_entity_marker": [71, 75], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "282_565_1_383", "text": "DJ-1 enhances cell survival through the binding of Cezanne, a negative regulator of NF-kappaB.", "text_with_entity_marker": "DJ-1 enhances cell survival through the binding of [E1]Cezanne[/E1], a negative regulator of [E2]NF-kappaB.[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cezanne", "entity_1_idx": [[51, 58]], "entity_1_idx_in_text_with_entity_marker": [55, 62], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "NF-kappaB.", "entity_2_idx": [[84, 94]], "entity_2_idx_in_text_with_entity_marker": [97, 107], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "282_566_3_384", "text": "Mass spectrometry shows that DJ-1 interacts with BBS1, CLCF1, MTREF, and Cezanne/OTUD7B/Za20d1", "text_with_entity_marker": "Mass spectrometry shows that [E1]DJ-1[/E1] interacts with [E2]BBS1[/E2], CLCF1, MTREF, and Cezanne/OTUD7B/Za20d1", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DJ-1", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "BBS1", "entity_2_idx": [[49, 53]], "entity_2_idx_in_text_with_entity_marker": [62, 66], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "282_566_3_385", "text": "Mass spectrometry shows that DJ-1 interacts with BBS1, CLCF1, MTREF, and Cezanne/OTUD7B/Za20d1", "text_with_entity_marker": "Mass spectrometry shows that [E1]DJ-1[/E1] interacts with BBS1, [E2]CLCF1[/E2], MTREF, and Cezanne/OTUD7B/Za20d1", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DJ-1", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CLCF1", "entity_2_idx": [[55, 60]], "entity_2_idx_in_text_with_entity_marker": [68, 73], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "282_566_3_386", "text": "Mass spectrometry shows that DJ-1 interacts with BBS1, CLCF1, MTREF, and Cezanne/OTUD7B/Za20d1", "text_with_entity_marker": "Mass spectrometry shows that [E1]DJ-1[/E1] interacts with BBS1, CLCF1, [E2]MTREF[/E2], and Cezanne/OTUD7B/Za20d1", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DJ-1", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "MTREF", "entity_2_idx": [[62, 67]], "entity_2_idx_in_text_with_entity_marker": [75, 80], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "282_566_3_387", "text": "Mass spectrometry shows that DJ-1 interacts with BBS1, CLCF1, MTREF, and Cezanne/OTUD7B/Za20d1", "text_with_entity_marker": "Mass spectrometry shows that [E1]DJ-1[/E1] interacts with BBS1, CLCF1, MTREF, [E2]and Cezanne/OTUD7B/Za20d1[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "DJ-1", "entity_1_idx": [[29, 33]], "entity_1_idx_in_text_with_entity_marker": [33, 37], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "and Cezanne/OTUD7B/Za20d1", "entity_2_idx": [[69, 94]], "entity_2_idx_in_text_with_entity_marker": [82, 107], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "267_536_1_357", "text": "ADAMTS13 controls the multimeric size of circulating von Willebrand factor (VWF) by cleaving the Tyr1605-Met1606 bond in theA2 domain", "text_with_entity_marker": "[E1]ADAMTS13[/E1] controls the multimeric size of circulating [E2]von Willebrand factor (VWF)[/E2] by cleaving the Tyr1605-Met1606 bond in theA2 domain", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ADAMTS13", "entity_1_idx": [[0, 8]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "von Willebrand factor (VWF)", "entity_2_idx": [[53, 80]], "entity_2_idx_in_text_with_entity_marker": [66, 93], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "20_41_1_38", "text": "Mutation of an N-terminal acidic-rich region of p115-RhoGEF dissociates alpha13 binding and alpha13-promoted plasma membrane recruitment.", "text_with_entity_marker": "Mutation of an N-terminal acidic-rich region of [E1]p115-RhoGEF[/E1] dissociates [E2]alpha13[/E2] binding and alpha13-promoted plasma membrane recruitment.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p115-RhoGEF", "entity_1_idx": [[48, 59]], "entity_1_idx_in_text_with_entity_marker": [52, 63], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "alpha13", "entity_2_idx": [[72, 79]], "entity_2_idx_in_text_with_entity_marker": [85, 92], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "20_42_2_39", "text": "Alpha(13) binds to a regulator of G protein signaling (RGS) domain in p115-RhoGEF, but the mechanism of alpha(13) activation of p115-RhoGEF is poorly understood", "text_with_entity_marker": "[E1]Alpha(13)[/E1] binds to a regulator of G protein signaling (RGS) domain in [E2]p115-RhoGEF[/E2], but the mechanism of alpha(13) activation of p115-RhoGEF is poorly understood", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Alpha(13)", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "p115-RhoGEF", "entity_2_idx": [[70, 81]], "entity_2_idx_in_text_with_entity_marker": [83, 94], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "82_165_1_107", "text": "14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.", "text_with_entity_marker": "14-3-3gamma binds to MDMX that is phosphorylated by UV-activated [E1]Chk1[/E1][E2]MDMX[/E2] that is phosphorylated by UV-activated Chk1, resulting in p53 activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Chk1", "entity_1_idx": [[65, 69]], "entity_1_idx_in_text_with_entity_marker": [69, 73], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "MDMX", "entity_2_idx": [[21, 25]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "82_165_1_108", "text": "14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.", "text_with_entity_marker": "[E1]14-3-3[/E1]gamma binds to [E2]MDMX[/E2] that is phosphorylated by UV-activated Chk1, resulting in p53 activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "14-3-3", "entity_1_idx": [[0, 6]], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "MDMX", "entity_2_idx": [[21, 25]], "entity_2_idx_in_text_with_entity_marker": [34, 38], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "82_166_9_109", "text": "Thus, these results demonstrate 14-3-3gamma and Chk1 as two novel regulators of MDMX in response to UV irradiation.", "text_with_entity_marker": "Thus, these results demonstrate [E1]14-3-3gamma[/E1] and Chk1 as two novel regulators of [E2]MDMX[/E2] in response to UV irradiation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "14-3-3gamma", "entity_1_idx": [[32, 43]], "entity_1_idx_in_text_with_entity_marker": [36, 47], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "MDMX", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "82_166_9_110", "text": "Thus, these results demonstrate 14-3-3gamma and Chk1 as two novel regulators of MDMX in response to UV irradiation.", "text_with_entity_marker": "Thus, these results demonstrate 14-3-3gamma and [E1]Chk1[/E1] as two novel regulators of [E2]MDMX[/E2] in response to UV irradiation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Chk1", "entity_1_idx": [[48, 52]], "entity_1_idx_in_text_with_entity_marker": [52, 56], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "MDMX", "entity_2_idx": [[80, 84]], "entity_2_idx_in_text_with_entity_marker": [93, 97], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "246_493_1_322", "text": "The Agrobacterium T-DNA transport pore proteins VirB8, VirB9, and VirB10 interact with one another.", "text_with_entity_marker": "The Agrobacterium T-DNA transport pore proteins [E1]VirB8[/E1], [E2]VirB9[/E2], and VirB10 interact with one another.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VirB8", "entity_1_idx": [[48, 53]], "entity_1_idx_in_text_with_entity_marker": [52, 57], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "VirB9", "entity_2_idx": [[55, 60]], "entity_2_idx_in_text_with_entity_marker": [68, 73], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "246_493_1_323", "text": "The Agrobacterium T-DNA transport pore proteins VirB8, VirB9, and VirB10 interact with one another.", "text_with_entity_marker": "The Agrobacterium T-DNA transport pore proteins [E1]VirB8[/E1], VirB9, and [E2]VirB10[/E2] interact with one another.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VirB8", "entity_1_idx": [[48, 53]], "entity_1_idx_in_text_with_entity_marker": [52, 57], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "VirB10", "entity_2_idx": [[66, 72]], "entity_2_idx_in_text_with_entity_marker": [79, 85], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "246_493_1_324", "text": "The Agrobacterium T-DNA transport pore proteins VirB8, VirB9, and VirB10 interact with one another.", "text_with_entity_marker": "The Agrobacterium T-DNA transport pore proteins VirB8, [E1]VirB9[/E1], and [E2]VirB10[/E2] interact with one another.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VirB9", "entity_1_idx": [[55, 60]], "entity_1_idx_in_text_with_entity_marker": [59, 64], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "VirB10", "entity_2_idx": [[66, 72]], "entity_2_idx_in_text_with_entity_marker": [79, 85], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "246_494_5_325", "text": "Using the yeast two-hybrid assay, we observed that VirB8, VirB9, and VirB10 interact with one another", "text_with_entity_marker": "Using the yeast two-hybrid assay, we observed that [E1]VirB8[/E1], [E2]VirB9[/E2], and VirB10 interact with one another", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VirB8", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "VirB9", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "246_494_5_326", "text": "Using the yeast two-hybrid assay, we observed that VirB8, VirB9, and VirB10 interact with one another", "text_with_entity_marker": "Using the yeast two-hybrid assay, we observed that [E1]VirB8[/E1], VirB9, and [E2]VirB10[/E2] interact with one another", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VirB8", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "VirB10", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "246_494_5_327", "text": "Using the yeast two-hybrid assay, we observed that VirB8, VirB9, and VirB10 interact with one another", "text_with_entity_marker": "Using the yeast two-hybrid assay, we observed that VirB8, [E1]VirB9[/E1], and [E2]VirB10[/E2] interact with one another", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "VirB9", "entity_1_idx": [[58, 63]], "entity_1_idx_in_text_with_entity_marker": [62, 67], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "VirB10", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "19_40_1_37", "text": "Calmodulin-like protein (CLP) is a specific light chain of unconventional myosin-10 (Myo10) and enhances Myo10-dependent filopodial extension", "text_with_entity_marker": "[E1]Calmodulin-like protein (CLP)[/E1] is a specific light chain of unconventional [E2]myosin-10 (Myo10)[/E2] and enhances Myo10-dependent filopodial extension", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Calmodulin-like protein (CLP)", "entity_1_idx": [[0, 29]], "entity_1_idx_in_text_with_entity_marker": [4, 33], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "myosin-10 (Myo10)", "entity_2_idx": [[74, 91]], "entity_2_idx_in_text_with_entity_marker": [87, 104], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "44_89_1_69", "text": "The scaffold protein JIP3 functions as a downstream effector of the small GTPase ARF6 to regulate neurite morphogenesis of cortical neurons.", "text_with_entity_marker": "The scaffold protein [E1]JIP3[/E1] functions as a downstream effector of the small GTPase [E2]ARF6[/E2] to regulate neurite morphogenesis of cortical neurons.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "JIP3", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ARF6", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "44_90_3_70", "text": "We identified the signaling scaffold protein JNK-interacting protein 3 (JIP3), which is exclusively expressed in neurons, as a downstream effector of ARF6", "text_with_entity_marker": "We identified the signaling scaffold protein JNK-interacting protein 3 ([E1]JIP3[/E1]), which is exclusively expressed in neurons, as a downstream effector of [E2]ARF6[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "JIP3", "entity_1_idx": [[72, 76]], "entity_1_idx_in_text_with_entity_marker": [76, 80], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ARF6", "entity_2_idx": [[150, 154]], "entity_2_idx_in_text_with_entity_marker": [163, 167], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "270_541_1_362", "text": "Characterization of the Escherichia coli ClpY (HslU) substrate recognition site in the ClpYQ (HslUV) protease using the yeast two-hybrid system.", "text_with_entity_marker": "Characterization of the Escherichia coli [E1]ClpY[/E1] (HslU) substrate recognition site in the [E2]ClpYQ[/E2] (HslUV) protease using the yeast two-hybrid system.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ClpY", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "ClpYQ", "entity_2_idx": [[87, 92]], "entity_2_idx_in_text_with_entity_marker": [100, 105], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "270_542_4_363", "text": "In vivo, ClpYQ targets SulA, RcsA, RpoH, and TraJ molecules", "text_with_entity_marker": "In vivo, [E1]ClpYQ[/E1] targets [E2]SulA[/E2], RcsA, RpoH, and TraJ molecules", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ClpYQ", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "SulA", "entity_2_idx": [[23, 27]], "entity_2_idx_in_text_with_entity_marker": [36, 40], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "270_542_4_364", "text": "In vivo, ClpYQ targets SulA, RcsA, RpoH, and TraJ molecules", "text_with_entity_marker": "In vivo, [E1]ClpYQ[/E1] targets SulA, [E2]RcsA[/E2], RpoH, and TraJ molecules", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ClpYQ", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RcsA", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "270_542_4_365", "text": "In vivo, ClpYQ targets SulA, RcsA, RpoH, and TraJ molecules", "text_with_entity_marker": "In vivo, [E1]ClpYQ[/E1] targets SulA, RcsA, [E2]RpoH[/E2], and TraJ molecules", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ClpYQ", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RpoH", "entity_2_idx": [[35, 39]], "entity_2_idx_in_text_with_entity_marker": [48, 52], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "270_542_4_366", "text": "In vivo, ClpYQ targets SulA, RcsA, RpoH, and TraJ molecules", "text_with_entity_marker": "In vivo, [E1]ClpYQ[/E1] targets SulA, RcsA, RpoH, and [E2]TraJ[/E2] molecules", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ClpYQ", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "TraJ", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "113_228_9_152", "text": "Our data demonstrate that PP4R4 forms a novel cytosolic complex with PP4c, independent from the complexes containing PP4R1, PP4R2.PP4R3, and alpha4, and that the regulatory subunits of PP4c have evolved different modes of interaction with the catalytic subunit.", "text_with_entity_marker": "Our data demonstrate that [E1]PP4R4[/E1] forms a novel cytosolic complex with [E2]PP4c[/E2], independent from the complexes containing PP4R1, PP4R2.PP4R3, and alpha4, and that the regulatory subunits of PP4c have evolved different modes of interaction with the catalytic subunit.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PP4R4", "entity_1_idx": [[26, 31]], "entity_1_idx_in_text_with_entity_marker": [30, 35], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PP4c", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "84_169_1_112", "text": "Mutations in host cell factor 1 separate its role in cell proliferation from recruitment of VP16 and LZIP.", "text_with_entity_marker": "Mutations in [E1]host cell factor 1[/E1] separate its role in cell proliferation from recruitment of [E2]VP16[/E2] and LZIP.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "host cell factor 1", "entity_1_idx": [[13, 31]], "entity_1_idx_in_text_with_entity_marker": [17, 35], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "VP16", "entity_2_idx": [[92, 96]], "entity_2_idx_in_text_with_entity_marker": [105, 109], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "84_169_1_113", "text": "Mutations in host cell factor 1 separate its role in cell proliferation from recruitment of VP16 and LZIP.", "text_with_entity_marker": "Mutations in [E1]host cell factor 1[/E1] separate its role in cell proliferation from recruitment of VP16 and [E2]LZIP[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "host cell factor 1", "entity_1_idx": [[13, 31]], "entity_1_idx_in_text_with_entity_marker": [17, 35], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "LZIP", "entity_2_idx": [[101, 105]], "entity_2_idx_in_text_with_entity_marker": [114, 118], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "57_115_1_83", "text": "The novel coactivator C1 (HCF) coordinates multiprotein enhancer formation and mediates transcription activation by GABP.", "text_with_entity_marker": "The novel coactivator C1 ([E1]HCF[/E1]) coordinates multiprotein enhancer formation and mediates transcription activation by [E2]GABP[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HCF", "entity_1_idx": [[26, 29]], "entity_1_idx_in_text_with_entity_marker": [30, 33], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "GABP", "entity_2_idx": [[116, 120]], "entity_2_idx_in_text_with_entity_marker": [129, 133], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "173_347_1_223", "text": "A novel yeast two-hybrid approach to identify CDPK substrates: characterization of the interaction between AtCPK11 and AtDi19, a nuclear zinc finger protein.", "text_with_entity_marker": "A novel yeast two-hybrid approach to identify CDPK substrates: characterization of the interaction between [E1]AtCPK11[/E1] and [E2]AtDi19[/E2], a nuclear zinc finger protein.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AtCPK11", "entity_1_idx": [[107, 114]], "entity_1_idx_in_text_with_entity_marker": [111, 118], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "AtDi19", "entity_2_idx": [[119, 125]], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "173_348_5_224", "text": "We further showed that the interaction of AtDi19 is specific to both AtCPK4 and AtCPK11, whereas other closely related CPKs from Arabidopsis interacted weakly (e.g., AtCPK12) or did not interact (e.g., AtCPK26, AtCPK5 and AtCPK1) with AtDi19", "text_with_entity_marker": "We further showed that the interaction of [E1]AtDi19[/E1] is specific to both [E2]AtCPK4[/E2] and AtCPK11, whereas other closely related CPKs from Arabidopsis interacted weakly (e.g., AtCPK12) or did not interact (e.g., AtCPK26, AtCPK5 and AtCPK1) with AtDi19", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AtDi19", "entity_1_idx": [[42, 48]], "entity_1_idx_in_text_with_entity_marker": [46, 52], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "AtCPK4", "entity_2_idx": [[69, 75]], "entity_2_idx_in_text_with_entity_marker": [82, 88], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "173_348_5_225", "text": "We further showed that the interaction of AtDi19 is specific to both AtCPK4 and AtCPK11, whereas other closely related CPKs from Arabidopsis interacted weakly (e.g., AtCPK12) or did not interact (e.g., AtCPK26, AtCPK5 and AtCPK1) with AtDi19", "text_with_entity_marker": "We further showed that the interaction of [E1]AtDi19[/E1] is specific to both AtCPK4 and [E2]AtCPK11[/E2], whereas other closely related CPKs from Arabidopsis interacted weakly (e.g., AtCPK12) or did not interact (e.g., AtCPK26, AtCPK5 and AtCPK1) with AtDi19", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AtDi19", "entity_1_idx": [[42, 48]], "entity_1_idx_in_text_with_entity_marker": [46, 52], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "AtCPK11", "entity_2_idx": [[80, 87]], "entity_2_idx_in_text_with_entity_marker": [93, 100], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "255_512_12_339", "text": "We discuss how PRUNE regulates nm23-H1 protein and postulate possible implications of PRUNE in neuroblastoma progression.", "text_with_entity_marker": "We discuss how [E1]PRUNE[/E1] regulates [E2]nm23-H1[/E2] protein and postulate possible implications of PRUNE in neuroblastoma progression.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PRUNE", "entity_1_idx": [[15, 20]], "entity_1_idx_in_text_with_entity_marker": [19, 24], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "nm23-H1", "entity_2_idx": [[31, 38]], "entity_2_idx_in_text_with_entity_marker": [44, 51], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "244_489_1_316", "text": "Optineurin mediates a negative regulation of Rab8 by the GTPase-activating protein TBC1D17.", "text_with_entity_marker": "Optineurin mediates a negative regulation of Rab8 by the GTPase-activating protein [E1]TBC1D17[/E1][E2]Rab8[/E2] by the GTPase-activating protein TBC1D17.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBC1D17", "entity_1_idx": [[83, 90]], "entity_1_idx_in_text_with_entity_marker": [87, 94], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Rab8", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [103, 107], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "244_489_1_317", "text": "Optineurin mediates a negative regulation of Rab8 by the GTPase-activating protein TBC1D17.", "text_with_entity_marker": "[E1]Optineurin[/E1] mediates a negative regulation of [E2]Rab8[/E2] by the GTPase-activating protein TBC1D17.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Optineurin", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Rab8", "entity_2_idx": [[45, 49]], "entity_2_idx_in_text_with_entity_marker": [58, 62], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "244_490_11_318", "text": "Our results show that TBC1D17, through its interaction with optineurin, regulates Rab8-mediated endocytic recycling of transferrin receptor and recruitment of Rab8 to the endocytic recycling tubules", "text_with_entity_marker": "Our results show that [E1]TBC1D17[/E1], through its interaction with [E2]optineurin[/E2], regulates Rab8-mediated endocytic recycling of transferrin receptor and recruitment of Rab8 to the endocytic recycling tubules", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBC1D17", "entity_1_idx": [[22, 29]], "entity_1_idx_in_text_with_entity_marker": [26, 33], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "optineurin", "entity_2_idx": [[60, 70]], "entity_2_idx_in_text_with_entity_marker": [73, 83], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "244_490_11_319", "text": "Our results show that TBC1D17, through its interaction with optineurin, regulates Rab8-mediated endocytic recycling of transferrin receptor and recruitment of Rab8 to the endocytic recycling tubules", "text_with_entity_marker": "Our results show that [E1]TBC1D1[/E1]7, through its interaction with optineurin, regulates [E2]Rab8[/E2]-mediated endocytic recycling of transferrin receptor and recruitment of Rab8 to the endocytic recycling tubules", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "TBC1D1", "entity_1_idx": [[22, 28]], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Rab8", "entity_2_idx": [[82, 86]], "entity_2_idx_in_text_with_entity_marker": [95, 99], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "244_490_11_320", "text": "Our results show that TBC1D17, through its interaction with optineurin, regulates Rab8-mediated endocytic recycling of transferrin receptor and recruitment of Rab8 to the endocytic recycling tubules", "text_with_entity_marker": "Our results show that TBC1D17, through its interaction with [E1]optineurin[/E1], regulates [E2]Rab8[/E2]-mediated endocytic recycling of transferrin receptor and recruitment of Rab8 to the endocytic recycling tubules", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "optineurin", "entity_1_idx": [[60, 70]], "entity_1_idx_in_text_with_entity_marker": [64, 74], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Rab8", "entity_2_idx": [[82, 86]], "entity_2_idx_in_text_with_entity_marker": [95, 99], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "261_524_2_349", "text": "This interaction between HY5 and COP1 results in targeted deg radation of HY5 by the 26S proteasome", "text_with_entity_marker": "This interaction between [E1]HY5[/E1] and [E2]COP1[/E2] results in targeted deg radation of HY5 by the 26S proteasome", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HY5", "entity_1_idx": [[25, 28]], "entity_1_idx_in_text_with_entity_marker": [29, 32], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "COP1", "entity_2_idx": [[33, 37]], "entity_2_idx_in_text_with_entity_marker": [46, 50], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "30_62_4_54", "text": "Furthermore, we present evidence that RET induces apoptosis via its own cleavage by caspases, a phenomenon allowing the liberation/exposure of a pro-apoptotic domain of RET", "text_with_entity_marker": "Furthermore, we present evidence that RET induces apoptosis via its own cleavage by [E1]caspases[/E1][E2]RET[/E2] induces apoptosis via its own cleavage by caspases, a phenomenon allowing the liberation/exposure of a pro-apoptotic domain of RET", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "caspases", "entity_1_idx": [[84, 92]], "entity_1_idx_in_text_with_entity_marker": [88, 96], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "RET", "entity_2_idx": [[38, 41]], "entity_2_idx_in_text_with_entity_marker": [105, 108], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "208_417_1_273", "text": "The decapping enzyme Dcp1 participates in translation termination through its interaction with the release factor eRF3 in budding yeast.", "text_with_entity_marker": "The decapping enzyme [E1]Dcp1[/E1] participates in translation termination through its interaction with the release factor [E2]eRF3[/E2] in budding yeast.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dcp1", "entity_1_idx": [[21, 25]], "entity_1_idx_in_text_with_entity_marker": [25, 29], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "eRF3", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "208_418_2_274", "text": "We find here that Dcp1p can interact with the release factor eRF3p (Sup35p) in Saccharomyces cerevisiae", "text_with_entity_marker": "We find here that [E1]Dcp1p[/E1] can interact with the release factor [E2]eRF3p (Sup35p)[/E2] in Saccharomyces cerevisiae", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Dcp1p", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "eRF3p (Sup35p)", "entity_2_idx": [[61, 75]], "entity_2_idx_in_text_with_entity_marker": [74, 88], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "5_12_7_15", "text": "We also observed that the triple mutant was functionally deficient in beta2-microglobulin interactions and incapable of regulating transferrin binding, once again, reminiscent of the HFE-C282Y variant", "text_with_entity_marker": "We also observed that the triple mutant was functionally deficient in [E1]beta2-microglobulin[/E1] interactions and incapable of regulating transferrin binding, once again, reminiscent of the [E2]HFE[/E2]-C282Y variant", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta2-microglobulin", "entity_1_idx": [[70, 89]], "entity_1_idx_in_text_with_entity_marker": [74, 93], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "HFE", "entity_2_idx": [[183, 186]], "entity_2_idx_in_text_with_entity_marker": [196, 199], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "40_82_6_65", "text": "CILP inhibited TGF-beta1-mediated induction of cartilage matrix genes through direct interaction with TGF-beta1 and inhibition of TGF-beta1 signaling", "text_with_entity_marker": "[E1]CILP[/E1] inhibited [E2]TGF-beta1[/E2]-mediated induction of cartilage matrix genes through direct interaction with TGF-beta1 and inhibition of TGF-beta1 signaling", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CILP", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "TGF-beta1", "entity_2_idx": [[15, 24]], "entity_2_idx_in_text_with_entity_marker": [28, 37], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "272_545_1_368", "text": "The histone chaperone protein Nucleosome Assembly Protein-1 (hNAP-1) binds HIV-1 Tat and promotes viral transcription.", "text_with_entity_marker": "The histone chaperone protein [E1]Nucleosome Assembly Protein-1 (hNAP-1)[/E1] binds HIV-1 [E2]Tat[/E2] and promotes viral transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Nucleosome Assembly Protein-1 (hNAP-1)", "entity_1_idx": [[30, 68]], "entity_1_idx_in_text_with_entity_marker": [34, 72], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Tat", "entity_2_idx": [[81, 84]], "entity_2_idx_in_text_with_entity_marker": [94, 97], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "272_546_4_369", "text": "RESULTS: Using a proteomic screening, we identified hNAP-1 as a novel cellular protein interacting with HIV-1 Tat", "text_with_entity_marker": "RESULTS: Using a proteomic screening, we identified [E1]hNAP-1[/E1] as a novel cellular protein interacting with HIV-1 [E2]Tat[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "hNAP-1", "entity_1_idx": [[52, 58]], "entity_1_idx_in_text_with_entity_marker": [56, 62], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Tat", "entity_2_idx": [[110, 113]], "entity_2_idx_in_text_with_entity_marker": [123, 126], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "269_539_1_359", "text": "The phosphatase PHLPP controls the cellular levels of protein kinase C.", "text_with_entity_marker": "The phosphatase [E1]PHLPP[/E1] controls the cellular levels of [E2]protein kinase C.[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PHLPP", "entity_1_idx": [[16, 21]], "entity_1_idx_in_text_with_entity_marker": [20, 25], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "protein kinase C.", "entity_2_idx": [[54, 71]], "entity_2_idx_in_text_with_entity_marker": [67, 84], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "269_540_5_360", "text": "Here we show that the two PHLPP isoforms, PHLPP1 and PHLPP2, also dephosphorylate the hydrophobic motif on PKC betaII, an event that shunts PKC to the detergent-insoluble fraction, effectively terminating its life cycle", "text_with_entity_marker": "Here we show that the two PHLPP isoforms, [E1]PHLPP1[/E1] and PHLPP2, also dephosphorylate the hydrophobic motif on [E2]PKC betaII[/E2], an event that shunts PKC to the detergent-insoluble fraction, effectively terminating its life cycle", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PHLPP1", "entity_1_idx": [[42, 48]], "entity_1_idx_in_text_with_entity_marker": [46, 52], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PKC betaII", "entity_2_idx": [[107, 117]], "entity_2_idx_in_text_with_entity_marker": [120, 130], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "269_540_5_361", "text": "Here we show that the two PHLPP isoforms, PHLPP1 and PHLPP2, also dephosphorylate the hydrophobic motif on PKC betaII, an event that shunts PKC to the detergent-insoluble fraction, effectively terminating its life cycle", "text_with_entity_marker": "Here we show that the two PHLPP isoforms, PHLPP1 and [E1]PHLPP2[/E1], also dephosphorylate the hydrophobic motif on [E2]PKC betaII[/E2], an event that shunts PKC to the detergent-insoluble fraction, effectively terminating its life cycle", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PHLPP2", "entity_1_idx": [[53, 59]], "entity_1_idx_in_text_with_entity_marker": [57, 63], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "PKC betaII", "entity_2_idx": [[107, 117]], "entity_2_idx_in_text_with_entity_marker": [120, 130], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "105_211_1_136", "text": "Regulation of RKIP binding to the N-region of the Raf-1 kinase.", "text_with_entity_marker": "Regulation of [E1]RKIP[/E1] binding to the N-region of the [E2]Raf-1[/E2] kinase.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RKIP", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[50, 55]], "entity_2_idx_in_text_with_entity_marker": [63, 68], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "105_212_1_137", "text": "The Raf kinase inhibitory protein (RKIP) binds to Raf-1 interfering with binding of the MEK substrate and potentially also Raf-1 activation", "text_with_entity_marker": "The [E1]Raf kinase inhibitory protein (RKIP)[/E1] binds to [E2]Raf-1[/E2] interfering with binding of the MEK substrate and potentially also Raf-1 activation", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Raf kinase inhibitory protein (RKIP)", "entity_1_idx": [[4, 40]], "entity_1_idx_in_text_with_entity_marker": [8, 44], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "Raf-1", "entity_2_idx": [[50, 55]], "entity_2_idx_in_text_with_entity_marker": [63, 68], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "191_383_1_249", "text": "Interaction between BRCA2 and replication protein A is compromised by a cancer-predisposing mutation in BRCA2.", "text_with_entity_marker": "Interaction between [E1]BRCA2[/E1] and [E2]replication protein A[/E2] is compromised by a cancer-predisposing mutation in BRCA2.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "BRCA2", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "replication protein A", "entity_2_idx": [[30, 51]], "entity_2_idx_in_text_with_entity_marker": [43, 64], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "191_384_4_250", "text": "In experiments reported here, we have used protein affinity chromatography and coimmunoprecipitation techniques to show that the putative N-terminal acidic transcriptional activation domain of BRCA2 interacts with replication protein A (RPA), a protein essential for DNA repair, replication and recombination", "text_with_entity_marker": "In experiments reported here, we have used protein affinity chromatography and coimmunoprecipitation techniques to show that the putative N-terminal acidic transcriptional activation domain of [E1]BRCA2[/E1] interacts with [E2]replication protein A (RPA)[/E2], a protein essential for DNA repair, replication and recombination", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "BRCA2", "entity_1_idx": [[193, 198]], "entity_1_idx_in_text_with_entity_marker": [197, 202], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "replication protein A (RPA)", "entity_2_idx": [[214, 241]], "entity_2_idx_in_text_with_entity_marker": [227, 254], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "274_549_1_370", "text": "A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP.", "text_with_entity_marker": "A L225A substitution in the human tumour suppressor [E1]HIC1[/E1] abolishes its interaction with the corepressor [E2]CtBP[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HIC1", "entity_1_idx": [[52, 56]], "entity_1_idx_in_text_with_entity_marker": [56, 60], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CtBP", "entity_2_idx": [[104, 108]], "entity_2_idx_in_text_with_entity_marker": [117, 121], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "274_550_6_371", "text": "Here, we show that HIC1 interacts with both CtBP1 and CtBP2 and that this interaction is stimulated by agents increasing NADH levels", "text_with_entity_marker": "Here, we show that [E1]HIC1[/E1] interacts with both [E2]CtBP1[/E2] and CtBP2 and that this interaction is stimulated by agents increasing NADH levels", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HIC1", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CtBP1", "entity_2_idx": [[44, 49]], "entity_2_idx_in_text_with_entity_marker": [57, 62], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "274_550_6_372", "text": "Here, we show that HIC1 interacts with both CtBP1 and CtBP2 and that this interaction is stimulated by agents increasing NADH levels", "text_with_entity_marker": "Here, we show that [E1]HIC1[/E1] interacts with both CtBP1 and [E2]CtBP2[/E2] and that this interaction is stimulated by agents increasing NADH levels", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "HIC1", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "CtBP2", "entity_2_idx": [[54, 59]], "entity_2_idx_in_text_with_entity_marker": [67, 72], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "315_631_1_426", "text": "FoxM1 promotes b-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis.", "text_with_entity_marker": "[E1]FoxM1[/E1] promotes [E2]b-catenin[/E2] nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FoxM1", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "b-catenin", "entity_2_idx": [[15, 24]], "entity_2_idx_in_text_with_entity_marker": [28, 37], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "315_632_2_427", "text": "Here, we report that FoxM1 is a downstream component of Wnt signaling and is critical for b-catenin transcriptional function in tumor cells", "text_with_entity_marker": "Here, we report that [E1]FoxM1[/E1] is a downstream component of Wnt signaling and is critical for [E2]b-catenin[/E2] transcriptional function in tumor cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FoxM1", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "gene", "entity_1_type_id": 0, "entity_2": "b-catenin", "entity_2_idx": [[90, 99]], "entity_2_idx_in_text_with_entity_marker": [103, 112], "entity_2_type": "gene", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d168.s1413_AIMed.d168.s1413.p1", "text": "The erythropoietin receptor (EPOR) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.", "text_with_entity_marker": "The [E1]erythropoietin[/E1] receptor ([E2]EPOR[/E2]) is a member of a family of cytokine and growth factor receptors that share conserved features in their extracellular and cytoplasmic domains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "erythropoietin", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EPOR", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d168.s1414_AIMed.d168.s1414.p0", "text": "We have used site-specific mutagenesis within the extracellular domain of the EPOR to search for amino acid residues involved in erythropoietin (EPO) binding.", "text_with_entity_marker": "We have used site-specific mutagenesis within the extracellular domain of the [E1]EPOR[/E1] to search for amino acid residues involved in [E2]erythropoietin[/E2] (EPO) binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "EPOR", "entity_1_idx": [[78, 82]], "entity_1_idx_in_text_with_entity_marker": [82, 86], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "erythropoietin", "entity_2_idx": [[129, 143]], "entity_2_idx_in_text_with_entity_marker": [142, 156], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d168.s1414_AIMed.d168.s1414.p1", "text": "We have used site-specific mutagenesis within the extracellular domain of the EPOR to search for amino acid residues involved in erythropoietin (EPO) binding.", "text_with_entity_marker": "We have used site-specific mutagenesis within the extracellular domain of the [E1]EPOR[/E1] to search for amino acid residues involved in erythropoietin ([E2]EPO[/E2]) binding.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "EPOR", "entity_1_idx": [[78, 82]], "entity_1_idx_in_text_with_entity_marker": [82, 86], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "EPO", "entity_2_idx": [[145, 148]], "entity_2_idx_in_text_with_entity_marker": [158, 161], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d107.s899_AIMed.d107.s899.p0", "text": "A direct interaction between G-protein beta gamma subunits and the Raf-1 protein kinase.", "text_with_entity_marker": "A direct interaction between [E1]G-protein beta gamma[/E1] subunits and the [E2]Raf-1 protein kinase[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "G-protein beta gamma", "entity_1_idx": [[29, 49]], "entity_1_idx_in_text_with_entity_marker": [33, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf-1 protein kinase", "entity_2_idx": [[67, 87]], "entity_2_idx_in_text_with_entity_marker": [80, 100], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d107.s904_AIMed.d107.s904.p9", "text": "In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of G beta gamma to Raf/330; however, the Raf-1-binding proteins, Ras and 14-3-3, had no effect.", "text_with_entity_marker": "In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of [E1]G beta gamma[/E1] to [E2]Raf/330[/E2]; however, the Raf-1-binding proteins, Ras and 14-3-3, had no effect.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "G beta gamma", "entity_1_idx": [[119, 131]], "entity_1_idx_in_text_with_entity_marker": [123, 135], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf/330", "entity_2_idx": [[135, 142]], "entity_2_idx_in_text_with_entity_marker": [148, 155], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d107.s904_AIMed.d107.s904.p14", "text": "In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of G beta gamma to Raf/330; however, the Raf-1-binding proteins, Ras and 14-3-3, had no effect.", "text_with_entity_marker": "In competition experiments, the carboxyl terminus of beta-adrenergic receptor kinase (beta ARK) blocked the binding of G beta gamma to Raf/330; however, the [E1]Raf-1[/E1]-binding proteins, [E2]Ras[/E2] and 14-3-3, had no effect.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Raf-1", "entity_1_idx": [[157, 162]], "entity_1_idx_in_text_with_entity_marker": [161, 166], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ras", "entity_2_idx": [[181, 184]], "entity_2_idx_in_text_with_entity_marker": [194, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d57.s504_AIMed.d57.s504.p2", "text": "A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (hsp90) has been used here to form complexes between the pp60src tyrosine kinase and hsp90.", "text_with_entity_marker": "A rabbit reticulocyte lysate system that has been used to reconstitute functional complexes between steroid receptors and the 90-kDa heat shock protein (hsp90) has been used here to form complexes between the [E1]pp60src[/E1] tyrosine kinase and [E2]hsp90[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "pp60src", "entity_1_idx": [[209, 216]], "entity_1_idx_in_text_with_entity_marker": [213, 220], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hsp90", "entity_2_idx": [[237, 242]], "entity_2_idx_in_text_with_entity_marker": [250, 255], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1094_AIMed.d128.s1094.p1", "text": "The hGH and hPRL receptors (hGHR and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.", "text_with_entity_marker": "The [E1]hGH[/E1] and hPRL receptors ([E2]hGHR[/E2] and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "hGH", "entity_1_idx": [[4, 7]], "entity_1_idx_in_text_with_entity_marker": [8, 11], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hGHR", "entity_2_idx": [[28, 32]], "entity_2_idx_in_text_with_entity_marker": [41, 45], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1094_AIMed.d128.s1094.p4", "text": "The hGH and hPRL receptors (hGHR and hPRLR, respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.", "text_with_entity_marker": "The hGH and [E1]hPRL[/E1] receptors (hGHR and [E2]hPRLR[/E2], respectively) are single-pass transmembrane receptors from class 1 of the haematopoietic receptor superfamily.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "hPRL", "entity_1_idx": [[12, 16]], "entity_1_idx_in_text_with_entity_marker": [16, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hPRLR", "entity_2_idx": [[37, 42]], "entity_2_idx_in_text_with_entity_marker": [50, 55], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1097_AIMed.d128.s1097.p15", "text": "In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.", "text_with_entity_marker": "In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but [E1]hGH[/E1] binds to both the [E2]hGHR[/E2] and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "hGH", "entity_1_idx": [[291, 294]], "entity_1_idx_in_text_with_entity_marker": [295, 298], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hGHR", "entity_2_idx": [[313, 317]], "entity_2_idx_in_text_with_entity_marker": [326, 330], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1097_AIMed.d128.s1097.p16", "text": "In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but hGH binds to both the hGHR and hPRLR, and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.", "text_with_entity_marker": "In the case of hGH, activation involves receptor homodimerization in a sequential process: the active ternary complex containing one ligand and two receptor molecules is formed by association of a receptor molecule to an intermediate 1:1 complex. hPRL does not bind to the hGH receptor, but [E1]hGH[/E1] binds to both the hGHR and [E2]hPRLR[/E2], and mutagenesis studies have shown that the receptor-binding sites on hGH overlap.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "hGH", "entity_1_idx": [[291, 294]], "entity_1_idx_in_text_with_entity_marker": [295, 298], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hPRLR", "entity_2_idx": [[322, 327]], "entity_2_idx_in_text_with_entity_marker": [335, 340], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1098_AIMed.d128.s1098.p0", "text": "We present here the crystal structure of the 1:1 complex of hGH bound to the extracellular domain of the hPRLR.", "text_with_entity_marker": "We present here the crystal structure of the 1:1 complex of [E1]hGH[/E1] bound to the extracellular domain of the [E2]hPRLR[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "hGH", "entity_1_idx": [[60, 63]], "entity_1_idx_in_text_with_entity_marker": [64, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hPRLR", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d128.s1099_AIMed.d128.s1099.p0", "text": "Comparisons with the hGH-hGHR complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.", "text_with_entity_marker": "Comparisons with the [E1]hGH[/E1]-[E2]hGHR[/E2] complex reveal how hGH can bind to the two distinctly different receptor binding surfaces.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "hGH", "entity_1_idx": [[21, 24]], "entity_1_idx_in_text_with_entity_marker": [25, 28], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hGHR", "entity_2_idx": [[25, 29]], "entity_2_idx_in_text_with_entity_marker": [38, 42], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d200.s1726_AIMed.d200.s1726.p0", "text": "A cDNA encoding part of the nucleolin protein sequence interacted with the E47 basic-helix-loop-helix only when fused to a beta-galactosidase tag.", "text_with_entity_marker": "A cDNA encoding part of the [E1]nucleolin[/E1] protein sequence interacted with the [E2]E47[/E2] basic-helix-loop-helix only when fused to a beta-galactosidase tag.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "nucleolin", "entity_1_idx": [[28, 37]], "entity_1_idx_in_text_with_entity_marker": [32, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "E47", "entity_2_idx": [[75, 78]], "entity_2_idx_in_text_with_entity_marker": [88, 91], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d115.s970_AIMed.d115.s970.p1", "text": "Interaction with RAP74 subunit of TFIIF is required for transcriptional activation by serum response factor.", "text_with_entity_marker": "Interaction with [E1]RAP74[/E1] subunit of TFIIF is required for transcriptional activation by [E2]serum response factor[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAP74", "entity_1_idx": [[17, 22]], "entity_1_idx_in_text_with_entity_marker": [21, 26], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "serum response factor", "entity_2_idx": [[86, 107]], "entity_2_idx_in_text_with_entity_marker": [99, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d115.s973_AIMed.d115.s973.p0", "text": "Using a yeast interaction assay, we find that SRF binds the RAP74 subunit of TFIIF and that SRF's transcriptional activation domain is the region involved in this binding.", "text_with_entity_marker": "Using a yeast interaction assay, we find that [E1]SRF[/E1] binds the [E2]RAP74[/E2] subunit of TFIIF and that SRF's transcriptional activation domain is the region involved in this binding.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SRF", "entity_1_idx": [[46, 49]], "entity_1_idx_in_text_with_entity_marker": [50, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RAP74", "entity_2_idx": [[60, 65]], "entity_2_idx_in_text_with_entity_marker": [73, 78], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d115.s976_AIMed.d115.s976.p0", "text": "The correlation of SRF-RAP74 binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.", "text_with_entity_marker": "The correlation of [E1]SRF[/E1]-[E2]RAP74[/E2] binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SRF", "entity_1_idx": [[19, 22]], "entity_1_idx_in_text_with_entity_marker": [23, 26], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "RAP74", "entity_2_idx": [[23, 28]], "entity_2_idx_in_text_with_entity_marker": [36, 41], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d115.s976_AIMed.d115.s976.p5", "text": "The correlation of SRF-RAP74 binding with transcriptional activation suggests that RAP74 is a critical target for SRF-activated transcription.", "text_with_entity_marker": "The correlation of SRF-RAP74 binding with transcriptional activation suggests that [E1]RAP74[/E1] is a critical target for [E2]SRF[/E2]-activated transcription.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAP74", "entity_1_idx": [[83, 88]], "entity_1_idx_in_text_with_entity_marker": [87, 92], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "SRF", "entity_2_idx": [[114, 117]], "entity_2_idx_in_text_with_entity_marker": [127, 130], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d68.s581_AIMed.d68.s581.p0", "text": "Association between cdc25A and cyclin B1/cdc2 was detected in the HeLa cells.", "text_with_entity_marker": "Association between [E1]cdc25A[/E1] and [E2]cyclin B1[/E2]/cdc2 was detected in the HeLa cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cdc25A", "entity_1_idx": [[20, 26]], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "cyclin B1", "entity_2_idx": [[31, 40]], "entity_2_idx_in_text_with_entity_marker": [44, 53], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d165.s1384_AIMed.d165.s1384.p3", "text": "Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein XPG, and Cockayne syndrome group B (CSB) protein.", "text_with_entity_marker": "Interactions involving the human RNA polymerase II transcription/nucleotide excision repair complex TFIIH, the nucleotide excision repair protein [E1]XPG[/E1], and Cockayne syndrome group B ([E2]CSB[/E2]) protein.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "XPG", "entity_1_idx": [[146, 149]], "entity_1_idx_in_text_with_entity_marker": [150, 153], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CSB", "entity_2_idx": [[182, 185]], "entity_2_idx_in_text_with_entity_marker": [195, 198], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1402_AIMed.d167.s1402.p0", "text": "The glut 1 glucose transporter interacts with calnexin and calreticulin.", "text_with_entity_marker": "The [E1]glut 1[/E1] glucose transporter interacts with [E2]calnexin[/E2] and calreticulin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "glut 1", "entity_1_idx": [[4, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calnexin", "entity_2_idx": [[46, 54]], "entity_2_idx_in_text_with_entity_marker": [59, 67], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1402_AIMed.d167.s1402.p1", "text": "The glut 1 glucose transporter interacts with calnexin and calreticulin.", "text_with_entity_marker": "The [E1]glut 1[/E1] glucose transporter interacts with calnexin and [E2]calreticulin[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "glut 1", "entity_1_idx": [[4, 10]], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[59, 71]], "entity_2_idx_in_text_with_entity_marker": [72, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1406_AIMed.d167.s1406.p0", "text": "Following immunoprecipitation with an anticalnexin antiserum, a cross-linker-independent association was observed between GT155 and calnexin.", "text_with_entity_marker": "Following immunoprecipitation with an anticalnexin antiserum, a cross-linker-independent association was observed between [E1]GT155[/E1] and [E2]calnexin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "GT155", "entity_1_idx": [[122, 127]], "entity_1_idx_in_text_with_entity_marker": [126, 131], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calnexin", "entity_2_idx": [[132, 140]], "entity_2_idx_in_text_with_entity_marker": [145, 153], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1407_AIMed.d167.s1407.p0", "text": "In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of GT155 and a protein of approximately 60 kDa designated CAP-60 (calnexin-associated protein of 60 kDa).", "text_with_entity_marker": "In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of [E1]GT155[/E1] and a protein of approximately 60 kDa designated [E2]CAP-60[/E2] (calnexin-associated protein of 60 kDa).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GT155", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CAP-60", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1407_AIMed.d167.s1407.p1", "text": "In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of GT155 and a protein of approximately 60 kDa designated CAP-60 (calnexin-associated protein of 60 kDa).", "text_with_entity_marker": "In addition, the anti-calnexin antiserum immunoprecipitated a UV-dependent cross-linking product consisting of [E1]GT155[/E1] and a protein of approximately 60 kDa designated CAP-60 ([E2]calnexin-associated protein[/E2] of 60 kDa).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GT155", "entity_1_idx": [[111, 116]], "entity_1_idx_in_text_with_entity_marker": [115, 120], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calnexin-associated protein", "entity_2_idx": [[174, 201]], "entity_2_idx_in_text_with_entity_marker": [187, 214], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1408_AIMed.d167.s1408.p0", "text": "Both the GT155-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.", "text_with_entity_marker": "Both the [E1]GT155[/E1]-[E2]calnexin[/E2] and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GT155", "entity_1_idx": [[9, 14]], "entity_1_idx_in_text_with_entity_marker": [13, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calnexin", "entity_2_idx": [[15, 23]], "entity_2_idx_in_text_with_entity_marker": [28, 36], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1408_AIMed.d167.s1408.p9", "text": "Both the GT155-calnexin and the GT155-CAP-60 interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.", "text_with_entity_marker": "Both the GT155-calnexin and the [E1]GT155[/E1]-[E2]CAP-60[/E2] interactions were dependent on the presence of a correctly modified oligosaccharide group on GT155, a characteristic of many calnexin interactions.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GT155", "entity_1_idx": [[32, 37]], "entity_1_idx_in_text_with_entity_marker": [36, 41], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CAP-60", "entity_2_idx": [[38, 44]], "entity_2_idx_in_text_with_entity_marker": [51, 57], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1410_AIMed.d167.s1410.p1", "text": "Calreticulin, the soluble homologue of calnexin, was also shown to interact with GT155 only when the protein bore a correctly modified oligosaccharide group.", "text_with_entity_marker": "[E1]Calreticulin[/E1], the soluble homologue of calnexin, was also shown to interact with [E2]GT155[/E2] only when the protein bore a correctly modified oligosaccharide group.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Calreticulin", "entity_1_idx": [[0, 12]], "entity_1_idx_in_text_with_entity_marker": [4, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "GT155", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1411_AIMed.d167.s1411.p1", "text": "Thus, our data show that both calnexin and calreticulin interact with Glut 1 in a glycosylation-dependent manner.", "text_with_entity_marker": "Thus, our data show that both [E1]calnexin[/E1] and calreticulin interact with [E2]Glut 1[/E2] in a glycosylation-dependent manner.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "calnexin", "entity_1_idx": [[30, 38]], "entity_1_idx_in_text_with_entity_marker": [34, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Glut 1", "entity_2_idx": [[70, 76]], "entity_2_idx_in_text_with_entity_marker": [83, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d167.s1411_AIMed.d167.s1411.p2", "text": "Thus, our data show that both calnexin and calreticulin interact with Glut 1 in a glycosylation-dependent manner.", "text_with_entity_marker": "Thus, our data show that both calnexin and [E1]calreticulin[/E1] interact with [E2]Glut 1[/E2] in a glycosylation-dependent manner.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "calreticulin", "entity_1_idx": [[43, 55]], "entity_1_idx_in_text_with_entity_marker": [47, 59], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Glut 1", "entity_2_idx": [[70, 76]], "entity_2_idx_in_text_with_entity_marker": [83, 89], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d186.s1582_AIMed.d186.s1582.p0", "text": "Only weak IL-13 binding activity was found in cells transfected with only IL-13Ralpha; however, the combination of both IL-13Ralpha and IL-4Ralpha resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the IL-13 receptor.", "text_with_entity_marker": "Only weak [E1]IL-13[/E1] binding activity was found in cells transfected with only [E2]IL-13Ralpha[/E2]; however, the combination of both IL-13Ralpha and IL-4Ralpha resulted in substantial binding activity, with a Kd of approximately 400 pM, indicating that both chains are essential components of the IL-13 receptor.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-13", "entity_1_idx": [[10, 15]], "entity_1_idx_in_text_with_entity_marker": [14, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-13Ralpha", "entity_2_idx": [[74, 85]], "entity_2_idx_in_text_with_entity_marker": [87, 98], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d186.s1583_AIMed.d186.s1583.p2", "text": "Whereas IL-13Ralpha serves as an alternative accessory protein to the common cytokine receptor gamma chain (gammac) for IL-4 signaling, it could not replace the function of gammac in allowing enhanced IL-2 binding activity.", "text_with_entity_marker": "Whereas [E1]IL-13Ralpha[/E1] serves as an alternative accessory protein to the common cytokine receptor gamma chain (gammac) for [E2]IL-4[/E2] signaling, it could not replace the function of gammac in allowing enhanced IL-2 binding activity.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-13Ralpha", "entity_1_idx": [[8, 19]], "entity_1_idx_in_text_with_entity_marker": [12, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IL-4", "entity_2_idx": [[120, 124]], "entity_2_idx_in_text_with_entity_marker": [133, 137], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d106.s893_AIMed.d106.s893.p0", "text": "Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation.", "text_with_entity_marker": "[E1]Raf1[/E1] interaction with [E2]Cdc25 phosphatase[/E2] ties mitogenic signal transduction to cell cycle activation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Raf1", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Cdc25 phosphatase", "entity_2_idx": [[22, 39]], "entity_2_idx_in_text_with_entity_marker": [35, 52], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d106.s896_AIMed.d106.s896.p0", "text": "We show here that Cdc25 phosphatase associates with raf1 in somatic mammalian cells and in meiotic frog oocytes.", "text_with_entity_marker": "We show here that [E1]Cdc25 phosphatase[/E1] associates with [E2]raf1[/E2] in somatic mammalian cells and in meiotic frog oocytes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cdc25 phosphatase", "entity_1_idx": [[18, 35]], "entity_1_idx_in_text_with_entity_marker": [22, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "raf1", "entity_2_idx": [[52, 56]], "entity_2_idx_in_text_with_entity_marker": [65, 69], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d106.s897_AIMed.d106.s897.p0", "text": "Furthermore, Cdc25 phosphatase can be activated in vitro in a Raf1-dependent manner.", "text_with_entity_marker": "Furthermore, [E1]Cdc25 phosphatase[/E1] can be activated in vitro in a [E2]Raf1[/E2]-dependent manner.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Cdc25 phosphatase", "entity_1_idx": [[13, 30]], "entity_1_idx_in_text_with_entity_marker": [17, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Raf1", "entity_2_idx": [[62, 66]], "entity_2_idx_in_text_with_entity_marker": [75, 79], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1879_AIMed.d217.s1879.p3", "text": "Characterization of Fas (Apo-1, CD95)-Fas ligand interaction.", "text_with_entity_marker": "Characterization of [E1]Fas[/E1] (Apo-1, CD95)-[E2]Fas ligand[/E2] interaction.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[20, 23]], "entity_1_idx_in_text_with_entity_marker": [24, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas ligand", "entity_2_idx": [[38, 48]], "entity_2_idx_in_text_with_entity_marker": [51, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1879_AIMed.d217.s1879.p6", "text": "Characterization of Fas (Apo-1, CD95)-Fas ligand interaction.", "text_with_entity_marker": "Characterization of Fas ([E1]Apo-1[/E1], CD95)-[E2]Fas ligand[/E2] interaction.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Apo-1", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas ligand", "entity_2_idx": [[38, 48]], "entity_2_idx_in_text_with_entity_marker": [51, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1879_AIMed.d217.s1879.p8", "text": "Characterization of Fas (Apo-1, CD95)-Fas ligand interaction.", "text_with_entity_marker": "Characterization of Fas (Apo-1, [E1]CD95[/E1])-[E2]Fas ligand[/E2] interaction.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "CD95", "entity_1_idx": [[32, 36]], "entity_1_idx_in_text_with_entity_marker": [36, 40], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas ligand", "entity_2_idx": [[38, 48]], "entity_2_idx_in_text_with_entity_marker": [51, 61], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1880_AIMed.d217.s1880.p1", "text": "The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein Fas ligand (FasL).", "text_with_entity_marker": "The death-inducing receptor [E1]Fas[/E1] is activated when cross-linked by the type II membrane protein [E2]Fas ligand[/E2] (FasL).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas ligand", "entity_2_idx": [[95, 105]], "entity_2_idx_in_text_with_entity_marker": [108, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1880_AIMed.d217.s1880.p2", "text": "The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein Fas ligand (FasL).", "text_with_entity_marker": "The death-inducing receptor [E1]Fas[/E1] is activated when cross-linked by the type II membrane protein Fas ligand ([E2]FasL[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[28, 31]], "entity_1_idx_in_text_with_entity_marker": [32, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FasL", "entity_2_idx": [[107, 111]], "entity_2_idx_in_text_with_entity_marker": [120, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1880_AIMed.d217.s1880.p4", "text": "The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein Fas ligand (FasL).", "text_with_entity_marker": "The death-inducing receptor Fas is activated when cross-linked by the type II membrane protein [E1]Fas[/E1] ligand ([E2]FasL[/E2]).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Fas", "entity_1_idx": [[95, 98]], "entity_1_idx_in_text_with_entity_marker": [99, 102], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "FasL", "entity_2_idx": [[107, 111]], "entity_2_idx_in_text_with_entity_marker": [120, 124], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1882_AIMed.d217.s1882.p0", "text": "Based on the structure of the closely related lymphotoxin alpha-tumor necrosis factor receptor I complex, a molecular model of the FasL homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.", "text_with_entity_marker": "Based on the structure of the closely related [E1]lymphotoxin alpha[/E1]-[E2]tumor necrosis factor receptor I[/E2] complex, a molecular model of the FasL homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "lymphotoxin alpha", "entity_1_idx": [[46, 63]], "entity_1_idx_in_text_with_entity_marker": [50, 67], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "tumor necrosis factor receptor I", "entity_2_idx": [[64, 96]], "entity_2_idx_in_text_with_entity_marker": [77, 109], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1882_AIMed.d217.s1882.p5", "text": "Based on the structure of the closely related lymphotoxin alpha-tumor necrosis factor receptor I complex, a molecular model of the FasL homotrimer bound to three Fas molecules was generated using knowledge-based protein modeling methods.", "text_with_entity_marker": "Based on the structure of the closely related lymphotoxin alpha-tumor necrosis factor receptor I complex, a molecular model of the [E1]FasL[/E1] homotrimer bound to three [E2]Fas[/E2] molecules was generated using knowledge-based protein modeling methods.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FasL", "entity_1_idx": [[131, 135]], "entity_1_idx_in_text_with_entity_marker": [135, 139], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[162, 165]], "entity_2_idx_in_text_with_entity_marker": [175, 178], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d217.s1886_AIMed.d217.s1886.p0", "text": "Although the cytotoxic activity of mutant Y218D was unaltered, mutant Y218R was inactive, correlating with the prediction that Tyr-218 of FasL interacts with a cluster of three basic amino acid side chains of Fas.", "text_with_entity_marker": "Although the cytotoxic activity of mutant Y218D was unaltered, mutant Y218R was inactive, correlating with the prediction that Tyr-218 of [E1]FasL[/E1] interacts with a cluster of three basic amino acid side chains of [E2]Fas[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "FasL", "entity_1_idx": [[138, 142]], "entity_1_idx_in_text_with_entity_marker": [142, 146], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Fas", "entity_2_idx": [[209, 212]], "entity_2_idx_in_text_with_entity_marker": [222, 225], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d83.s704_AIMed.d83.s704.p1", "text": "By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of ciliary neurotrophic factor (CNTF) with CNTFR alpha and not with the beta-components, gp130 and LIFR.", "text_with_entity_marker": "By rational mutagenesis, receptor-specific functional analysis, and visualization of complex formation in solution, we identified individual amino acid side chains involved specifically in the interaction of [E1]ciliary neurotrophic factor[/E1] (CNTF) with [E2]CNTFR alpha[/E2] and not with the beta-components, gp130 and LIFR.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ciliary neurotrophic factor", "entity_1_idx": [[208, 235]], "entity_1_idx_in_text_with_entity_marker": [212, 239], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CNTFR alpha", "entity_2_idx": [[248, 259]], "entity_2_idx_in_text_with_entity_marker": [261, 272], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d102.s859_AIMed.d102.s859.p2", "text": "The retinoblastoma-susceptibility gene product binds directly to the human TATA-binding protein-associated factor TAFII250.", "text_with_entity_marker": "The [E1]retinoblastoma[/E1]-susceptibility gene product binds directly to the human TATA-binding protein-associated factor [E2]TAFII250[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "retinoblastoma", "entity_1_idx": [[4, 18]], "entity_1_idx_in_text_with_entity_marker": [8, 22], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII250", "entity_2_idx": [[114, 122]], "entity_2_idx_in_text_with_entity_marker": [127, 135], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d102.s865_AIMed.d102.s865.p0", "text": "Furthermore, we demonstrate that RB binds directly to hTAFII250 in vitro and in vivo.", "text_with_entity_marker": "Furthermore, we demonstrate that [E1]RB[/E1] binds directly to [E2]hTAFII250[/E2] in vitro and in vivo.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RB", "entity_1_idx": [[33, 35]], "entity_1_idx_in_text_with_entity_marker": [37, 39], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "hTAFII250", "entity_2_idx": [[54, 63]], "entity_2_idx_in_text_with_entity_marker": [67, 76], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d102.s866_AIMed.d102.s866.p1", "text": "These results suggest that RB can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with TFIID, in particular with TAFII250.", "text_with_entity_marker": "These results suggest that [E1]RB[/E1] can confer transcriptional regulation and possibly cell cycle control and tumor suppression through an interaction with TFIID, in particular with [E2]TAFII250[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RB", "entity_1_idx": [[27, 29]], "entity_1_idx_in_text_with_entity_marker": [31, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TAFII250", "entity_2_idx": [[176, 184]], "entity_2_idx_in_text_with_entity_marker": [189, 197], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1209_AIMed.d143.s1209.p1", "text": "The results showed that IL-11 and IL-6 can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene (junB) expression in TF-1 cells.", "text_with_entity_marker": "The results showed that [E1]IL-11[/E1] and IL-6 can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene ([E2]junB[/E2]) expression in TF-1 cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-11", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "junB", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d143.s1209_AIMed.d143.s1209.p2", "text": "The results showed that IL-11 and IL-6 can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene (junB) expression in TF-1 cells.", "text_with_entity_marker": "The results showed that IL-11 and [E1]IL-6[/E1] can both stimulate cell proliferation, induce similar pattern of protein tyrosine phosphorylation, and activate the same proto-oncogene ([E2]junB[/E2]) expression in TF-1 cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "IL-6", "entity_1_idx": [[34, 38]], "entity_1_idx_in_text_with_entity_marker": [38, 42], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "junB", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s642_AIMed.d76.s642.p0", "text": "Coexpression of CD5 with p56lck in the baculovirus expression system resulted in the phosphorylation of CD5 on tyrosine residues.", "text_with_entity_marker": "Coexpression of [E1]CD5[/E1] with [E2]p56lck[/E2] in the baculovirus expression system resulted in the phosphorylation of CD5 on tyrosine residues.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD5", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p56lck", "entity_2_idx": [[25, 31]], "entity_2_idx_in_text_with_entity_marker": [38, 44], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s642_AIMed.d76.s642.p1", "text": "Coexpression of CD5 with p56lck in the baculovirus expression system resulted in the phosphorylation of CD5 on tyrosine residues.", "text_with_entity_marker": "Coexpression of [E1]CD5[/E1] with p56lck in the baculovirus expression system resulted in the phosphorylation of [E2]CD5[/E2] on tyrosine residues.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD5", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD5", "entity_2_idx": [[104, 107]], "entity_2_idx_in_text_with_entity_marker": [117, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s642_AIMed.d76.s642.p2", "text": "Coexpression of CD5 with p56lck in the baculovirus expression system resulted in the phosphorylation of CD5 on tyrosine residues.", "text_with_entity_marker": "Coexpression of CD5 with [E1]p56lck[/E1] in the baculovirus expression system resulted in the phosphorylation of [E2]CD5[/E2] on tyrosine residues.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p56lck", "entity_1_idx": [[25, 31]], "entity_1_idx_in_text_with_entity_marker": [29, 35], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD5", "entity_2_idx": [[104, 107]], "entity_2_idx_in_text_with_entity_marker": [117, 120], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s643_AIMed.d76.s643.p0", "text": "Further, anti-CD5 and anti-p56lck coprecipitated each other in a variety of detergents, including Nonidet P-40 and Triton X-100.", "text_with_entity_marker": "Further, anti-[E1]CD5[/E1] and anti-[E2]p56lck[/E2] coprecipitated each other in a variety of detergents, including Nonidet P-40 and Triton X-100.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD5", "entity_1_idx": [[14, 17]], "entity_1_idx_in_text_with_entity_marker": [18, 21], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p56lck", "entity_2_idx": [[27, 33]], "entity_2_idx_in_text_with_entity_marker": [40, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s644_AIMed.d76.s644.p0", "text": "Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.", "text_with_entity_marker": "Anti-[E1]CD5[/E1] also precipitated the kinase from various T cells irrespective of the expression of [E2]TcR zeta[/E2]/CD3 or CD4.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD5", "entity_1_idx": [[5, 8]], "entity_1_idx_in_text_with_entity_marker": [9, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TcR zeta", "entity_2_idx": [[93, 101]], "entity_2_idx_in_text_with_entity_marker": [106, 114], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s644_AIMed.d76.s644.p1", "text": "Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.", "text_with_entity_marker": "Anti-[E1]CD5[/E1] also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/[E2]CD3[/E2] or CD4.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD5", "entity_1_idx": [[5, 8]], "entity_1_idx_in_text_with_entity_marker": [9, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD3", "entity_2_idx": [[102, 105]], "entity_2_idx_in_text_with_entity_marker": [115, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s644_AIMed.d76.s644.p2", "text": "Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.", "text_with_entity_marker": "Anti-[E1]CD5[/E1] also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or [E2]CD4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD5", "entity_1_idx": [[5, 8]], "entity_1_idx_in_text_with_entity_marker": [9, 12], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD4", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s644_AIMed.d76.s644.p3", "text": "Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.", "text_with_entity_marker": "Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of [E1]TcR zeta[/E1]/[E2]CD3[/E2] or CD4.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TcR zeta", "entity_1_idx": [[93, 101]], "entity_1_idx_in_text_with_entity_marker": [97, 105], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD3", "entity_2_idx": [[102, 105]], "entity_2_idx_in_text_with_entity_marker": [115, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s644_AIMed.d76.s644.p4", "text": "Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.", "text_with_entity_marker": "Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of [E1]TcR zeta[/E1]/CD3 or [E2]CD4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TcR zeta", "entity_1_idx": [[93, 101]], "entity_1_idx_in_text_with_entity_marker": [97, 105], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD4", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s644_AIMed.d76.s644.p5", "text": "Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/CD3 or CD4.", "text_with_entity_marker": "Anti-CD5 also precipitated the kinase from various T cells irrespective of the expression of TcR zeta/[E1]CD3[/E1] or [E2]CD4[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD3", "entity_1_idx": [[102, 105]], "entity_1_idx_in_text_with_entity_marker": [106, 109], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD4", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d76.s645_AIMed.d76.s645.p0", "text": "No binding between p59fyn(T) and CD5 was detected in T cells.", "text_with_entity_marker": "No binding between [E1]p59fyn[/E1](T) and [E2]CD5[/E2] was detected in T cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p59fyn", "entity_1_idx": [[19, 25]], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD5", "entity_2_idx": [[33, 36]], "entity_2_idx_in_text_with_entity_marker": [46, 49], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d71.s607_AIMed.d71.s607.p0", "text": "The MAP kinase enzymes pp54 and pp42/44 are regulated by tyrosine as well as serine/threonine phosphorylation.", "text_with_entity_marker": "The [E1]MAP kinase[/E1] enzymes [E2]pp54[/E2] and pp42/44 are regulated by tyrosine as well as serine/threonine phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MAP kinase", "entity_1_idx": [[4, 14]], "entity_1_idx_in_text_with_entity_marker": [8, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pp54", "entity_2_idx": [[23, 27]], "entity_2_idx_in_text_with_entity_marker": [36, 40], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d71.s607_AIMed.d71.s607.p1", "text": "The MAP kinase enzymes pp54 and pp42/44 are regulated by tyrosine as well as serine/threonine phosphorylation.", "text_with_entity_marker": "The [E1]MAP kinase[/E1] enzymes pp54 and [E2]pp42[/E2]/44 are regulated by tyrosine as well as serine/threonine phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MAP kinase", "entity_1_idx": [[4, 14]], "entity_1_idx_in_text_with_entity_marker": [8, 18], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pp42", "entity_2_idx": [[32, 36]], "entity_2_idx_in_text_with_entity_marker": [45, 49], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d71.s607_AIMed.d71.s607.p2", "text": "The MAP kinase enzymes pp54 and pp42/44 are regulated by tyrosine as well as serine/threonine phosphorylation.", "text_with_entity_marker": "The MAP kinase enzymes [E1]pp54[/E1] and [E2]pp42[/E2]/44 are regulated by tyrosine as well as serine/threonine phosphorylation.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "pp54", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "pp42", "entity_2_idx": [[32, 36]], "entity_2_idx_in_text_with_entity_marker": [45, 49], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d71.s608_AIMed.d71.s608.p0", "text": "MAP kinase activation of c-jun may underlie the common stimulation of this transcription factor by mitogens, growth factors and oncogenes.", "text_with_entity_marker": "[E1]MAP kinase[/E1] activation of [E2]c-jun[/E2] may underlie the common stimulation of this transcription factor by mitogens, growth factors and oncogenes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MAP kinase", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-jun", "entity_2_idx": [[25, 30]], "entity_2_idx_in_text_with_entity_marker": [38, 43], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d89.s761_AIMed.d89.s761.p0", "text": "Immunoprecipitation experiments employing a polyclonal anti-calreticulin antibody provided further evidence that the 60-kDa protein isolated in this study was calreticulin.", "text_with_entity_marker": "Immunoprecipitation experiments employing a polyclonal anti-[E1]calreticulin[/E1] antibody provided further evidence that the 60-kDa protein isolated in this study was [E2]calreticulin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calreticulin", "entity_1_idx": [[60, 72]], "entity_1_idx_in_text_with_entity_marker": [64, 76], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "calreticulin", "entity_2_idx": [[159, 171]], "entity_2_idx_in_text_with_entity_marker": [172, 184], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d205.s1768_AIMed.d205.s1768.p0", "text": "Antibody-mediated cross-linking studies or studies on CD5 knockout mice implicate CD5 as a co-stimulatory or negative regulatory molecule.", "text_with_entity_marker": "Antibody-mediated cross-linking studies or studies on [E1]CD5[/E1] knockout mice implicate [E2]CD5[/E2] as a co-stimulatory or negative regulatory molecule.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD5", "entity_1_idx": [[54, 57]], "entity_1_idx_in_text_with_entity_marker": [58, 61], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD5", "entity_2_idx": [[82, 85]], "entity_2_idx_in_text_with_entity_marker": [95, 98], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d205.s1770_AIMed.d205.s1770.p0", "text": "Y429 and Y441 occur in an imperfect immunoreceptor tyrosine-based activation motif (ITAM)-like sequence.", "text_with_entity_marker": "Y429 and Y441 occur in an imperfect [E1]immunoreceptor tyrosine-based activation motif[/E1] ([E2]ITAM[/E2])-like sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "immunoreceptor tyrosine-based activation motif", "entity_1_idx": [[36, 82]], "entity_1_idx_in_text_with_entity_marker": [40, 86], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "ITAM", "entity_2_idx": [[84, 88]], "entity_2_idx_in_text_with_entity_marker": [97, 101], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d205.s1773_AIMed.d205.s1773.p0", "text": "Cellular p85 as well as the recombinant Src homology 2 (SH2) domains of p85 bound a tyrosine-phosphorylated peptide encompassing Y463 with approximately threefold greater affinity than a doubly tyrosine-phosphorylated Y429-Y441 peptide.", "text_with_entity_marker": "Cellular [E1]p85[/E1] as well as the recombinant Src homology 2 (SH2) domains of [E2]p85[/E2] bound a tyrosine-phosphorylated peptide encompassing Y463 with approximately threefold greater affinity than a doubly tyrosine-phosphorylated Y429-Y441 peptide.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p85", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p85", "entity_2_idx": [[72, 75]], "entity_2_idx_in_text_with_entity_marker": [85, 88], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d6.s50_AIMed.d6.s50.p0", "text": "Apoptotic proteins. p53 and c-myc related pathways.", "text_with_entity_marker": "Apoptotic proteins. [E1]p53[/E1] and [E2]c-myc[/E2] related pathways.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[20, 23]], "entity_1_idx_in_text_with_entity_marker": [24, 27], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "c-myc", "entity_2_idx": [[28, 33]], "entity_2_idx_in_text_with_entity_marker": [41, 46], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d6.s51_AIMed.d6.s51.p0", "text": "c-Myc and p53 are two proteins that have critical roles in the regulation of apoptosis and the cell cycle.", "text_with_entity_marker": "[E1]c-Myc[/E1] and [E2]p53[/E2] are two proteins that have critical roles in the regulation of apoptosis and the cell cycle.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "c-Myc", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[10, 13]], "entity_2_idx_in_text_with_entity_marker": [23, 26], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d66.s566_AIMed.d66.s566.p0", "text": "One was CDC2-HS, and the second was the human homolog of Xenopus CDK2.", "text_with_entity_marker": "One was [E1-E2]CDC2[/E1]-HS[/E2], and the second was the human homolog of Xenopus CDK2.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CDC2", "entity_1_idx": [[8, 12]], "entity_1_idx_in_text_with_entity_marker": [15, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CDC2[/E1]-HS", "entity_2_idx": [[8, 15]], "entity_2_idx_in_text_with_entity_marker": [15, 27], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d66.s566_AIMed.d66.s566.p1", "text": "One was CDC2-HS, and the second was the human homolog of Xenopus CDK2.", "text_with_entity_marker": "One was [E1]CDC2[/E1]-HS, and the second was the human homolog of Xenopus [E2]CDK2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CDC2", "entity_1_idx": [[8, 12]], "entity_1_idx_in_text_with_entity_marker": [12, 16], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[65, 69]], "entity_2_idx_in_text_with_entity_marker": [78, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d66.s566_AIMed.d66.s566.p2", "text": "One was CDC2-HS, and the second was the human homolog of Xenopus CDK2.", "text_with_entity_marker": "One was [E1]CDC2-HS[/E1], and the second was the human homolog of Xenopus [E2]CDK2[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CDC2-HS", "entity_1_idx": [[8, 15]], "entity_1_idx_in_text_with_entity_marker": [12, 19], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CDK2", "entity_2_idx": [[65, 69]], "entity_2_idx_in_text_with_entity_marker": [78, 82], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d221.s1922_AIMed.d221.s1922.p0", "text": "Coexpression of the alpha and betaL subunits of the human interferon alpha (IFNalpha) receptor is required for the induction of an antiviral state by human IFNalpha.", "text_with_entity_marker": "Coexpression of the alpha and betaL subunits of the human [E1]interferon alpha[/E1] ([E2]IFNalpha[/E2]) receptor is required for the induction of an antiviral state by human IFNalpha.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon alpha", "entity_1_idx": [[58, 74]], "entity_1_idx_in_text_with_entity_marker": [62, 78], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFNalpha", "entity_2_idx": [[76, 84]], "entity_2_idx_in_text_with_entity_marker": [89, 97], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d221.s1922_AIMed.d221.s1922.p1", "text": "Coexpression of the alpha and betaL subunits of the human interferon alpha (IFNalpha) receptor is required for the induction of an antiviral state by human IFNalpha.", "text_with_entity_marker": "Coexpression of the alpha and betaL subunits of the human [E1-E2]interferon alpha[/E1] (IFNalpha) receptor[/E2] is required for the induction of an antiviral state by human IFNalpha.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon alpha", "entity_1_idx": [[58, 74]], "entity_1_idx_in_text_with_entity_marker": [65, 81], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "interferon alpha[/E1] (IFNalpha) receptor", "entity_2_idx": [[58, 94]], "entity_2_idx_in_text_with_entity_marker": [65, 106], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d221.s1922_AIMed.d221.s1922.p2", "text": "Coexpression of the alpha and betaL subunits of the human interferon alpha (IFNalpha) receptor is required for the induction of an antiviral state by human IFNalpha.", "text_with_entity_marker": "Coexpression of the alpha and betaL subunits of the human [E1]interferon alpha[/E1] (IFNalpha) receptor is required for the induction of an antiviral state by human [E2]IFNalpha[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon alpha", "entity_1_idx": [[58, 74]], "entity_1_idx_in_text_with_entity_marker": [62, 78], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFNalpha", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d221.s1922_AIMed.d221.s1922.p3", "text": "Coexpression of the alpha and betaL subunits of the human interferon alpha (IFNalpha) receptor is required for the induction of an antiviral state by human IFNalpha.", "text_with_entity_marker": "Coexpression of the alpha and betaL subunits of the human [E1]interferon alpha (IFNalpha) receptor[/E1][E2]IFNalpha[/E2]) receptor is required for the induction of an antiviral state by human IFNalpha.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon alpha (IFNalpha) receptor", "entity_1_idx": [[58, 94]], "entity_1_idx_in_text_with_entity_marker": [62, 98], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFNalpha", "entity_2_idx": [[76, 84]], "entity_2_idx_in_text_with_entity_marker": [107, 115], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d221.s1922_AIMed.d221.s1922.p4", "text": "Coexpression of the alpha and betaL subunits of the human interferon alpha (IFNalpha) receptor is required for the induction of an antiviral state by human IFNalpha.", "text_with_entity_marker": "Coexpression of the alpha and betaL subunits of the human interferon alpha ([E1]IFNalpha[/E1]) receptor is required for the induction of an antiviral state by human [E2]IFNalpha[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "IFNalpha", "entity_1_idx": [[76, 84]], "entity_1_idx_in_text_with_entity_marker": [80, 88], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFNalpha", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d221.s1922_AIMed.d221.s1922.p5", "text": "Coexpression of the alpha and betaL subunits of the human interferon alpha (IFNalpha) receptor is required for the induction of an antiviral state by human IFNalpha.", "text_with_entity_marker": "Coexpression of the alpha and betaL subunits of the human [E1]interferon alpha (IFNalpha) receptor[/E1] is required for the induction of an antiviral state by human [E2]IFNalpha[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "interferon alpha (IFNalpha) receptor", "entity_1_idx": [[58, 94]], "entity_1_idx_in_text_with_entity_marker": [62, 98], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "IFNalpha", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d221.s1925_AIMed.d221.s1925.p0", "text": "This region of the betaL chain, required for Jak1 binding and activation, contains the Box 1 motif that is important for the interaction of some cytokine receptors with Jak kinases.", "text_with_entity_marker": "This region of the betaL chain, required for [E1]Jak1[/E1] binding and activation, contains the Box 1 motif that is important for the interaction of some cytokine receptors with [E2]Jak[/E2] kinases.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Jak1", "entity_1_idx": [[45, 49]], "entity_1_idx_in_text_with_entity_marker": [49, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Jak", "entity_2_idx": [[169, 172]], "entity_2_idx_in_text_with_entity_marker": [182, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d139.s1177_AIMed.d139.s1177.p0", "text": "Following linkage studies which were most consistent with a beta spectrin gene mutation, a nucleotide change was identified in codon 2018, resulting in an Ala-->Gly substitution in the first helical domain of beta spectrin repeat 17.", "text_with_entity_marker": "Following linkage studies which were most consistent with a [E1]beta spectrin[/E1] gene mutation, a nucleotide change was identified in codon 2018, resulting in an Ala-->Gly substitution in the first helical domain of [E2]beta spectrin[/E2] repeat 17.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta spectrin", "entity_1_idx": [[60, 73]], "entity_1_idx_in_text_with_entity_marker": [64, 77], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "beta spectrin", "entity_2_idx": [[209, 222]], "entity_2_idx_in_text_with_entity_marker": [222, 235], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d176.s1485_AIMed.d176.s1485.p0", "text": "One of these proteins, p60, appears transiently during assembly and is not a component of functionally mature PR complexes.", "text_with_entity_marker": "One of these proteins, [E1]p60[/E1], appears transiently during assembly and is not a component of functionally mature [E2]PR[/E2] complexes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p60", "entity_1_idx": [[23, 26]], "entity_1_idx_in_text_with_entity_marker": [27, 30], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PR", "entity_2_idx": [[110, 112]], "entity_2_idx_in_text_with_entity_marker": [123, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d53.s472_AIMed.d53.s472.p0", "text": "The cross-reactivity of gp130 is apparently due to a chemical plasticity evident in the amphipathic gp130 cytokine-binding sites.", "text_with_entity_marker": "The cross-reactivity of [E1]gp130[/E1] is apparently due to a chemical plasticity evident in the amphipathic [E2]gp130[/E2] cytokine-binding sites.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "gp130", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "gp130", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d121.s1031_AIMed.d121.s1031.p0", "text": "These mutations have no impact on the ability of the p53 protein to bind to a p53-specific DNA element.", "text_with_entity_marker": "These mutations have no impact on the ability of the [E1]p53[/E1] protein to bind to a [E2]p53[/E2]-specific DNA element.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[53, 56]], "entity_1_idx_in_text_with_entity_marker": [57, 60], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p53", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d56.s495_AIMed.d56.s495.p0", "text": "A cDNA clone, designated TRAP (TNF-related activation protein) was isolated from a collection of T cell activation genes.", "text_with_entity_marker": "A cDNA clone, designated [E1]TRAP[/E1] ([E2]TNF-related activation protein[/E2]) was isolated from a collection of T cell activation genes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAP", "entity_1_idx": [[25, 29]], "entity_1_idx_in_text_with_entity_marker": [29, 33], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "TNF-related activation protein", "entity_2_idx": [[31, 61]], "entity_2_idx_in_text_with_entity_marker": [44, 74], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d56.s499_AIMed.d56.s499.p0", "text": "TRAP is highly similar to an identified murine CD40 ligand both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/lymphotoxin.", "text_with_entity_marker": "[E1]TRAP[/E1] is highly similar to an identified murine [E2]CD40 ligand[/E2] both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/lymphotoxin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAP", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "CD40 ligand", "entity_2_idx": [[47, 58]], "entity_2_idx_in_text_with_entity_marker": [60, 71], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d56.s499_AIMed.d56.s499.p1", "text": "TRAP is highly similar to an identified murine CD40 ligand both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/lymphotoxin.", "text_with_entity_marker": "[E1]TRAP[/E1] is highly similar to an identified murine CD40 ligand both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/[E2]lymphotoxin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAP", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "lymphotoxin", "entity_2_idx": [[171, 182]], "entity_2_idx_in_text_with_entity_marker": [184, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d56.s499_AIMed.d56.s499.p2", "text": "TRAP is highly similar to an identified murine CD40 ligand both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/lymphotoxin.", "text_with_entity_marker": "TRAP is highly similar to an identified murine [E1]CD40 ligand[/E1] both at the cDNA (82.8% identity) and the protein (77.4% identity) levels, and related to tumor necrosis factor/[E2]lymphotoxin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD40 ligand", "entity_1_idx": [[47, 58]], "entity_1_idx_in_text_with_entity_marker": [51, 62], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "lymphotoxin", "entity_2_idx": [[171, 182]], "entity_2_idx_in_text_with_entity_marker": [184, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s12_AIMed.d1.s12.p0", "text": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "text_with_entity_marker": "This study describes the distributions of [E1]bone morphogenetic protein (BMP)-2[/E1] as well as mRNAs for [E2]BMP receptor type IB[/E2] (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "bone morphogenetic protein (BMP)-2", "entity_1_idx": [[42, 76]], "entity_1_idx_in_text_with_entity_marker": [46, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMP receptor type IB", "entity_2_idx": [[98, 118]], "entity_2_idx_in_text_with_entity_marker": [111, 131], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s12_AIMed.d1.s12.p1", "text": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "text_with_entity_marker": "This study describes the distributions of [E1]bone morphogenetic protein (BMP)-2[/E1] as well as mRNAs for BMP receptor type IB ([E2]BMPRIB[/E2]). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "bone morphogenetic protein (BMP)-2", "entity_1_idx": [[42, 76]], "entity_1_idx_in_text_with_entity_marker": [46, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMPRIB", "entity_2_idx": [[120, 126]], "entity_2_idx_in_text_with_entity_marker": [133, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s12_AIMed.d1.s12.p2", "text": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "text_with_entity_marker": "This study describes the distributions of [E1]bone morphogenetic protein (BMP)-2[/E1] as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II ([E2]Col II[/E2]) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "bone morphogenetic protein (BMP)-2", "entity_1_idx": [[42, 76]], "entity_1_idx_in_text_with_entity_marker": [46, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Col II", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s12_AIMed.d1.s12.p3", "text": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "text_with_entity_marker": "This study describes the distributions of [E1]bone morphogenetic protein (BMP)-2[/E1] as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III ([E2]Col III[/E2]) in a growing \"cartilage cap\" of osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "bone morphogenetic protein (BMP)-2", "entity_1_idx": [[42, 76]], "entity_1_idx_in_text_with_entity_marker": [46, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Col III", "entity_2_idx": [[165, 172]], "entity_2_idx_in_text_with_entity_marker": [178, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s12_AIMed.d1.s12.p4", "text": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "text_with_entity_marker": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for [E1]BMP receptor type IB[/E1] ([E2]BMPRIB[/E2]). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMP receptor type IB", "entity_1_idx": [[98, 118]], "entity_1_idx_in_text_with_entity_marker": [102, 122], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMPRIB", "entity_2_idx": [[120, 126]], "entity_2_idx_in_text_with_entity_marker": [133, 139], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s12_AIMed.d1.s12.p5", "text": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "text_with_entity_marker": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for [E1]BMP receptor type IB[/E1] (BMPRIB). collagen types II ([E2]Col II[/E2]) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMP receptor type IB", "entity_1_idx": [[98, 118]], "entity_1_idx_in_text_with_entity_marker": [102, 122], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Col II", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s12_AIMed.d1.s12.p6", "text": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "text_with_entity_marker": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for [E1]BMP receptor type IB[/E1] (BMPRIB). collagen types II (Col II) and III ([E2]Col III[/E2]) in a growing \"cartilage cap\" of osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMP receptor type IB", "entity_1_idx": [[98, 118]], "entity_1_idx_in_text_with_entity_marker": [102, 122], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Col III", "entity_2_idx": [[165, 172]], "entity_2_idx_in_text_with_entity_marker": [178, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s12_AIMed.d1.s12.p7", "text": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "text_with_entity_marker": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB ([E1]BMPRIB[/E1]). collagen types II ([E2]Col II[/E2]) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMPRIB", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Col II", "entity_2_idx": [[148, 154]], "entity_2_idx_in_text_with_entity_marker": [161, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s12_AIMed.d1.s12.p8", "text": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "text_with_entity_marker": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB ([E1]BMPRIB[/E1]). collagen types II (Col II) and III ([E2]Col III[/E2]) in a growing \"cartilage cap\" of osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMPRIB", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Col III", "entity_2_idx": [[165, 172]], "entity_2_idx_in_text_with_entity_marker": [178, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s12_AIMed.d1.s12.p9", "text": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II (Col II) and III (Col III) in a growing \"cartilage cap\" of osteochondroma.", "text_with_entity_marker": "This study describes the distributions of bone morphogenetic protein (BMP)-2 as well as mRNAs for BMP receptor type IB (BMPRIB). collagen types II ([E1]Col II[/E1]) and III ([E2]Col III[/E2]) in a growing \"cartilage cap\" of osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Col II", "entity_1_idx": [[148, 154]], "entity_1_idx_in_text_with_entity_marker": [152, 158], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Col III", "entity_2_idx": [[165, 172]], "entity_2_idx_in_text_with_entity_marker": [178, 185], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s14_AIMed.d1.s14.p0", "text": "BMP-2 was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix, positive for Col III and Col II, respectively.", "text_with_entity_marker": "[E1]BMP-2[/E1] was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix, positive for [E2]Col III[/E2] and Col II, respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMP-2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Col III", "entity_2_idx": [[132, 139]], "entity_2_idx_in_text_with_entity_marker": [145, 152], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s14_AIMed.d1.s14.p1", "text": "BMP-2 was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix, positive for Col III and Col II, respectively.", "text_with_entity_marker": "[E1]BMP-2[/E1] was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix, positive for Col III and [E2]Col II[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMP-2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Col II", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s14_AIMed.d1.s14.p2", "text": "BMP-2 was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix, positive for Col III and Col II, respectively.", "text_with_entity_marker": "BMP-2 was detected in mesenchymal cells in the outer fibrous layer and chondrocytes in the inner cartilaginous matrix, positive for [E1]Col III[/E1] and [E2]Col II[/E2], respectively.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Col III", "entity_1_idx": [[132, 139]], "entity_1_idx_in_text_with_entity_marker": [136, 143], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Col II", "entity_2_idx": [[144, 150]], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d1.s16_AIMed.d1.s16.p0", "text": "This is the first study to provide observational evidence of the involvement of BMP-2 signaling in the pathogenesis of cartilage cap of osteochondroma. and suggests the role of BMP-2 in the growth of cartilage cap in osteochondroma.", "text_with_entity_marker": "This is the first study to provide observational evidence of the involvement of [E1]BMP-2[/E1] signaling in the pathogenesis of cartilage cap of osteochondroma. and suggests the role of [E2]BMP-2[/E2] in the growth of cartilage cap in osteochondroma.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BMP-2", "entity_1_idx": [[80, 85]], "entity_1_idx_in_text_with_entity_marker": [84, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "BMP-2", "entity_2_idx": [[177, 182]], "entity_2_idx_in_text_with_entity_marker": [190, 195], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d70.s595_AIMed.d70.s595.p0", "text": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "text_with_entity_marker": "Computer-aided analysis of secondary structure, performed on four [E1]RII[/E1]-anchoring protein sequences (the [E2]microtubule-associated protein 2[/E2], P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RII", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "microtubule-associated protein 2", "entity_2_idx": [[103, 135]], "entity_2_idx_in_text_with_entity_marker": [116, 148], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d70.s595_AIMed.d70.s595.p1", "text": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "text_with_entity_marker": "Computer-aided analysis of secondary structure, performed on four [E1]RII[/E1]-anchoring protein sequences (the microtubule-associated protein 2, [E2]P150[/E2], and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RII", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "P150", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d70.s595_AIMed.d70.s595.p2", "text": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "text_with_entity_marker": "Computer-aided analysis of secondary structure, performed on four [E1]RII[/E1]-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins [E2]Ht 21[/E2] and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RII", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ht 21", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d70.s595_AIMed.d70.s595.p3", "text": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "text_with_entity_marker": "Computer-aided analysis of secondary structure, performed on four [E1]RII[/E1]-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and [E2]Ht 31[/E2]), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RII", "entity_1_idx": [[66, 69]], "entity_1_idx_in_text_with_entity_marker": [70, 73], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ht 31", "entity_2_idx": [[178, 183]], "entity_2_idx_in_text_with_entity_marker": [191, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d70.s595_AIMed.d70.s595.p4", "text": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "text_with_entity_marker": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the [E1]microtubule-associated protein 2[/E1], [E2]P150[/E2], and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "microtubule-associated protein 2", "entity_1_idx": [[103, 135]], "entity_1_idx_in_text_with_entity_marker": [107, 139], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "P150", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d70.s595_AIMed.d70.s595.p5", "text": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "text_with_entity_marker": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the [E1]microtubule-associated protein 2[/E1], P150, and two thyroid proteins [E2]Ht 21[/E2] and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "microtubule-associated protein 2", "entity_1_idx": [[103, 135]], "entity_1_idx_in_text_with_entity_marker": [107, 139], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ht 21", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d70.s595_AIMed.d70.s595.p6", "text": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "text_with_entity_marker": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the [E1]microtubule-associated protein 2[/E1], P150, and two thyroid proteins Ht 21 and [E2]Ht 31[/E2]), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "microtubule-associated protein 2", "entity_1_idx": [[103, 135]], "entity_1_idx_in_text_with_entity_marker": [107, 139], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ht 31", "entity_2_idx": [[178, 183]], "entity_2_idx_in_text_with_entity_marker": [191, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d70.s595_AIMed.d70.s595.p7", "text": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "text_with_entity_marker": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, [E1]P150[/E1], and two thyroid proteins [E2]Ht 21[/E2] and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P150", "entity_1_idx": [[137, 141]], "entity_1_idx_in_text_with_entity_marker": [141, 145], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ht 21", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d70.s595_AIMed.d70.s595.p8", "text": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "text_with_entity_marker": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, [E1]P150[/E1], and two thyroid proteins Ht 21 and [E2]Ht 31[/E2]), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P150", "entity_1_idx": [[137, 141]], "entity_1_idx_in_text_with_entity_marker": [141, 145], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ht 31", "entity_2_idx": [[178, 183]], "entity_2_idx_in_text_with_entity_marker": [191, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d70.s595_AIMed.d70.s595.p9", "text": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins Ht 21 and Ht 31), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "text_with_entity_marker": "Computer-aided analysis of secondary structure, performed on four RII-anchoring protein sequences (the microtubule-associated protein 2, P150, and two thyroid proteins [E1]Ht 21[/E1] and [E2]Ht 31[/E2]), has identified common regions of approximately 14 residues which display high probabilities of forming amphipathic helices.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Ht 21", "entity_1_idx": [[168, 173]], "entity_1_idx_in_text_with_entity_marker": [172, 177], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Ht 31", "entity_2_idx": [[178, 183]], "entity_2_idx_in_text_with_entity_marker": [191, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1069_AIMed.d125.s1069.p0", "text": "In contrast to LexA/Bcl-2 fusion proteins, expression of a LexA/Bax protein was lethal to yeast.", "text_with_entity_marker": "In contrast to LexA/[E1]Bcl-2[/E1] fusion proteins, expression of a LexA/[E2]Bax[/E2] protein was lethal to yeast.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bax", "entity_2_idx": [[64, 67]], "entity_2_idx_in_text_with_entity_marker": [77, 80], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1070_AIMed.d125.s1070.p0", "text": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "text_with_entity_marker": "This cytotoxicity could be abrogated by B42 fusion proteins containing [E1]Bcl-2[/E1], [E2]Bcl-X-L[/E2], or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X-L", "entity_2_idx": [[78, 85]], "entity_2_idx_in_text_with_entity_marker": [91, 98], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1070_AIMed.d125.s1070.p1", "text": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "text_with_entity_marker": "This cytotoxicity could be abrogated by B42 fusion proteins containing [E1]Bcl-2[/E1], Bcl-X-L, or [E2]Mcl-1[/E2] but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Mcl-1", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1070_AIMed.d125.s1070.p2", "text": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "text_with_entity_marker": "This cytotoxicity could be abrogated by B42 fusion proteins containing [E1]Bcl-2[/E1], Bcl-X-L, or Mcl-1 but not those containing [E2]Bcl-X-S[/E2] (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X-S", "entity_2_idx": [[121, 128]], "entity_2_idx_in_text_with_entity_marker": [134, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1070_AIMed.d125.s1070.p3", "text": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "text_with_entity_marker": "This cytotoxicity could be abrogated by B42 fusion proteins containing [E1]Bcl-2[/E1], Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of [E2]Bcl-X[/E2] that lacks a well-conserved 63-amino acid region).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-2", "entity_1_idx": [[71, 76]], "entity_1_idx_in_text_with_entity_marker": [75, 80], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1070_AIMed.d125.s1070.p4", "text": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "text_with_entity_marker": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, [E1]Bcl-X-L[/E1], or [E2]Mcl-1[/E2] but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-X-L", "entity_1_idx": [[78, 85]], "entity_1_idx_in_text_with_entity_marker": [82, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Mcl-1", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1070_AIMed.d125.s1070.p5", "text": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "text_with_entity_marker": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, [E1]Bcl-X-L[/E1], or Mcl-1 but not those containing [E2]Bcl-X-S[/E2] (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-X-L", "entity_1_idx": [[78, 85]], "entity_1_idx_in_text_with_entity_marker": [82, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X-S", "entity_2_idx": [[121, 128]], "entity_2_idx_in_text_with_entity_marker": [134, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1070_AIMed.d125.s1070.p6", "text": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "text_with_entity_marker": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, [E1]Bcl-X-L[/E1], or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of [E2]Bcl-X[/E2] that lacks a well-conserved 63-amino acid region).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-X-L", "entity_1_idx": [[78, 85]], "entity_1_idx_in_text_with_entity_marker": [82, 89], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1070_AIMed.d125.s1070.p7", "text": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "text_with_entity_marker": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or [E1]Mcl-1[/E1] but not those containing [E2]Bcl-X-S[/E2] (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Mcl-1", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X-S", "entity_2_idx": [[121, 128]], "entity_2_idx_in_text_with_entity_marker": [134, 141], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1070_AIMed.d125.s1070.p8", "text": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "text_with_entity_marker": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or [E1]Mcl-1[/E1] but not those containing Bcl-X-S (an alternatively spliced form of [E2]Bcl-X[/E2] that lacks a well-conserved 63-amino acid region).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Mcl-1", "entity_1_idx": [[90, 95]], "entity_1_idx_in_text_with_entity_marker": [94, 99], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d125.s1070_AIMed.d125.s1070.p9", "text": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing Bcl-X-S (an alternatively spliced form of Bcl-X that lacks a well-conserved 63-amino acid region).", "text_with_entity_marker": "This cytotoxicity could be abrogated by B42 fusion proteins containing Bcl-2, Bcl-X-L, or Mcl-1 but not those containing [E1]Bcl-X-S[/E1] (an alternatively spliced form of [E2]Bcl-X[/E2] that lacks a well-conserved 63-amino acid region).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Bcl-X-S", "entity_1_idx": [[121, 128]], "entity_1_idx_in_text_with_entity_marker": [125, 132], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Bcl-X", "entity_2_idx": [[163, 168]], "entity_2_idx_in_text_with_entity_marker": [176, 181], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d212.s1836_AIMed.d212.s1836.p0", "text": "The gene mutated in the autosomal recessive disorder ataxia telangiectasia (AT), designated ATM (for 'AT mutated'), is a member of a family of phosphatidylinositol-3-kinase-like enzymes that are involved in cell-cycle control, meiotic recombination, telomere length monitoring and DNA-damage response.", "text_with_entity_marker": "The gene mutated in the autosomal recessive disorder ataxia telangiectasia (AT), designated [E1]ATM[/E1] (for '[E2]AT mutated[/E2]'), is a member of a family of phosphatidylinositol-3-kinase-like enzymes that are involved in cell-cycle control, meiotic recombination, telomere length monitoring and DNA-damage response.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "ATM", "entity_1_idx": [[92, 95]], "entity_1_idx_in_text_with_entity_marker": [96, 99], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "AT mutated", "entity_2_idx": [[102, 112]], "entity_2_idx_in_text_with_entity_marker": [115, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s998_AIMed.d118.s998.p0", "text": "Levels of p21 protein are increased in senescent cells and p21 overexpression blocks the growth of tumour cells.", "text_with_entity_marker": "Levels of [E1]p21[/E1] protein are increased in senescent cells and [E2]p21[/E2] overexpression blocks the growth of tumour cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[10, 13]], "entity_1_idx_in_text_with_entity_marker": [14, 17], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[59, 62]], "entity_2_idx_in_text_with_entity_marker": [72, 75], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s1000_AIMed.d118.s1000.p0", "text": "p21 controls CDK activity, thereby affecting cell-cycle control, whereas PCNA functions in both DNA replication and repair.", "text_with_entity_marker": "[E1]p21[/E1] controls CDK activity, thereby affecting cell-cycle control, whereas [E2]PCNA[/E2] functions in both DNA replication and repair.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[73, 77]], "entity_2_idx_in_text_with_entity_marker": [86, 90], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s1004_AIMed.d118.s1004.p0", "text": "Thus, during p53-mediated suppression of cell proliferation, p21 and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.", "text_with_entity_marker": "Thus, during [E1]p53[/E1]-mediated suppression of cell proliferation, [E2]p21[/E2] and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[61, 64]], "entity_2_idx_in_text_with_entity_marker": [74, 77], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s1004_AIMed.d118.s1004.p1", "text": "Thus, during p53-mediated suppression of cell proliferation, p21 and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.", "text_with_entity_marker": "Thus, during [E1]p53[/E1]-mediated suppression of cell proliferation, p21 and [E2]PCNA[/E2] may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[13, 16]], "entity_1_idx_in_text_with_entity_marker": [17, 20], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d118.s1004_AIMed.d118.s1004.p2", "text": "Thus, during p53-mediated suppression of cell proliferation, p21 and PCNA may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.", "text_with_entity_marker": "Thus, during p53-mediated suppression of cell proliferation, [E1]p21[/E1] and [E2]PCNA[/E2] may be important for coordinating cell-cycle progression, DNA replication and repair of damaged DNA.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p21", "entity_1_idx": [[61, 64]], "entity_1_idx_in_text_with_entity_marker": [65, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "PCNA", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1456_AIMed.d173.s1456.p0", "text": "The kinetics of amyloid fibril formation by beta-amyloid peptide (Abeta) are typical of a nucleation-dependent polymerization mechanism.", "text_with_entity_marker": "The kinetics of amyloid fibril formation by [E1]beta-amyloid peptide[/E1] ([E2]Abeta[/E2]) are typical of a nucleation-dependent polymerization mechanism.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-amyloid peptide", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Abeta", "entity_2_idx": [[66, 71]], "entity_2_idx_in_text_with_entity_marker": [79, 84], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1459_AIMed.d173.s1459.p0", "text": "Fusion proteins were created by linking the Abeta fragment to a LexA DNA-binding domain (bait) and also to a B42 transactivation domain (prey).", "text_with_entity_marker": "Fusion proteins were created by linking the [E1]Abeta[/E1] fragment to a [E2]LexA[/E2] DNA-binding domain (bait) and also to a B42 transactivation domain (prey).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Abeta", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LexA", "entity_2_idx": [[64, 68]], "entity_2_idx_in_text_with_entity_marker": [77, 81], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1459_AIMed.d173.s1459.p1", "text": "Fusion proteins were created by linking the Abeta fragment to a LexA DNA-binding domain (bait) and also to a B42 transactivation domain (prey).", "text_with_entity_marker": "Fusion proteins were created by linking the [E1]Abeta[/E1] fragment to a LexA DNA-binding domain (bait) and also to a [E2]B42[/E2] transactivation domain (prey).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Abeta", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "B42", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1459_AIMed.d173.s1459.p2", "text": "Fusion proteins were created by linking the Abeta fragment to a LexA DNA-binding domain (bait) and also to a B42 transactivation domain (prey).", "text_with_entity_marker": "Fusion proteins were created by linking the Abeta fragment to a [E1]LexA[/E1] DNA-binding domain (bait) and also to a [E2]B42[/E2] transactivation domain (prey).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "LexA", "entity_1_idx": [[64, 68]], "entity_1_idx_in_text_with_entity_marker": [68, 72], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "B42", "entity_2_idx": [[109, 112]], "entity_2_idx_in_text_with_entity_marker": [122, 125], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1460_AIMed.d173.s1460.p0", "text": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators.", "text_with_entity_marker": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring [E1]lacZ[/E1] ([E2]beta-galactosidase[/E2]) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "lacZ", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "beta-galactosidase", "entity_2_idx": [[126, 144]], "entity_2_idx_in_text_with_entity_marker": [139, 157], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1460_AIMed.d173.s1460.p1", "text": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators.", "text_with_entity_marker": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring [E1]lacZ[/E1] (beta-galactosidase) and [E2]LEU2[/E2] (leucine utilization) genes under the control of LexA-dependent operators.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "lacZ", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LEU2", "entity_2_idx": [[150, 154]], "entity_2_idx_in_text_with_entity_marker": [163, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1460_AIMed.d173.s1460.p2", "text": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators.", "text_with_entity_marker": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring [E1]lacZ[/E1] (beta-galactosidase) and LEU2 ([E2]leucine utilization[/E2]) genes under the control of LexA-dependent operators.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "lacZ", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "leucine utilization", "entity_2_idx": [[156, 175]], "entity_2_idx_in_text_with_entity_marker": [169, 188], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1460_AIMed.d173.s1460.p3", "text": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators.", "text_with_entity_marker": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ ([E1]beta-galactosidase[/E1]) and [E2]LEU2[/E2] (leucine utilization) genes under the control of LexA-dependent operators.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-galactosidase", "entity_1_idx": [[126, 144]], "entity_1_idx_in_text_with_entity_marker": [130, 148], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "LEU2", "entity_2_idx": [[150, 154]], "entity_2_idx_in_text_with_entity_marker": [163, 167], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1460_AIMed.d173.s1460.p4", "text": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators.", "text_with_entity_marker": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ ([E1]beta-galactosidase[/E1]) and LEU2 ([E2]leucine utilization[/E2]) genes under the control of LexA-dependent operators.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-galactosidase", "entity_1_idx": [[126, 144]], "entity_1_idx_in_text_with_entity_marker": [130, 148], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "leucine utilization", "entity_2_idx": [[156, 175]], "entity_2_idx_in_text_with_entity_marker": [169, 188], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1460_AIMed.d173.s1460.p5", "text": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and LEU2 (leucine utilization) genes under the control of LexA-dependent operators.", "text_with_entity_marker": "Protein-protein interactions were measured by expression of these fusion proteins in Saccharomyces cerevisiae harboring lacZ (beta-galactosidase) and [E1]LEU2[/E1] ([E2]leucine utilization[/E2]) genes under the control of LexA-dependent operators.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "LEU2", "entity_1_idx": [[150, 154]], "entity_1_idx_in_text_with_entity_marker": [154, 158], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "leucine utilization", "entity_2_idx": [[156, 175]], "entity_2_idx_in_text_with_entity_marker": [169, 188], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1463_AIMed.d173.s1463.p0", "text": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "text_with_entity_marker": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing [E1]LexA[/E1]-[E2]Abeta[/E2] bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "LexA", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Abeta", "entity_2_idx": [[115, 120]], "entity_2_idx_in_text_with_entity_marker": [128, 133], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1463_AIMed.d173.s1463.p1", "text": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "text_with_entity_marker": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing [E1]LexA[/E1]-Abeta bait when the [E2]B42[/E2] transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "LexA", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "B42", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1463_AIMed.d173.s1463.p2", "text": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "text_with_entity_marker": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing [E1]LexA[/E1]-Abeta bait when the B42 transactivation domain was fused to an [E2]Abeta[/E2] fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "LexA", "entity_1_idx": [[110, 114]], "entity_1_idx_in_text_with_entity_marker": [114, 118], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Abeta", "entity_2_idx": [[178, 183]], "entity_2_idx_in_text_with_entity_marker": [191, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1463_AIMed.d173.s1463.p3", "text": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "text_with_entity_marker": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-[E1]Abeta[/E1] bait when the [E2]B42[/E2] transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Abeta", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "B42", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1463_AIMed.d173.s1463.p4", "text": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "text_with_entity_marker": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-[E1]Abeta[/E1] bait when the B42 transactivation domain was fused to an [E2]Abeta[/E2] fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Abeta", "entity_1_idx": [[115, 120]], "entity_1_idx_in_text_with_entity_marker": [119, 124], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Abeta", "entity_2_idx": [[178, 183]], "entity_2_idx_in_text_with_entity_marker": [191, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "AIMed.d173.s1463_AIMed.d173.s1463.p5", "text": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the B42 transactivation domain was fused to an Abeta fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "text_with_entity_marker": "Specificity was further shown by the finding that no significant interaction was observed in yeast expressing LexA-Abeta bait when the [E1]B42[/E1] transactivation domain was fused to an [E2]Abeta[/E2] fragment with Phe-Phe at residues 19 and 20 replaced by Thr-Thr (AbetaTT), a finding that is consistent with in vitro observations made by others.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "B42", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "protein", "entity_1_type_id": 0, "entity_2": "Abeta", "entity_2_idx": [[178, 183]], "entity_2_idx_in_text_with_entity_marker": [191, 196], "entity_2_type": "protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d357.s0_BioInfer.d357.s0.p0", "text": "Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "text_with_entity_marker": "[E1]Integrin[/E1] (beta) chains, for example, interact with [E2]actin-binding proteins[/E2] (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Integrin", "entity_1_idx": [[0, 8], [10, 14], [16, 22]], "entity_1_idx_in_text_with_entity_marker": [4, 12], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[51, 73]], "entity_2_idx_in_text_with_entity_marker": [64, 86], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d357.s0_BioInfer.d357.s0.p3", "text": "Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "text_with_entity_marker": "Integrin (beta) chains, for example, interact with [E1]actin-binding proteins[/E1] (e.g. [E2]talin[/E2] and filamin), which form mechanical links to the cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[51, 73]], "entity_1_idx_in_text_with_entity_marker": [55, 77], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[80, 85]], "entity_2_idx_in_text_with_entity_marker": [93, 98], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d357.s0_BioInfer.d357.s0.p4", "text": "Integrin (beta) chains, for example, interact with actin-binding proteins (e.g. talin and filamin), which form mechanical links to the cytoskeleton.", "text_with_entity_marker": "Integrin (beta) chains, for example, interact with [E1]actin-binding proteins[/E1] (e.g. talin and [E2]filamin[/E2]), which form mechanical links to the cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[51, 73]], "entity_1_idx_in_text_with_entity_marker": [55, 77], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "filamin", "entity_2_idx": [[90, 97]], "entity_2_idx_in_text_with_entity_marker": [103, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p2", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "Profilin II binds [E1]actin[/E1] with a similar affinity to that of [E2]profilin I[/E2], although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[59, 69]], "entity_2_idx_in_text_with_entity_marker": [72, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p5", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "[E1]Profilin II[/E1] binds [E2]actin[/E2] with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Profilin II", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[18, 23]], "entity_2_idx_in_text_with_entity_marker": [31, 36], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p6", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "[E1]Profilin II[/E1] binds actin with a similar affinity to that of profilin I, although it inhibits [E2]actin[/E2] polymerization more strongly than profilin I under non-equilibrium conditions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Profilin II", "entity_1_idx": [[0, 11]], "entity_1_idx_in_text_with_entity_marker": [4, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[92, 97]], "entity_2_idx_in_text_with_entity_marker": [105, 110], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s0_BioInfer.d496.s0.p8", "text": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits actin polymerization more strongly than profilin I under non-equilibrium conditions.", "text_with_entity_marker": "Profilin II binds actin with a similar affinity to that of profilin I, although it inhibits [E1]actin[/E1] polymerization more strongly than [E2]profilin I[/E2] under non-equilibrium conditions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[92, 97]], "entity_1_idx_in_text_with_entity_marker": [96, 101], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin I", "entity_2_idx": [[132, 142]], "entity_2_idx_in_text_with_entity_marker": [145, 155], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d496.s1_BioInfer.d496.s1.p0", "text": "Since functional characteristics for profilin II are lacking, we assayed the actin, the phosphatidylinositol 4,5-bisphosphate and the poly(L-proline) binding properties of this isoform.", "text_with_entity_marker": "Since functional characteristics for [E1]profilin II[/E1] are lacking, we assayed the [E2]actin[/E2], the phosphatidylinositol 4,5-bisphosphate and the poly(L-proline) binding properties of this isoform.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin II", "entity_1_idx": [[37, 48]], "entity_1_idx_in_text_with_entity_marker": [41, 52], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d403.s0_BioInfer.d403.s0.p0", "text": "Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "text_with_entity_marker": "Like TESK1, [E1]TESK2[/E1] phosphorylated cofilin specifically at Ser-3 and induced formation of [E2]actin[/E2] stress fibers and focal adhesions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "TESK2", "entity_1_idx": [[12, 17]], "entity_1_idx_in_text_with_entity_marker": [16, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[88, 93]], "entity_2_idx_in_text_with_entity_marker": [101, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d403.s0_BioInfer.d403.s0.p2", "text": "Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "text_with_entity_marker": "Like [E1]TESK1[/E1], TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of [E2]actin[/E2] stress fibers and focal adhesions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "TESK1", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[88, 93]], "entity_2_idx_in_text_with_entity_marker": [101, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d403.s0_BioInfer.d403.s0.p3", "text": "Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "text_with_entity_marker": "Like TESK1, [E1]TESK2[/E1] phosphorylated [E2]cofilin[/E2] specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "TESK2", "entity_1_idx": [[12, 17]], "entity_1_idx_in_text_with_entity_marker": [16, 21], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[33, 40]], "entity_2_idx_in_text_with_entity_marker": [46, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d403.s0_BioInfer.d403.s0.p5", "text": "Like TESK1, TESK2 phosphorylated cofilin specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "text_with_entity_marker": "Like [E1]TESK1[/E1], TESK2 phosphorylated [E2]cofilin[/E2] specifically at Ser-3 and induced formation of actin stress fibers and focal adhesions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "TESK1", "entity_1_idx": [[5, 10]], "entity_1_idx_in_text_with_entity_marker": [9, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cofilin", "entity_2_idx": [[33, 40]], "entity_2_idx_in_text_with_entity_marker": [46, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d608.s0_BioInfer.d608.s0.p2", "text": "The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.", "text_with_entity_marker": "The [E1]E-cadherin[/E1]-associated proteins [E2]alpha-catenin[/E2] and beta-catenin were not significantly affected by treatment with TPA.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[4, 14]], "entity_1_idx_in_text_with_entity_marker": [8, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[35, 48]], "entity_2_idx_in_text_with_entity_marker": [48, 61], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d608.s0_BioInfer.d608.s0.p4", "text": "The E-cadherin-associated proteins alpha-catenin and beta-catenin were not significantly affected by treatment with TPA.", "text_with_entity_marker": "The [E1]E-cadherin[/E1]-associated proteins alpha-catenin and [E2]beta-catenin[/E2] were not significantly affected by treatment with TPA.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[4, 14]], "entity_1_idx_in_text_with_entity_marker": [8, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[53, 65]], "entity_2_idx_in_text_with_entity_marker": [66, 78], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d477.s0_BioInfer.d477.s0.p0", "text": "Overexpression of cofilin stimulates bundling of actin filaments, membrane ruffling, and cell movement in Dictyostelium.", "text_with_entity_marker": "Overexpression of [E1]cofilin[/E1] stimulates bundling of [E2]actin[/E2] filaments, membrane ruffling, and cell movement in Dictyostelium.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[18, 25]], "entity_1_idx_in_text_with_entity_marker": [22, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[49, 54]], "entity_2_idx_in_text_with_entity_marker": [62, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s0_BioInfer.d226.s0.p0", "text": "Further, we show that talin, a high molecular weight structural protein that links integrins to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "text_with_entity_marker": "Further, we show that talin, a high molecular weight structural protein that links [E1]integrins[/E1] to the [E2]actin[/E2] cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "integrins", "entity_1_idx": [[83, 92]], "entity_1_idx_in_text_with_entity_marker": [87, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s0_BioInfer.d226.s0.p1", "text": "Further, we show that talin, a high molecular weight structural protein that links integrins to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "text_with_entity_marker": "Further, we show that [E1]talin[/E1], a high molecular weight structural protein that links [E2]integrins[/E2] to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "integrins", "entity_2_idx": [[83, 92]], "entity_2_idx_in_text_with_entity_marker": [96, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s0_BioInfer.d226.s0.p2", "text": "Further, we show that talin, a high molecular weight structural protein that links integrins to the actin cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "text_with_entity_marker": "Further, we show that [E1]talin[/E1], a high molecular weight structural protein that links integrins to the [E2]actin[/E2] cytoskeleton, is proteolytically cleaved in fetal, but not in neonatal melanocytes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p0", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and [E1]vinculin[/E1] at the ends of [E2]actin[/E2] stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[107, 115]], "entity_1_idx_in_text_with_entity_marker": [111, 119], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p2", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of [E1]paxillin[/E1], talin, and vinculin at the ends of [E2]actin[/E2] stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "paxillin", "entity_1_idx": [[86, 94]], "entity_1_idx_in_text_with_entity_marker": [90, 98], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d226.s1_BioInfer.d226.s1.p3", "text": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, talin, and vinculin at the ends of actin stress fibers at presumptive focal contacts in melanocytes.", "text_with_entity_marker": "Immunofluorescence microscopy of cells grown on fibronectin confirmed the presence of paxillin, [E1]talin[/E1], and vinculin at the ends of [E2]actin[/E2] stress fibers at presumptive focal contacts in melanocytes.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[96, 101]], "entity_1_idx_in_text_with_entity_marker": [100, 105], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[131, 136]], "entity_2_idx_in_text_with_entity_marker": [144, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p4", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the [E1]Arp2[/E1]/3 complex, leading to rapid [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp2", "entity_1_idx": [[162, 166]], "entity_1_idx_in_text_with_entity_marker": [166, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p6", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the [E1-E2]Arp[/E1]2[/E2]/3 complex, leading to rapid actin polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[162, 165], [167, 168]], "entity_1_idx_in_text_with_entity_marker": [169, 172], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[162, 166]], "entity_2_idx_in_text_with_entity_marker": [169, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d704.s0_BioInfer.d704.s0.p8", "text": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the Arp2/3 complex, leading to rapid actin polymerization.", "text_with_entity_marker": "These proteins each have a verprolin-homology (V) domain, cofilin-homology (C) domain and an acidic (A) region at the C-terminus, through which they activate the [E1]Arp[/E1]2/3 complex, leading to rapid [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[162, 165], [167, 168]], "entity_1_idx_in_text_with_entity_marker": [166, 169], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d596.s0_BioInfer.d596.s0.p0", "text": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The comparison of [E1]E-CD[/E1] proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-CD", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[217, 228]], "entity_2_idx_in_text_with_entity_marker": [230, 241], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d596.s0_BioInfer.d596.s0.p2", "text": "The comparison of E-CD proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with alpha-catenin, beta-catenin, and plakoglobin.", "text_with_entity_marker": "The comparison of [E1]E-CD[/E1] proteins synthesized by E62 and E24 cell lines revealed no structural or functional differences because both localized at cell-cell contacts and associated with [E2]alpha-catenin[/E2], beta-catenin, and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-CD", "entity_1_idx": [[18, 22]], "entity_1_idx_in_text_with_entity_marker": [22, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[184, 197]], "entity_2_idx_in_text_with_entity_marker": [197, 210], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d493.s0_BioInfer.d493.s0.p0", "text": "Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of actin polymerization.", "text_with_entity_marker": "Previous studies have yielded conflicting results concerning the physiological role of [E1]profilin[/E1], a 12-15-kD [E2]actin[/E2]- and phosphoinositide-binding protein, as a regulator of actin polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[87, 95]], "entity_1_idx_in_text_with_entity_marker": [91, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[108, 113]], "entity_2_idx_in_text_with_entity_marker": [121, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d493.s0_BioInfer.d493.s0.p1", "text": "Previous studies have yielded conflicting results concerning the physiological role of profilin, a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of actin polymerization.", "text_with_entity_marker": "Previous studies have yielded conflicting results concerning the physiological role of [E1]profilin[/E1], a 12-15-kD actin- and phosphoinositide-binding protein, as a regulator of [E2]actin[/E2] polymerization.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[87, 95]], "entity_1_idx_in_text_with_entity_marker": [91, 99], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[171, 176]], "entity_2_idx_in_text_with_entity_marker": [184, 189], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p92", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, [E1]histones[/E1] H2A, H2B, H3, and [E2]H4[/E2], are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[60, 62]], "entity_2_idx_in_text_with_entity_marker": [73, 75], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p95", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, [E1]histones[/E1] [E2]H2A[/E2], H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2A", "entity_2_idx": [[42, 45]], "entity_2_idx_in_text_with_entity_marker": [55, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p96", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, [E1]histones[/E1] H2A, H2B, [E2]H3[/E2], and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[52, 54]], "entity_2_idx_in_text_with_entity_marker": [65, 67], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d599.s0_BioInfer.d599.s0.p97", "text": "The core histones from Physarum, histones H2A, H2B, H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "text_with_entity_marker": "The core histones from Physarum, [E1]histones[/E1] H2A, [E2]H2B[/E2], H3, and H4, are rapidly acetylated; histone H4 shows five subfractions, analogous to the five subfractions of mammalian histone H4 (containing zero to four acetyllysine residues per molecule); histone H3 has a more complex pattern that we interpret as zero to four acetyllysine residues on each of two sequence variants of histone H3; histones H2A and H2B show less heterogeneity.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histones", "entity_1_idx": [[33, 41]], "entity_1_idx_in_text_with_entity_marker": [37, 45], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H2B", "entity_2_idx": [[47, 50]], "entity_2_idx_in_text_with_entity_marker": [60, 63], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d786.s0_BioInfer.d786.s0.p0", "text": "Using a complementary sequence or antipeptide to selectively neutralize the stretch of residues 633-642 of skeletal myosin heavy chain, we recently demonstrated that this segment is an actin binding site operating in the absence as in the presence of nucleotide and that this stretch 633-642 is not part of the nucleotide binding site [Chaussepied & Morales (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 7471-7475].", "text_with_entity_marker": "Using a complementary sequence or antipeptide to selectively neutralize the stretch of residues 633-642 of [E1]skeletal myosin heavy chain[/E1], we recently demonstrated that this segment is an [E2]actin[/E2] binding site operating in the absence as in the presence of nucleotide and that this stretch 633-642 is not part of the nucleotide binding site [Chaussepied & Morales (1988) Proc. Natl. Acad. Sci. U.S.A. 85, 7471-7475].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "skeletal myosin heavy chain", "entity_1_idx": [[107, 134]], "entity_1_idx_in_text_with_entity_marker": [111, 138], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[185, 190]], "entity_2_idx_in_text_with_entity_marker": [198, 203], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p1", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with [E1]talin[/E1], another [E2]actin[/E2] and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[233, 238]], "entity_1_idx_in_text_with_entity_marker": [237, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[248, 253]], "entity_2_idx_in_text_with_entity_marker": [261, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p6", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that [E1]vinculin[/E1] has a negligible influence on internal actin filament dynamics and [E2]actin[/E2] bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[157, 162]], "entity_2_idx_in_text_with_entity_marker": [170, 175], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p8", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that [E1]vinculin[/E1] has a negligible influence on internal [E2]actin[/E2] filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "vinculin", "entity_1_idx": [[81, 89]], "entity_1_idx_in_text_with_entity_marker": [85, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[129, 134]], "entity_2_idx_in_text_with_entity_marker": [142, 147], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d54.s0_BioInfer.d54.s0.p10", "text": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with talin, another actin and vinculin-binding protein from focal adhesions.", "text_with_entity_marker": "Analyses of dynamic light scattering data by stretched exponential fit show that vinculin has a negligible influence on internal actin filament dynamics and actin bending stiffness which contrasts with our previous observations with [E1]talin[/E1], another actin and [E2]vinculin[/E2]-binding protein from focal adhesions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[233, 238]], "entity_1_idx_in_text_with_entity_marker": [237, 242], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[258, 266]], "entity_2_idx_in_text_with_entity_marker": [271, 279], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p0", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of [E1]alpha-catenin[/E1] binds beta-catenin and plakoglobin, and can form a structural complex with [E2]E-cadherin[/E2] via these interactions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[87, 100]], "entity_1_idx_in_text_with_entity_marker": [91, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[176, 186]], "entity_2_idx_in_text_with_entity_marker": [189, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p1", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of [E1]alpha-catenin[/E1] binds [E2]beta-catenin[/E2] and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[87, 100]], "entity_1_idx_in_text_with_entity_marker": [91, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[107, 119]], "entity_2_idx_in_text_with_entity_marker": [120, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p2", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of [E1]alpha-catenin[/E1] binds beta-catenin and [E2]plakoglobin[/E2], and can form a structural complex with E-cadherin via these interactions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[87, 100]], "entity_1_idx_in_text_with_entity_marker": [91, 104], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[124, 135]], "entity_2_idx_in_text_with_entity_marker": [137, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p3", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds [E1]beta-catenin[/E1] and plakoglobin, and can form a structural complex with [E2]E-cadherin[/E2] via these interactions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[107, 119]], "entity_1_idx_in_text_with_entity_marker": [111, 123], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[176, 186]], "entity_2_idx_in_text_with_entity_marker": [189, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d155.s0_BioInfer.d155.s0.p4", "text": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and plakoglobin, and can form a structural complex with E-cadherin via these interactions.", "text_with_entity_marker": "Co-precipitation experiments using whole cell lysates indicate that the mutant form of alpha-catenin binds beta-catenin and [E1]plakoglobin[/E1], and can form a structural complex with [E2]E-cadherin[/E2] via these interactions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[124, 135]], "entity_1_idx_in_text_with_entity_marker": [128, 139], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[176, 186]], "entity_2_idx_in_text_with_entity_marker": [189, 199], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d127.s0_BioInfer.d127.s0.p1", "text": "Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.", "text_with_entity_marker": "Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and [E1]talin[/E1], two known substrates of [E2]calpain[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[94, 99]], "entity_1_idx_in_text_with_entity_marker": [98, 103], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calpain", "entity_2_idx": [[125, 132]], "entity_2_idx_in_text_with_entity_marker": [138, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d127.s0_BioInfer.d127.s0.p3", "text": "Calpain activity in vivo was determined by observing proteolysis of actin-binding protein and talin, two known substrates of calpain.", "text_with_entity_marker": "Calpain activity in vivo was determined by observing proteolysis of [E1]actin-binding protein[/E1] and talin, two known substrates of [E2]calpain[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[68, 89]], "entity_1_idx_in_text_with_entity_marker": [72, 93], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calpain", "entity_2_idx": [[125, 132]], "entity_2_idx_in_text_with_entity_marker": [138, 145], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d584.s0_BioInfer.d584.s0.p1", "text": "The myosin heavy chain (MHC) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.", "text_with_entity_marker": "The [E1]myosin heavy chain[/E1] (MHC) contains the [E2]actin[/E2]- and ATP-binding sites and represents the molecular motor of muscle contraction.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin heavy chain", "entity_1_idx": [[4, 22]], "entity_1_idx_in_text_with_entity_marker": [8, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d584.s0_BioInfer.d584.s0.p2", "text": "The myosin heavy chain (MHC) contains the actin- and ATP-binding sites and represents the molecular motor of muscle contraction.", "text_with_entity_marker": "The myosin heavy chain ([E1]MHC[/E1]) contains the [E2]actin[/E2]- and ATP-binding sites and represents the molecular motor of muscle contraction.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "MHC", "entity_1_idx": [[24, 27]], "entity_1_idx_in_text_with_entity_marker": [28, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[42, 47]], "entity_2_idx_in_text_with_entity_marker": [55, 60], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d384.s0_BioInfer.d384.s0.p3", "text": "In three of the cell lines with CTNNB1 mutations, complexes of beta-catenin with alpha-catenin and APC were detectable.", "text_with_entity_marker": "In three of the cell lines with CTNNB1 mutations, complexes of [E1]beta-catenin[/E1] with [E2]alpha-catenin[/E2] and APC were detectable.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[63, 75]], "entity_1_idx_in_text_with_entity_marker": [67, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[81, 94]], "entity_2_idx_in_text_with_entity_marker": [94, 107], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d510.s0_BioInfer.d510.s0.p0", "text": "Recruitment of a myosin heavy chain kinase to actin-rich protrusions in Dictyostelium.", "text_with_entity_marker": "Recruitment of a [E1]myosin heavy chain kinase[/E1] to [E2]actin[/E2]-rich protrusions in Dictyostelium.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "myosin heavy chain kinase", "entity_1_idx": [[17, 42]], "entity_1_idx_in_text_with_entity_marker": [21, 46], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[46, 51]], "entity_2_idx_in_text_with_entity_marker": [59, 64], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d458.s0_BioInfer.d458.s0.p0", "text": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the cyclin-dependent kinase inhibitor p21, and E2F was released.", "text_with_entity_marker": "p130 and pRb were phosphorylated before the infected myotubes entered S phase, despite the high expression of the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p21[/E2], and E2F was released.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[114, 147]], "entity_1_idx_in_text_with_entity_marker": [118, 151], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p21", "entity_2_idx": [[148, 151]], "entity_2_idx_in_text_with_entity_marker": [161, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p18", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "[E1]PF4[/E1]-dependent downregulation of cyclin E-[E2]cdk2[/E2] activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PF4", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[41, 45]], "entity_2_idx_in_text_with_entity_marker": [54, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p19", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-[E2]cdk2[/E2] activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[41, 45]], "entity_2_idx_in_text_with_entity_marker": [54, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p20", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-[E1]cdk2[/E1] activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E2]p21[/E2](Cip1/WAF1), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cdk2", "entity_1_idx": [[41, 45]], "entity_1_idx_in_text_with_entity_marker": [45, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[135, 138]], "entity_2_idx_in_text_with_entity_marker": [148, 151], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p21", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/[E1]WAF1[/E1]), to the [E2]cyclin E[/E2]-cdk2 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "WAF1", "entity_1_idx": [[144, 148]], "entity_1_idx_in_text_with_entity_marker": [148, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p22", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the [E1]cyclin E[/E1]-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[158, 166]], "entity_1_idx_in_text_with_entity_marker": [162, 170], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p24", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the [E2]cyclin E[/E2]-cdk2 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p25", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, [E1]p21[/E1](Cip1/WAF1), to the [E2]cyclin E[/E2]-cdk2 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cyclin E", "entity_2_idx": [[158, 166]], "entity_2_idx_in_text_with_entity_marker": [171, 179], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p26", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/[E1]WAF1[/E1]), to the cyclin E-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "WAF1", "entity_1_idx": [[144, 148]], "entity_1_idx_in_text_with_entity_marker": [148, 152], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p28", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/[E2]WAF1[/E2]), to the cyclin E-cdk2 complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "WAF1", "entity_2_idx": [[144, 148]], "entity_2_idx_in_text_with_entity_marker": [157, 161], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d485.s0_BioInfer.d485.s0.p31", "text": "PF4-dependent downregulation of cyclin E-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-cdk2 complex.", "text_with_entity_marker": "PF4-dependent downregulation of [E1]cyclin E[/E1]-cdk2 activity was associated with increased binding of the cyclin-dependent kinase inhibitor, p21(Cip1/WAF1), to the cyclin E-[E2]cdk2[/E2] complex.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin E", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cdk2", "entity_2_idx": [[167, 171]], "entity_2_idx_in_text_with_entity_marker": [180, 184], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d641.s0_BioInfer.d641.s0.p0", "text": "The majority of the aromatic residues in profilin are exposed to solvent and lie in either of two hydrophobic patches, neither of which takes part in an interface with actin.", "text_with_entity_marker": "The majority of the aromatic residues in [E1]profilin[/E1] are exposed to solvent and lie in either of two hydrophobic patches, neither of which takes part in an interface with [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[41, 49]], "entity_1_idx_in_text_with_entity_marker": [45, 53], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p3", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for [E1]RAD51[/E1] protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme [E2]MluI[/E2]; the presence of MluI restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "MluI", "entity_2_idx": [[263, 267]], "entity_2_idx_in_text_with_entity_marker": [276, 280], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p7", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of [E1]RAD54[/E1], an upstream activating sequence required for damage regulation of the [E2]RAD54[/E2] transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD54", "entity_1_idx": [[118, 123]], "entity_1_idx_in_text_with_entity_marker": [122, 127], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[195, 200]], "entity_2_idx_in_text_with_entity_marker": [208, 213], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d531.s0_BioInfer.d531.s0.p8", "text": "Sequences upstream of the coding region for RAD51 protein share homology with the damage response sequence element of RAD54, an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "text_with_entity_marker": "Sequences upstream of the coding region for [E1]RAD51[/E1] protein share homology with the damage response sequence element of [E2]RAD54[/E2], an upstream activating sequence required for damage regulation of the RAD54 transcript, and also contain two sites for restriction enzyme MluI; the presence of MluI restriction sites has been associated with cell cycle regulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "RAD51", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "RAD54", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p6", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by [E1]GBD[/E1]-[E2]SIR1[/E2] requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GBD", "entity_1_idx": [[22, 25]], "entity_1_idx_in_text_with_entity_marker": [26, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SIR1", "entity_2_idx": [[26, 30]], "entity_2_idx_in_text_with_entity_marker": [39, 43], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d539.s0_BioInfer.d539.s0.p19", "text": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and histone H4.", "text_with_entity_marker": "Silencing mediated by GBD-SIR1 requires the trans-acting factors that normally participate in repression, namely, SIR2, SIR3, SIR4, and [E1]histone[/E1] [E2]H4[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[136, 143]], "entity_1_idx_in_text_with_entity_marker": [140, 147], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[144, 146]], "entity_2_idx_in_text_with_entity_marker": [157, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d605.s0_BioInfer.d605.s0.p1", "text": "The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the actin/poly-proline binding protein, profilin, and the GAF/PAS family of regulatory modules.", "text_with_entity_marker": "The domain consists of a mixed alpha-helical/beta-sheet fold that resembles a circular permutation of the [E1]actin[/E1]/poly-proline binding protein, [E2]profilin[/E2], and the GAF/PAS family of regulatory modules.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[106, 111]], "entity_1_idx_in_text_with_entity_marker": [110, 115], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[142, 150]], "entity_2_idx_in_text_with_entity_marker": [155, 163], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p0", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of [E1]class II myosins[/E1], have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium [E2]myosin II[/E2] requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "class II myosins", "entity_1_idx": [[123, 139]], "entity_1_idx_in_text_with_entity_marker": [127, 143], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin II", "entity_2_idx": [[317, 326]], "entity_2_idx_in_text_with_entity_marker": [330, 339], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p3", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all [E1]myosin heavy chains[/E1], and light chains at least of [E2]class II myosins[/E2], have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin heavy chains", "entity_1_idx": [[73, 92]], "entity_1_idx_in_text_with_entity_marker": [77, 96], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "class II myosins", "entity_2_idx": [[123, 139]], "entity_2_idx_in_text_with_entity_marker": [136, 152], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p4", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated [E1]actin[/E1]-dependent MgATPase activity of Dictyostelium [E2]myosin II[/E2] requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[266, 271]], "entity_1_idx_in_text_with_entity_marker": [270, 275], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin II", "entity_2_idx": [[317, 326]], "entity_2_idx_in_text_with_entity_marker": [330, 339], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p5", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent [E1]MgATPase[/E1] activity of Dictyostelium [E2]myosin II[/E2] requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "MgATPase", "entity_1_idx": [[282, 290]], "entity_1_idx_in_text_with_entity_marker": [286, 294], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin II", "entity_2_idx": [[317, 326]], "entity_2_idx_in_text_with_entity_marker": [330, 339], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d694.s0_BioInfer.d694.s0.p6", "text": "These data strongly suggest that the head, neck, and tail domains of all myosin heavy chains, and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium myosin II requires isoform specific interactions between the heavy chain head and tail and light chains.", "text_with_entity_marker": "These data strongly suggest that the head, neck, and tail domains of all [E1]myosin heavy chains[/E1], and light chains at least of class II myosins, have coevolved and are likely to be functionally interdependent, consistent with biochemical evidence showing that regulated actin-dependent MgATPase activity of Dictyostelium [E2]myosin II[/E2] requires isoform specific interactions between the heavy chain head and tail and light chains.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin heavy chains", "entity_1_idx": [[73, 92]], "entity_1_idx_in_text_with_entity_marker": [77, 96], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin II", "entity_2_idx": [[317, 326]], "entity_2_idx_in_text_with_entity_marker": [330, 339], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s0_BioInfer.d87.s0.p0", "text": "A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "text_with_entity_marker": "A truncated [E1]beta-catenin[/E1] disrupts the interaction between [E2]E-cadherin[/E2] and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-cadherin", "entity_2_idx": [[58, 68]], "entity_2_idx_in_text_with_entity_marker": [71, 81], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s0_BioInfer.d87.s0.p1", "text": "A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "text_with_entity_marker": "A truncated beta-catenin disrupts the interaction between [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2]: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[58, 68]], "entity_1_idx_in_text_with_entity_marker": [62, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[73, 86]], "entity_2_idx_in_text_with_entity_marker": [86, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s0_BioInfer.d87.s0.p2", "text": "A truncated beta-catenin disrupts the interaction between E-cadherin and alpha-catenin: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "text_with_entity_marker": "A truncated [E1]beta-catenin[/E1] disrupts the interaction between E-cadherin and [E2]alpha-catenin[/E2]: a cause of loss of intercellular adhesiveness in human cancer cell lines.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[12, 24]], "entity_1_idx_in_text_with_entity_marker": [16, 28], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[73, 86]], "entity_2_idx_in_text_with_entity_marker": [86, 99], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s2_BioInfer.d87.s2.p0", "text": "These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in beta-catenin.", "text_with_entity_marker": "These results suggest that the dysfunction of [E1]E-cadherin[/E1] in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in [E2]beta-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[46, 56]], "entity_1_idx_in_text_with_entity_marker": [50, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[191, 203]], "entity_2_idx_in_text_with_entity_marker": [204, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s2_BioInfer.d87.s2.p1", "text": "These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in beta-catenin.", "text_with_entity_marker": "These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with [E1]alpha-catenin[/E1], and that this defect results from the mutation in [E2]beta-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[126, 139]], "entity_1_idx_in_text_with_entity_marker": [130, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[191, 203]], "entity_2_idx_in_text_with_entity_marker": [204, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s2_BioInfer.d87.s2.p2", "text": "These results suggest that the dysfunction of E-cadherin in these cell lines is due primarily to its failure to interact with alpha-catenin, and that this defect results from the mutation in beta-catenin.", "text_with_entity_marker": "These results suggest that the dysfunction of [E1]E-cadherin[/E1] in these cell lines is due primarily to its failure to interact with [E2]alpha-catenin[/E2], and that this defect results from the mutation in beta-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[46, 56]], "entity_1_idx_in_text_with_entity_marker": [50, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[126, 139]], "entity_2_idx_in_text_with_entity_marker": [139, 152], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p0", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between [E1]E-cadherin[/E1] and [E2]alpha-catenin[/E2] is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[53, 63]], "entity_1_idx_in_text_with_entity_marker": [57, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[68, 81]], "entity_2_idx_in_text_with_entity_marker": [81, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p1", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between E-cadherin and [E1]alpha-catenin[/E1] is mediated by [E2]beta-catenin[/E2], and that this process is blocked by NH2-terminal deletion in beta-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p2", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between E-cadherin and [E1]alpha-catenin[/E1] is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in [E2]beta-catenin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[68, 81]], "entity_1_idx_in_text_with_entity_marker": [72, 85], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[172, 184]], "entity_2_idx_in_text_with_entity_marker": [185, 197], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d87.s3_BioInfer.d87.s3.p3", "text": "Thus, it is most likely that the association between E-cadherin and alpha-catenin is mediated by beta-catenin, and that this process is blocked by NH2-terminal deletion in beta-catenin.", "text_with_entity_marker": "Thus, it is most likely that the association between [E1]E-cadherin[/E1] and alpha-catenin is mediated by [E2]beta-catenin[/E2], and that this process is blocked by NH2-terminal deletion in beta-catenin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[53, 63]], "entity_1_idx_in_text_with_entity_marker": [57, 67], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p3", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that [E1]tropomyosin[/E1], which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the [E2]villin[/E2] and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[20, 31]], "entity_1_idx_in_text_with_entity_marker": [24, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "villin", "entity_2_idx": [[201, 207]], "entity_2_idx_in_text_with_entity_marker": [214, 220], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p6", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect [E1]actin[/E1] binding by 110-kD [E2]calmodulin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[255, 260]], "entity_1_idx_in_text_with_entity_marker": [259, 264], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calmodulin", "entity_2_idx": [[279, 289]], "entity_2_idx_in_text_with_entity_marker": [292, 302], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p7", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that [E1]tropomyosin[/E1], which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD [E2]calmodulin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[20, 31]], "entity_1_idx_in_text_with_entity_marker": [24, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "calmodulin", "entity_2_idx": [[279, 289]], "entity_2_idx_in_text_with_entity_marker": [292, 302], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p10", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that [E1]tropomyosin[/E1], which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and [E2]fimbrin[/E2] from the cores but does not affect actin binding by 110-kD calmodulin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[20, 31]], "entity_1_idx_in_text_with_entity_marker": [24, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "fimbrin", "entity_2_idx": [[212, 219]], "entity_2_idx_in_text_with_entity_marker": [225, 232], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p12", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that [E1]tropomyosin[/E1], which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect [E2]actin[/E2] binding by 110-kD calmodulin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[20, 31]], "entity_1_idx_in_text_with_entity_marker": [24, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[255, 260]], "entity_2_idx_in_text_with_entity_marker": [268, 273], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d819.s0_BioInfer.d819.s0.p14", "text": "We report here that tropomyosin, which is found in the rootlet but not in the microvillus core, can bind to and saturate the actin of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "text_with_entity_marker": "We report here that [E1]tropomyosin[/E1], which is found in the rootlet but not in the microvillus core, can bind to and saturate the [E2]actin[/E2] of isolated cores, and can cause the dissociation of up to 30% of the villin and fimbrin from the cores but does not affect actin binding by 110-kD calmodulin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[20, 31]], "entity_1_idx_in_text_with_entity_marker": [24, 35], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d630.s0_BioInfer.d630.s0.p0", "text": "The interaction of a mouse monoclonal antibody (4A6) and birch profilin, a structurally well conserved actin- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.", "text_with_entity_marker": "The interaction of a mouse monoclonal antibody ([E1]4A6[/E1]) and birch [E2]profilin[/E2], a structurally well conserved actin- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "4A6", "entity_1_idx": [[48, 51]], "entity_1_idx_in_text_with_entity_marker": [52, 55], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[63, 71]], "entity_2_idx_in_text_with_entity_marker": [76, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d630.s0_BioInfer.d630.s0.p2", "text": "The interaction of a mouse monoclonal antibody (4A6) and birch profilin, a structurally well conserved actin- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.", "text_with_entity_marker": "The interaction of a mouse monoclonal antibody (4A6) and birch [E1]profilin[/E1], a structurally well conserved [E2]actin[/E2]- and phosphoinositide-binding protein and cross-reactive allergen, was characterized.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[63, 71]], "entity_1_idx_in_text_with_entity_marker": [67, 75], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[103, 108]], "entity_2_idx_in_text_with_entity_marker": [116, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p7", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone H3 shares many structural features with [E1]histone[/E1] [E2]H4[/E2] and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[56, 63]], "entity_1_idx_in_text_with_entity_marker": [60, 67], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[64, 66]], "entity_2_idx_in_text_with_entity_marker": [77, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p8", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone [E1]H3[/E1] shares many structural features with histone [E2]H4[/E2] and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[16, 18]], "entity_1_idx_in_text_with_entity_marker": [20, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[64, 66]], "entity_2_idx_in_text_with_entity_marker": [77, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p11", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because [E1]histone[/E1] [E2]H3[/E2] shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[8, 15]], "entity_1_idx_in_text_with_entity_marker": [12, 19], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[16, 18]], "entity_2_idx_in_text_with_entity_marker": [29, 31], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d93.s0_BioInfer.d93.s0.p13", "text": "Because histone H3 shares many structural features with histone H4 and is intimately associated with H4 in the assembled nucleosome, we asked whether H3 has similar functions.", "text_with_entity_marker": "Because histone [E1]H3[/E1] shares many structural features with histone H4 and is intimately associated with [E2]H4[/E2] in the assembled nucleosome, we asked whether H3 has similar functions.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[16, 18]], "entity_1_idx_in_text_with_entity_marker": [20, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[101, 103]], "entity_2_idx_in_text_with_entity_marker": [114, 116], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p2", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link [E1]actin[/E1] filaments to membrane were also examined, including alpha-catenin, [E2]beta-catenin[/E2], plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[97, 109]], "entity_2_idx_in_text_with_entity_marker": [110, 122], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p5", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link [E1]actin[/E1] filaments to membrane were also examined, including alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], and zyxin, but none was identified at the host-parasite junction.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[111, 122]], "entity_2_idx_in_text_with_entity_marker": [124, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p7", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link [E1]actin[/E1] filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and [E2]zyxin[/E2], but none was identified at the host-parasite junction.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "zyxin", "entity_2_idx": [[128, 133]], "entity_2_idx_in_text_with_entity_marker": [141, 146], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s0_BioInfer.d432.s0.p9", "text": "Molecules known to link actin filaments to membrane were also examined, including alpha-catenin, beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "text_with_entity_marker": "Molecules known to link [E1]actin[/E1] filaments to membrane were also examined, including [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, and zyxin, but none was identified at the host-parasite junction.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[24, 29]], "entity_1_idx_in_text_with_entity_marker": [28, 33], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[82, 95]], "entity_2_idx_in_text_with_entity_marker": [95, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s1_BioInfer.d432.s1.p0", "text": "Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.", "text_with_entity_marker": "Other [E1]actin[/E1]-associated proteins, including [E2]vinculin[/E2], talin, and ezrin, are not present.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "vinculin", "entity_2_idx": [[43, 51]], "entity_2_idx_in_text_with_entity_marker": [56, 64], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s1_BioInfer.d432.s1.p3", "text": "Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.", "text_with_entity_marker": "Other [E1]actin[/E1]-associated proteins, including vinculin, talin, and [E2]ezrin[/E2], are not present.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "ezrin", "entity_2_idx": [[64, 69]], "entity_2_idx_in_text_with_entity_marker": [77, 82], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d432.s1_BioInfer.d432.s1.p4", "text": "Other actin-associated proteins, including vinculin, talin, and ezrin, are not present.", "text_with_entity_marker": "Other [E1]actin[/E1]-associated proteins, including vinculin, [E2]talin[/E2], and ezrin, are not present.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[6, 11]], "entity_1_idx_in_text_with_entity_marker": [10, 15], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d785.s0_BioInfer.d785.s0.p1", "text": "Up to now three allergens have been identified as responsible for cross-reactivity in these associations: profilin, a 14 kd protein that regulates actin; Bet v 1, the 18 kd birch pollen allergen; and a 60-69 kd allergen.", "text_with_entity_marker": "Up to now three allergens have been identified as responsible for cross-reactivity in these associations: [E1]profilin[/E1], a 14 kd protein that regulates [E2]actin[/E2]; Bet v 1, the 18 kd birch pollen allergen; and a 60-69 kd allergen.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[106, 114]], "entity_1_idx_in_text_with_entity_marker": [110, 118], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d343.s0_BioInfer.d343.s0.p1", "text": "In higher plants, a large number of isoforms for the actin monomer-binding protein profilin have been identified, whereas other organisms express only few profilins.", "text_with_entity_marker": "In higher plants, a large number of isoforms for the [E1]actin[/E1] monomer-binding protein [E2]profilin[/E2] have been identified, whereas other organisms express only few profilins.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[53, 58]], "entity_1_idx_in_text_with_entity_marker": [57, 62], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[83, 91]], "entity_2_idx_in_text_with_entity_marker": [96, 104], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d632.s0_BioInfer.d632.s0.p0", "text": "The interactions of actin with thymosin beta 4, actobindin and profilin are compared.", "text_with_entity_marker": "The interactions of [E1]actin[/E1] with thymosin beta 4, [E2]actobindin[/E2] and profilin are compared.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actobindin", "entity_2_idx": [[48, 58]], "entity_2_idx_in_text_with_entity_marker": [61, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d632.s0_BioInfer.d632.s0.p1", "text": "The interactions of actin with thymosin beta 4, actobindin and profilin are compared.", "text_with_entity_marker": "The interactions of [E1]actin[/E1] with [E2]thymosin beta 4[/E2], actobindin and profilin are compared.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "thymosin beta 4", "entity_2_idx": [[31, 46]], "entity_2_idx_in_text_with_entity_marker": [44, 59], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d632.s0_BioInfer.d632.s0.p2", "text": "The interactions of actin with thymosin beta 4, actobindin and profilin are compared.", "text_with_entity_marker": "The interactions of [E1]actin[/E1] with thymosin beta 4, actobindin and [E2]profilin[/E2] are compared.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[63, 71]], "entity_2_idx_in_text_with_entity_marker": [76, 84], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d680.s0_BioInfer.d680.s0.p0", "text": "There are only 14 non-conservative substitutions in the two myosin heavy chains, three of which are located in the secondary actin-binding loop and flanking regions and others correspond to residues so far not assigned a functional role, including two residues in the proximal S2 domain.", "text_with_entity_marker": "There are only 14 non-conservative substitutions in the two [E1]myosin heavy chains[/E1], three of which are located in the secondary [E2]actin[/E2]-binding loop and flanking regions and others correspond to residues so far not assigned a functional role, including two residues in the proximal S2 domain.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "myosin heavy chains", "entity_1_idx": [[60, 79]], "entity_1_idx_in_text_with_entity_marker": [64, 83], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d746.s0_BioInfer.d746.s0.p0", "text": "This shows that structural changes in the poly(L-proline)-binding region of profilin can affect the distantly located actin-binding site.", "text_with_entity_marker": "This shows that structural changes in the poly(L-proline)-binding region of [E1]profilin[/E1] can affect the distantly located [E2]actin[/E2]-binding site.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[76, 84]], "entity_1_idx_in_text_with_entity_marker": [80, 88], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[118, 123]], "entity_2_idx_in_text_with_entity_marker": [131, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d552.s0_BioInfer.d552.s0.p0", "text": "Studies on cultured cells have suggested that both alpha-catenin and plakoglobin are important for the adhesive function of cadherins.", "text_with_entity_marker": "Studies on cultured cells have suggested that both [E1]alpha-catenin[/E1] and plakoglobin are important for the adhesive function of [E2]cadherins[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[51, 64]], "entity_1_idx_in_text_with_entity_marker": [55, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[124, 133]], "entity_2_idx_in_text_with_entity_marker": [137, 146], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d552.s0_BioInfer.d552.s0.p1", "text": "Studies on cultured cells have suggested that both alpha-catenin and plakoglobin are important for the adhesive function of cadherins.", "text_with_entity_marker": "Studies on cultured cells have suggested that both alpha-catenin and [E1]plakoglobin[/E1] are important for the adhesive function of [E2]cadherins[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[69, 80]], "entity_1_idx_in_text_with_entity_marker": [73, 84], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cadherins", "entity_2_idx": [[124, 133]], "entity_2_idx_in_text_with_entity_marker": [137, 146], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d673.s0_BioInfer.d673.s0.p0", "text": "The protein profilin binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.", "text_with_entity_marker": "The protein [E1]profilin[/E1] binds to both [E2]actin[/E2] and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[35, 40]], "entity_2_idx_in_text_with_entity_marker": [48, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d673.s0_BioInfer.d673.s0.p2", "text": "The protein profilin binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both actin assembly and the phosphoinositide signaling pathway.", "text_with_entity_marker": "The protein [E1]profilin[/E1] binds to both actin and the head groups of poly)phosphoinositide)s and may regulate both [E2]actin[/E2] assembly and the phosphoinositide signaling pathway.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[12, 20]], "entity_1_idx_in_text_with_entity_marker": [16, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[110, 115]], "entity_2_idx_in_text_with_entity_marker": [123, 128], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d686.s0_BioInfer.d686.s0.p1", "text": "The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant cofilin with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with actin.", "text_with_entity_marker": "The results clearly showed that the mutated cofilin possessing KTLKK instead of KKRKK did not translocate into the nuclei in response to heat shock whereas a recombinant [E1]cofilin[/E1] with the unaltered sequence of KKRKK responded to heat shock and formed intranuclear rods together with [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[170, 177]], "entity_1_idx_in_text_with_entity_marker": [174, 181], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[282, 287]], "entity_2_idx_in_text_with_entity_marker": [295, 300], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d352.s0_BioInfer.d352.s0.p0", "text": "In resting leukocytes, beta2 integrins are constitutively linked to the actin cytoskeleton via the protein talin.", "text_with_entity_marker": "In resting leukocytes, [E1]beta2 integrins[/E1] are constitutively linked to the [E2]actin[/E2] cytoskeleton via the protein talin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta2 integrins", "entity_1_idx": [[23, 38]], "entity_1_idx_in_text_with_entity_marker": [27, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[72, 77]], "entity_2_idx_in_text_with_entity_marker": [85, 90], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d352.s0_BioInfer.d352.s0.p1", "text": "In resting leukocytes, beta2 integrins are constitutively linked to the actin cytoskeleton via the protein talin.", "text_with_entity_marker": "In resting leukocytes, beta2 integrins are constitutively linked to the [E1]actin[/E1] cytoskeleton via the protein [E2]talin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[72, 77]], "entity_1_idx_in_text_with_entity_marker": [76, 81], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d352.s0_BioInfer.d352.s0.p2", "text": "In resting leukocytes, beta2 integrins are constitutively linked to the actin cytoskeleton via the protein talin.", "text_with_entity_marker": "In resting leukocytes, [E1]beta2 integrins[/E1] are constitutively linked to the actin cytoskeleton via the protein [E2]talin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta2 integrins", "entity_1_idx": [[23, 38]], "entity_1_idx_in_text_with_entity_marker": [27, 42], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[107, 112]], "entity_2_idx_in_text_with_entity_marker": [120, 125], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d135.s0_BioInfer.d135.s0.p0", "text": "Characterization of actin and poly-L-proline binding sites of Acanthamoeba profilin with monoclonal antibodies and by mutagenesis.", "text_with_entity_marker": "Characterization of [E1]actin[/E1] and poly-L-proline binding sites of Acanthamoeba [E2]profilin[/E2] with monoclonal antibodies and by mutagenesis.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[20, 25]], "entity_1_idx_in_text_with_entity_marker": [24, 29], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[75, 83]], "entity_2_idx_in_text_with_entity_marker": [88, 96], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d135.s1_BioInfer.d135.s1.p0", "text": "For example, profilin with a deletion of the eight C-terminal residues has many of the physical properties of a molten globule, yet remarkably still binds to actin.", "text_with_entity_marker": "For example, [E1]profilin[/E1] with a deletion of the eight C-terminal residues has many of the physical properties of a molten globule, yet remarkably still binds to [E2]actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[13, 21]], "entity_1_idx_in_text_with_entity_marker": [17, 25], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[158, 163]], "entity_2_idx_in_text_with_entity_marker": [171, 176], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d135.s2_BioInfer.d135.s2.p0", "text": "The results provide two independent lines of evidence about the binding sites for actin and poly-L-proline on the profilin molecule.", "text_with_entity_marker": "The results provide two independent lines of evidence about the binding sites for [E1]actin[/E1] and poly-L-proline on the [E2]profilin[/E2] molecule.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[82, 87]], "entity_1_idx_in_text_with_entity_marker": [86, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[114, 122]], "entity_2_idx_in_text_with_entity_marker": [127, 135], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s0_BioInfer.d355.s0.p1", "text": "Insulin-like growth factor I stimulates cardiac myosin heavy chain and actin synthesis in the awake rat.", "text_with_entity_marker": "[E1]Insulin-like growth factor I[/E1] stimulates [E2]cardiac myosin heavy chain[/E2] and actin synthesis in the awake rat.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Insulin-like growth factor I", "entity_1_idx": [[0, 28]], "entity_1_idx_in_text_with_entity_marker": [4, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "cardiac myosin heavy chain", "entity_2_idx": [[40, 66]], "entity_2_idx_in_text_with_entity_marker": [53, 79], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d355.s0_BioInfer.d355.s0.p2", "text": "Insulin-like growth factor I stimulates cardiac myosin heavy chain and actin synthesis in the awake rat.", "text_with_entity_marker": "[E1]Insulin-like growth factor I[/E1] stimulates cardiac myosin heavy chain and [E2]actin[/E2] synthesis in the awake rat.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Insulin-like growth factor I", "entity_1_idx": [[0, 28]], "entity_1_idx_in_text_with_entity_marker": [4, 32], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[71, 76]], "entity_2_idx_in_text_with_entity_marker": [84, 89], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p0", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone [E1]H4[/E1], and not histone H3, was acetylated from the endogenous [E2]p21[/E2]/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[80, 82]], "entity_1_idx_in_text_with_entity_marker": [84, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[139, 142]], "entity_2_idx_in_text_with_entity_marker": [152, 155], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p5", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone [E1]H4[/E1], and not histone H3, was acetylated from the endogenous p21/[E2]waf1[/E2] promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[80, 82]], "entity_1_idx_in_text_with_entity_marker": [84, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "waf1", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p10", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that [E1]histone[/E1] [E2]H4[/E2], and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[72, 79]], "entity_1_idx_in_text_with_entity_marker": [76, 83], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H4", "entity_2_idx": [[80, 82]], "entity_2_idx_in_text_with_entity_marker": [93, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p11", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone [E1]H3[/E1], was acetylated from the endogenous [E2]p21[/E2]/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "H3", "entity_1_idx": [[100, 102]], "entity_1_idx_in_text_with_entity_marker": [104, 106], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "p21", "entity_2_idx": [[139, 142]], "entity_2_idx_in_text_with_entity_marker": [152, 155], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p12", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that [E2]CBP[/E2]/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "CBP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p13", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that CBP/p300, and not the [E2]SAGA[/E2] complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "SAGA", "entity_2_idx": [[202, 206]], "entity_2_idx_in_text_with_entity_marker": [215, 219], "entity_2_type": "Protein_complex", "entity_2_type_id": 5}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p14", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that CBP/[E2]p300[/E2], and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "p300", "entity_2_idx": [[184, 188]], "entity_2_idx_in_text_with_entity_marker": [197, 201], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p15", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/[E2]waf1[/E2] promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "waf1", "entity_2_idx": [[143, 147]], "entity_2_idx_in_text_with_entity_marker": [156, 160], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p16", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/[E2]waf1[/E2] in HTLV-1-infected cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "waf1", "entity_2_idx": [[276, 280]], "entity_2_idx_in_text_with_entity_marker": [289, 293], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d123.s0_BioInfer.d123.s0.p17", "text": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous p21/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of p21/waf1 in HTLV-1-infected cells.", "text_with_entity_marker": "By using a chromatin immunoprecipitation (ChIP) assay, we observed that histone H4, and not histone H3, was acetylated from the endogenous [E1]p21[/E1]/waf1 promoter in vivo, implying that CBP/p300, and not the SAGA complex, was critical in complexing with E2A in up-regulation of [E2]p21[/E2]/waf1 in HTLV-1-infected cells.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "p21", "entity_1_idx": [[139, 142]], "entity_1_idx_in_text_with_entity_marker": [143, 146], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "p21", "entity_2_idx": [[272, 275]], "entity_2_idx_in_text_with_entity_marker": [285, 288], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d258.s0_BioInfer.d258.s0.p1", "text": "Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, UL8 and UL52 genes.", "text_with_entity_marker": "Herpes simplex virus type 1 expresses a heterotrimeric [E1]helicase-primase[/E1], the subunits of which are encoded by the viral UL5, [E2]UL8[/E2] and UL52 genes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[55, 71]], "entity_1_idx_in_text_with_entity_marker": [59, 75], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[125, 128]], "entity_2_idx_in_text_with_entity_marker": [138, 141], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d258.s0_BioInfer.d258.s0.p3", "text": "Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, UL8 and UL52 genes.", "text_with_entity_marker": "Herpes simplex virus type 1 expresses a heterotrimeric [E1]helicase-primase[/E1], the subunits of which are encoded by the viral [E2]UL5[/E2], UL8 and UL52 genes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[55, 71]], "entity_1_idx_in_text_with_entity_marker": [59, 75], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[120, 123]], "entity_2_idx_in_text_with_entity_marker": [133, 136], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d258.s0_BioInfer.d258.s0.p5", "text": "Herpes simplex virus type 1 expresses a heterotrimeric helicase-primase, the subunits of which are encoded by the viral UL5, UL8 and UL52 genes.", "text_with_entity_marker": "Herpes simplex virus type 1 expresses a heterotrimeric [E1]helicase-primase[/E1], the subunits of which are encoded by the viral UL5, UL8 and [E2]UL52[/E2] genes.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[55, 71]], "entity_1_idx_in_text_with_entity_marker": [59, 75], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[133, 137]], "entity_2_idx_in_text_with_entity_marker": [146, 150], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d545.s0_BioInfer.d545.s0.p0", "text": "Smooth muscle talin prepared from chicken gizzard binds to skeletal muscle actin in vitro.", "text_with_entity_marker": "[E1]Smooth muscle talin[/E1] prepared from chicken gizzard binds to [E2]skeletal muscle actin[/E2] in vitro.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Smooth muscle talin", "entity_1_idx": [[0, 19]], "entity_1_idx_in_text_with_entity_marker": [4, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[59, 80]], "entity_2_idx_in_text_with_entity_marker": [72, 93], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d304.s0_BioInfer.d304.s0.p1", "text": "Impact of profilin on actin-bound nucleotide exchange and actin polymerization dynamics.", "text_with_entity_marker": "Impact of [E1]profilin[/E1] on actin-bound nucleotide exchange and [E2]actin[/E2] polymerization dynamics.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[10, 18]], "entity_1_idx_in_text_with_entity_marker": [14, 22], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[58, 63]], "entity_2_idx_in_text_with_entity_marker": [71, 76], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d196.s0_BioInfer.d196.s0.p0", "text": "Evidence suggests that this differential recognition bears functional significance concerning the intricate roles of profilin and inositol lipids in modulating actin polymerization and PtdIns(4,5)P2 turnover.", "text_with_entity_marker": "Evidence suggests that this differential recognition bears functional significance concerning the intricate roles of [E1]profilin[/E1] and inositol lipids in modulating [E2]actin[/E2] polymerization and PtdIns(4,5)P2 turnover.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[117, 125]], "entity_1_idx_in_text_with_entity_marker": [121, 129], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[160, 165]], "entity_2_idx_in_text_with_entity_marker": [173, 178], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d645.s0_BioInfer.d645.s0.p1", "text": "The monomeric actin-binding protein, profilin, is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.", "text_with_entity_marker": "The monomeric [E1]actin-binding protein[/E1], [E2]profilin[/E2], is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding protein", "entity_1_idx": [[14, 35]], "entity_1_idx_in_text_with_entity_marker": [18, 39], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "profilin", "entity_2_idx": [[37, 45]], "entity_2_idx_in_text_with_entity_marker": [50, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d645.s0_BioInfer.d645.s0.p2", "text": "The monomeric actin-binding protein, profilin, is a key regulator of actin-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.", "text_with_entity_marker": "The monomeric actin-binding protein, [E1]profilin[/E1], is a key regulator of [E2]actin[/E2]-filament dynamics in animal cells and it has recently been identified in plants as a pollen allergen.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[37, 45]], "entity_1_idx_in_text_with_entity_marker": [41, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[69, 74]], "entity_2_idx_in_text_with_entity_marker": [82, 87], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d124.s0_BioInfer.d124.s0.p0", "text": "Cadherins are essential for embryonic morphogenesis since they mediate calcium-dependent cell-cell adhesion and can modulate beta-catenin signaling.", "text_with_entity_marker": "[E1]Cadherins[/E1] are essential for embryonic morphogenesis since they mediate calcium-dependent cell-cell adhesion and can modulate [E2]beta-catenin[/E2] signaling.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Cadherins", "entity_1_idx": [[0, 9]], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "beta-catenin", "entity_2_idx": [[125, 137]], "entity_2_idx_in_text_with_entity_marker": [138, 150], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d124.s1_BioInfer.d124.s1.p0", "text": "alpha-catenin links beta-catenin to the actin-based cytoskeleton.", "text_with_entity_marker": "[E1]alpha-catenin[/E1] links [E2]beta-catenin[/E2] to the actin-based cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[20, 32]], "entity_2_idx_in_text_with_entity_marker": [33, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d124.s1_BioInfer.d124.s1.p1", "text": "alpha-catenin links beta-catenin to the actin-based cytoskeleton.", "text_with_entity_marker": "[E1]alpha-catenin[/E1] links beta-catenin to the [E2]actin[/E2]-based cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[0, 13]], "entity_1_idx_in_text_with_entity_marker": [4, 17], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[40, 45]], "entity_2_idx_in_text_with_entity_marker": [53, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d124.s1_BioInfer.d124.s1.p2", "text": "alpha-catenin links beta-catenin to the actin-based cytoskeleton.", "text_with_entity_marker": "alpha-catenin links [E1]beta-catenin[/E1] to the [E2]actin[/E2]-based cytoskeleton.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[20, 32]], "entity_1_idx_in_text_with_entity_marker": [24, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[40, 45]], "entity_2_idx_in_text_with_entity_marker": [53, 58], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p6", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "[E1]Actin-depolymerizing factor[/E1] (ADF) and cofilin define a family of [E2]actin-binding proteins[/E2] essential for the rapid turnover of filamentous actin in vivo.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Actin-depolymerizing factor", "entity_1_idx": [[0, 27]], "entity_1_idx_in_text_with_entity_marker": [4, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[65, 87]], "entity_2_idx_in_text_with_entity_marker": [78, 100], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p8", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "Actin-depolymerizing factor (ADF) and [E1]cofilin[/E1] define a family of [E2]actin-binding proteins[/E2] essential for the rapid turnover of filamentous actin in vivo.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[38, 45]], "entity_1_idx_in_text_with_entity_marker": [42, 49], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[65, 87]], "entity_2_idx_in_text_with_entity_marker": [78, 100], "entity_2_type": "Protein_family_or_group", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "BioInfer.d16.s0_BioInfer.d16.s0.p9", "text": "Actin-depolymerizing factor (ADF) and cofilin define a family of actin-binding proteins essential for the rapid turnover of filamentous actin in vivo.", "text_with_entity_marker": "Actin-depolymerizing factor (ADF) and cofilin define a family of [E1]actin-binding proteins[/E1] essential for the rapid turnover of filamentous [E2]actin[/E2] in vivo.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin-binding proteins", "entity_1_idx": [[65, 87]], "entity_1_idx_in_text_with_entity_marker": [69, 91], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[136, 141]], "entity_2_idx_in_text_with_entity_marker": [149, 154], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p0", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-[E1]nucleosome[/E1] complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone [E2]H3[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "nucleosome", "entity_1_idx": [[60, 70]], "entity_1_idx_in_text_with_entity_marker": [64, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[175, 177]], "entity_2_idx_in_text_with_entity_marker": [188, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p1", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated [E1]histone[/E1] [E2]H3[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "histone", "entity_1_idx": [[167, 174]], "entity_1_idx_in_text_with_entity_marker": [171, 178], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "H3", "entity_2_idx": [[175, 177]], "entity_2_idx_in_text_with_entity_marker": [188, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p2", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-[E1]nucleosome[/E1] and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone [E2]H3[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "nucleosome", "entity_1_idx": [[37, 47]], "entity_1_idx_in_text_with_entity_marker": [41, 51], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[175, 177]], "entity_2_idx_in_text_with_entity_marker": [188, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p3", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-[E1]AH[/E1]-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone [E2]H3[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "AH", "entity_1_idx": [[57, 59]], "entity_1_idx_in_text_with_entity_marker": [61, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[175, 177]], "entity_2_idx_in_text_with_entity_marker": [188, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p5", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified [E1]USF[/E1]-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone [E2]H3[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "USF", "entity_1_idx": [[33, 36]], "entity_1_idx_in_text_with_entity_marker": [37, 40], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[175, 177]], "entity_2_idx_in_text_with_entity_marker": [188, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p6", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and [E1]GAL4[/E1]-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone [E2]H3[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "GAL4", "entity_1_idx": [[52, 56]], "entity_1_idx_in_text_with_entity_marker": [56, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[175, 177]], "entity_2_idx_in_text_with_entity_marker": [188, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p7", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone [E1]H4[/E1] relative to acetylated histone [E2]H3[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "H4", "entity_1_idx": [[141, 143]], "entity_1_idx_in_text_with_entity_marker": [145, 147], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H3", "entity_2_idx": [[175, 177]], "entity_2_idx_in_text_with_entity_marker": [188, 190], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p10", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-[E1]AH[/E1]-[E2]nucleosome[/E2] complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AH", "entity_1_idx": [[57, 59]], "entity_1_idx_in_text_with_entity_marker": [61, 63], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleosome", "entity_2_idx": [[60, 70]], "entity_2_idx_in_text_with_entity_marker": [73, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p13", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and [E1]GAL4[/E1]-AH-[E2]nucleosome[/E2] complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GAL4", "entity_1_idx": [[52, 56]], "entity_1_idx_in_text_with_entity_marker": [56, 60], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "nucleosome", "entity_2_idx": [[60, 70]], "entity_2_idx_in_text_with_entity_marker": [73, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d823.s0_BioInfer.d823.s0.p14", "text": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-nucleosome complexes demonstrated the predominant presence of acetylated histone H4 relative to acetylated histone H3.", "text_with_entity_marker": "Western analysis of gel-purified USF-nucleosome and GAL4-AH-[E1]nucleosome[/E1] complexes demonstrated the predominant presence of acetylated histone [E2]H4[/E2] relative to acetylated histone H3.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "nucleosome", "entity_1_idx": [[60, 70]], "entity_1_idx_in_text_with_entity_marker": [64, 74], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H4", "entity_2_idx": [[141, 143]], "entity_2_idx_in_text_with_entity_marker": [154, 156], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d745.s0_BioInfer.d745.s0.p4", "text": "This result was supported by a high protein expression of the cyclin-dependent kinase inhibitor p16 in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "text_with_entity_marker": "This result was supported by a high protein expression of the [E1]cyclin-dependent kinase inhibitor[/E1] [E2]p16[/E2] in 44% of the tumours with high cyclin E and low D1 expression, and all immunohistochemical pRB defect tumours showed a high p16 protein level.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "cyclin-dependent kinase inhibitor", "entity_1_idx": [[62, 95]], "entity_1_idx_in_text_with_entity_marker": [66, 99], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "p16", "entity_2_idx": [[96, 99]], "entity_2_idx_in_text_with_entity_marker": [109, 112], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s0_BioInfer.d245.s0.p0", "text": "Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with beta-catenin and plakoglobin.", "text_with_entity_marker": "Here we have now identified the reciprocal complementary binding site in [E1]alpha-catenin[/E1] which mediates its interaction with [E2]beta-catenin[/E2] and plakoglobin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[73, 86]], "entity_1_idx_in_text_with_entity_marker": [77, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[123, 135]], "entity_2_idx_in_text_with_entity_marker": [136, 148], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s0_BioInfer.d245.s0.p1", "text": "Here we have now identified the reciprocal complementary binding site in alpha-catenin which mediates its interaction with beta-catenin and plakoglobin.", "text_with_entity_marker": "Here we have now identified the reciprocal complementary binding site in [E1]alpha-catenin[/E1] which mediates its interaction with beta-catenin and [E2]plakoglobin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[73, 86]], "entity_1_idx_in_text_with_entity_marker": [77, 90], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[140, 151]], "entity_2_idx_in_text_with_entity_marker": [153, 164], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p0", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or [E1]plakoglobin[/E1], which both can assemble [E2]alpha-catenin[/E2] into the complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "plakoglobin", "entity_1_idx": [[94, 105]], "entity_1_idx_in_text_with_entity_marker": [98, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[131, 144]], "entity_2_idx_in_text_with_entity_marker": [144, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p2", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of [E1]E-cadherin[/E1] binds either beta-catenin or [E2]plakoglobin[/E2], which both can assemble alpha-catenin into the complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[94, 105]], "entity_2_idx_in_text_with_entity_marker": [107, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p3", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of E-cadherin binds either [E1]beta-catenin[/E1] or plakoglobin, which both can assemble [E2]alpha-catenin[/E2] into the complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "beta-catenin", "entity_1_idx": [[78, 90]], "entity_1_idx_in_text_with_entity_marker": [82, 94], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[131, 144]], "entity_2_idx_in_text_with_entity_marker": [144, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p4", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of [E1]E-cadherin[/E1] binds either beta-catenin or plakoglobin, which both can assemble [E2]alpha-catenin[/E2] into the complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[131, 144]], "entity_2_idx_in_text_with_entity_marker": [144, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s1_BioInfer.d245.s1.p5", "text": "It is well established that the cytoplasmic domain of E-cadherin binds either beta-catenin or plakoglobin, which both can assemble alpha-catenin into the complex.", "text_with_entity_marker": "It is well established that the cytoplasmic domain of [E1]E-cadherin[/E1] binds either [E2]beta-catenin[/E2] or plakoglobin, which both can assemble alpha-catenin into the complex.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "E-cadherin", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[78, 90]], "entity_2_idx_in_text_with_entity_marker": [91, 103], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s2_BioInfer.d245.s2.p0", "text": "Recently we have identified an alpha-catenin binding site in beta-catenin and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.", "text_with_entity_marker": "Recently we have identified an [E1]alpha-catenin[/E1] binding site in [E2]beta-catenin[/E2] and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[61, 73]], "entity_2_idx_in_text_with_entity_marker": [74, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d245.s2_BioInfer.d245.s2.p1", "text": "Recently we have identified an alpha-catenin binding site in beta-catenin and plakoglobin and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.", "text_with_entity_marker": "Recently we have identified an [E1]alpha-catenin[/E1] binding site in beta-catenin and [E2]plakoglobin[/E2] and postulated, based on sequence analysis, that these protein-protein interactions are mediated by a hydrophobic interaction mechanism.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-catenin", "entity_1_idx": [[31, 44]], "entity_1_idx_in_text_with_entity_marker": [35, 48], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "plakoglobin", "entity_2_idx": [[78, 89]], "entity_2_idx_in_text_with_entity_marker": [91, 102], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d152.s0_BioInfer.d152.s0.p0", "text": "CONCLUSION: The results show that Munc-18-2 and syntaxin 3 form a complex in vivo and suggest that they participate in epithelial cell differentiation and targeted vesicle transport processes in the developing kidney.", "text_with_entity_marker": "CONCLUSION: The results show that [E1]Munc-18-2[/E1] and [E2]syntaxin 3[/E2] form a complex in vivo and suggest that they participate in epithelial cell differentiation and targeted vesicle transport processes in the developing kidney.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Munc-18-2", "entity_1_idx": [[34, 43]], "entity_1_idx_in_text_with_entity_marker": [38, 47], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin 3", "entity_2_idx": [[48, 58]], "entity_2_idx_in_text_with_entity_marker": [61, 71], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d255.s0_BioInfer.d255.s0.p0", "text": "alpha-SNAP binds to predicted alpha-helical coiled-coil regions of syntaxin and SNAP-25, shown previously to be engaged in their direct interaction.", "text_with_entity_marker": "[E1]alpha-SNAP[/E1] binds to predicted alpha-helical coiled-coil regions of [E2]syntaxin[/E2] and SNAP-25, shown previously to be engaged in their direct interaction.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "alpha-SNAP", "entity_1_idx": [[0, 10]], "entity_1_idx_in_text_with_entity_marker": [4, 14], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "syntaxin", "entity_2_idx": [[67, 75]], "entity_2_idx_in_text_with_entity_marker": [80, 88], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d255.s0_BioInfer.d255.s0.p1", "text": "alpha-SNAP binds to predicted alpha-helical coiled-coil regions of syntaxin and SNAP-25, shown previously to be engaged in their direct interaction.", "text_with_entity_marker": "alpha-SNAP binds to predicted alpha-helical coiled-coil regions of [E1]syntaxin[/E1] and [E2]SNAP-25[/E2], shown previously to be engaged in their direct interaction.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "syntaxin", "entity_1_idx": [[67, 75]], "entity_1_idx_in_text_with_entity_marker": [71, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "SNAP-25", "entity_2_idx": [[80, 87]], "entity_2_idx_in_text_with_entity_marker": [93, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d472.s0_BioInfer.d472.s0.p1", "text": "Our data indicate that even profilins of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, profilins are engaged in regulating either the stability or the kinetic properties of actin filaments.", "text_with_entity_marker": "Our data indicate that even profilins of highly distant evolutionary origin can functionally substitute for each other and support the hypothesis that in animal cells, [E1]profilins[/E1] are engaged in regulating either the stability or the kinetic properties of [E2]actin[/E2] filaments.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilins", "entity_1_idx": [[168, 177]], "entity_1_idx_in_text_with_entity_marker": [172, 181], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "actin", "entity_2_idx": [[254, 259]], "entity_2_idx_in_text_with_entity_marker": [267, 272], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s0_BioInfer.d348.s0.p0", "text": "In order to clarify cofilin-dependent regulation of actin assembly in muscle cells, cofilin tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.", "text_with_entity_marker": "In order to clarify [E1]cofilin[/E1]-dependent regulation of [E2]actin[/E2] assembly in muscle cells, cofilin tagged with fluorescence dyes was introduced into C2 myoblasts by a micro injection method.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[52, 57]], "entity_2_idx_in_text_with_entity_marker": [65, 70], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s1_BioInfer.d348.s1.p1", "text": "The exogeneous cofilin, but not ADF, caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.", "text_with_entity_marker": "The exogeneous [E1]cofilin[/E1], but not ADF, caused quick disassembly of [E2]actin[/E2] filaments and accumulated in furrow region of dividing cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[15, 22]], "entity_1_idx_in_text_with_entity_marker": [19, 26], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s1_BioInfer.d348.s1.p2", "text": "The exogeneous cofilin, but not ADF, caused quick disassembly of actin filaments and accumulated in furrow region of dividing cells.", "text_with_entity_marker": "The exogeneous cofilin, but not [E1]ADF[/E1], caused quick disassembly of [E2]actin[/E2] filaments and accumulated in furrow region of dividing cells.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[32, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[65, 70]], "entity_2_idx_in_text_with_entity_marker": [78, 83], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d348.s2_BioInfer.d348.s2.p0", "text": "These results suggest that the subcellular distribution of cofilin as well as its interaction with actin in vivo is regulated by its phosphorylation and dephosphorylation.", "text_with_entity_marker": "These results suggest that the subcellular distribution of [E1]cofilin[/E1] as well as its interaction with [E2]actin[/E2] in vivo is regulated by its phosphorylation and dephosphorylation.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[59, 66]], "entity_1_idx_in_text_with_entity_marker": [63, 70], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[99, 104]], "entity_2_idx_in_text_with_entity_marker": [112, 117], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p0", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/[E1]cofilin[/E1], [E2]Arp[/E2]2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[29, 32], [34, 35]], "entity_2_idx_in_text_with_entity_marker": [42, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p1", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of [E1]ADF[/E1]/cofilin, [E2]Arp[/E2]2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "ADF", "entity_1_idx": [[16, 19]], "entity_1_idx_in_text_with_entity_marker": [20, 23], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp", "entity_2_idx": [[29, 32], [34, 35]], "entity_2_idx_in_text_with_entity_marker": [42, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p2", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/cofilin, [E1]Arp[/E1]2/3 complex, capping protein and profilin in remodeling of branched [E2]actin[/E2] filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[29, 32], [34, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p3", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/cofilin, [E1]Arp[/E1]2/3 complex, [E2]capping protein[/E2] and profilin in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[29, 32], [34, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[45, 60]], "entity_2_idx_in_text_with_entity_marker": [58, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p4", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/cofilin, [E1-E2]Arp[/E1]2[/E2]/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[29, 32], [34, 35]], "entity_1_idx_in_text_with_entity_marker": [36, 39], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp[/E1]2", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [36, 45], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p5", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/cofilin, [E1]Arp[/E1]2/3 complex, capping protein and [E2]profilin[/E2] in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "Arp", "entity_1_idx": [[29, 32], [34, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[65, 73]], "entity_2_idx_in_text_with_entity_marker": [78, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p7", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/[E1]cofilin[/E1], Arp2/3 complex, capping protein and profilin in remodeling of branched [E2]actin[/E2] filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p8", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/[E1]cofilin[/E1], Arp2/3 complex, [E2]capping protein[/E2] and profilin in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "capping protein", "entity_2_idx": [[45, 60]], "entity_2_idx_in_text_with_entity_marker": [58, 73], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p9", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/[E1]cofilin[/E1], [E2]Arp2[/E2]/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "Arp2", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d361.s0_BioInfer.d361.s0.p10", "text": "Interactions of ADF/cofilin, Arp2/3 complex, capping protein and profilin in remodeling of branched actin filament networks.", "text_with_entity_marker": "Interactions of ADF/[E1]cofilin[/E1], Arp2/3 complex, capping protein and [E2]profilin[/E2] in remodeling of branched actin filament networks.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[65, 73]], "entity_2_idx_in_text_with_entity_marker": [78, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d259.s0_BioInfer.d259.s0.p1", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of the products of the UL5, [E2]UL8[/E2], and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL8", "entity_2_idx": [[105, 108]], "entity_2_idx_in_text_with_entity_marker": [118, 121], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d259.s0_BioInfer.d259.s0.p3", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of the products of the UL5, UL8, and [E2]UL52[/E2] genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL52", "entity_2_idx": [[114, 118]], "entity_2_idx_in_text_with_entity_marker": [127, 131], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d259.s0_BioInfer.d259.s0.p5", "text": "Herpes simplex virus type 1 (HSV-1) encodes a helicase-primase that consists of the products of the UL5, UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "text_with_entity_marker": "Herpes simplex virus type 1 (HSV-1) encodes a [E1]helicase-primase[/E1] that consists of the products of the [E2]UL5[/E2], UL8, and UL52 genes (Crute, J. J., Tsurumi, T., Zhu, L., Weller, S. K., Olivo, P. D., Challberg, M. D., Mocarski, E. S. and Lehman, I. R. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 2186-2189).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "helicase-primase", "entity_1_idx": [[46, 62]], "entity_1_idx_in_text_with_entity_marker": [50, 66], "entity_1_type": "Protein_complex", "entity_1_type_id": 5, "entity_2": "UL5", "entity_2_idx": [[100, 103]], "entity_2_idx_in_text_with_entity_marker": [113, 116], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s0_BioInfer.d809.s0.p0", "text": "We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "text_with_entity_marker": "We have characterized this [E1]actin[/E1] with respect to its ability to interact with yeast [E2]profilin[/E2] and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[84, 92]], "entity_2_idx_in_text_with_entity_marker": [97, 105], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s0_BioInfer.d809.s0.p2", "text": "We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "text_with_entity_marker": "We have characterized this [E1]actin[/E1] with respect to its ability to interact with yeast profilin and [E2]tropomyosin[/E2], the only yeast actin-binding proteins so far purified and characterized.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin", "entity_1_idx": [[27, 32]], "entity_1_idx_in_text_with_entity_marker": [31, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "tropomyosin", "entity_2_idx": [[97, 108]], "entity_2_idx_in_text_with_entity_marker": [110, 121], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s0_BioInfer.d809.s0.p3", "text": "We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "text_with_entity_marker": "We have characterized this actin with respect to its ability to interact with yeast [E1]profilin[/E1] and tropomyosin, the only yeast [E2]actin-binding proteins[/E2] so far purified and characterized.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[84, 92]], "entity_1_idx_in_text_with_entity_marker": [88, 96], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[125, 147]], "entity_2_idx_in_text_with_entity_marker": [138, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s0_BioInfer.d809.s0.p5", "text": "We have characterized this actin with respect to its ability to interact with yeast profilin and tropomyosin, the only yeast actin-binding proteins so far purified and characterized.", "text_with_entity_marker": "We have characterized this actin with respect to its ability to interact with yeast profilin and [E1]tropomyosin[/E1], the only yeast [E2]actin-binding proteins[/E2] so far purified and characterized.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "tropomyosin", "entity_1_idx": [[97, 108]], "entity_1_idx_in_text_with_entity_marker": [101, 112], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin-binding proteins", "entity_2_idx": [[125, 147]], "entity_2_idx_in_text_with_entity_marker": [138, 160], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s1_BioInfer.d809.s1.p0", "text": "Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast [E1]profilin[/E1] can sequester yeast [E2]actin[/E2] monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[35, 40]], "entity_2_idx_in_text_with_entity_marker": [48, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s1_BioInfer.d809.s1.p1", "text": "Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast [E1]profilin[/E1] can sequester yeast actin monomers and thereby reduce the ability of yeast [E2]actin[/E2] to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[90, 95]], "entity_2_idx_in_text_with_entity_marker": [103, 108], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d809.s1_BioInfer.d809.s1.p2", "text": "Yeast profilin can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit skeletal muscle actin.", "text_with_entity_marker": "Yeast [E1]profilin[/E1] can sequester yeast actin monomers and thereby reduce the ability of yeast actin to polymerize, whereas it has little effect on the degree of polymerization of rabbit [E2]skeletal muscle actin[/E2].", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "profilin", "entity_1_idx": [[6, 14]], "entity_1_idx_in_text_with_entity_marker": [10, 18], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "skeletal muscle actin", "entity_2_idx": [[182, 203]], "entity_2_idx_in_text_with_entity_marker": [195, 216], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d282.s0_BioInfer.d282.s0.p2", "text": "Human platelet P-235, a talin-like actin binding protein, binds selectively to mixed lipid bilayers.", "text_with_entity_marker": "Human [E1]platelet P-235[/E1], a [E2]talin[/E2]-like actin binding protein, binds selectively to mixed lipid bilayers.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "platelet P-235", "entity_1_idx": [[6, 20]], "entity_1_idx_in_text_with_entity_marker": [10, 24], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "talin", "entity_2_idx": [[24, 29]], "entity_2_idx_in_text_with_entity_marker": [37, 42], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p4", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with [E1]IL-6[/E1] showed a dose dependent increase in TXB2 and [E2]BTG[/E2] secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IL-6", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "BTG", "entity_2_idx": [[78, 81]], "entity_2_idx_in_text_with_entity_marker": [91, 94], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p6", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, [E1]talin[/E1], and [E2]myosin[/E2] into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "talin", "entity_1_idx": [[168, 173]], "entity_1_idx_in_text_with_entity_marker": [172, 177], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "myosin", "entity_2_idx": [[179, 185]], "entity_2_idx_in_text_with_entity_marker": [192, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p7", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of [E1]actin binding protein[/E1], talin, and [E2]myosin[/E2] into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin binding protein", "entity_1_idx": [[145, 166]], "entity_1_idx_in_text_with_entity_marker": [149, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "myosin", "entity_2_idx": [[179, 185]], "entity_2_idx_in_text_with_entity_marker": [192, 198], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p11", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with [E1]IL-6[/E1] showed a dose dependent increase in [E2]TXB2[/E2] and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "IL-6", "entity_1_idx": [[28, 32]], "entity_1_idx_in_text_with_entity_marker": [32, 36], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TXB2", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d225.s0_BioInfer.d225.s0.p12", "text": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of actin binding protein, talin, and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "text_with_entity_marker": "Further, PRP incubated with IL-6 showed a dose dependent increase in TXB2 and BTG secretion as measured by RIA and an increased incorporation of [E1]actin binding protein[/E1], [E2]talin[/E2], and myosin into the cytoskeletal core (triton insoluble residue) as shown by SDS-PAGE.", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "actin binding protein", "entity_1_idx": [[145, 166]], "entity_1_idx_in_text_with_entity_marker": [149, 170], "entity_1_type": "Protein_family_or_group", "entity_1_type_id": 1, "entity_2": "talin", "entity_2_idx": [[168, 173]], "entity_2_idx_in_text_with_entity_marker": [181, 186], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p0", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, [E1]major DNA-binding protein[/E1], [E2]DNA polymerase[/E2], UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "major DNA-binding protein", "entity_1_idx": [[238, 263]], "entity_1_idx_in_text_with_entity_marker": [242, 267], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNA polymerase", "entity_2_idx": [[265, 279]], "entity_2_idx_in_text_with_entity_marker": [278, 292], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p1", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, [E1]UL8[/E1], major DNA-binding protein, [E2]DNA polymerase[/E2], UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNA polymerase", "entity_2_idx": [[265, 279]], "entity_2_idx_in_text_with_entity_marker": [278, 292], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p2", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding [E1]UL5[/E1], UL8, major DNA-binding protein, [E2]DNA polymerase[/E2], UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNA polymerase", "entity_2_idx": [[265, 279]], "entity_2_idx_in_text_with_entity_marker": [278, 292], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p3", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, [E1]DNA polymerase[/E1], UL42, and [E2]UL52[/E2]) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DNA polymerase", "entity_1_idx": [[265, 279]], "entity_1_idx_in_text_with_entity_marker": [269, 283], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[291, 295]], "entity_2_idx_in_text_with_entity_marker": [304, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p4", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, [E1]DNA polymerase[/E1], [E2]UL42[/E2], and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DNA polymerase", "entity_1_idx": [[265, 279]], "entity_1_idx_in_text_with_entity_marker": [269, 283], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p5", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, [E1]UL8[/E1], [E2]major DNA-binding protein[/E2], DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "major DNA-binding protein", "entity_2_idx": [[238, 263]], "entity_2_idx_in_text_with_entity_marker": [251, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p6", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding [E1]UL5[/E1], UL8, [E2]major DNA-binding protein[/E2], DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "major DNA-binding protein", "entity_2_idx": [[238, 263]], "entity_2_idx_in_text_with_entity_marker": [251, 276], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p7", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, [E1]major DNA-binding protein[/E1], DNA polymerase, UL42, and [E2]UL52[/E2]) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "major DNA-binding protein", "entity_1_idx": [[238, 263]], "entity_1_idx_in_text_with_entity_marker": [242, 267], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[291, 295]], "entity_2_idx_in_text_with_entity_marker": [304, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p8", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, [E1]major DNA-binding protein[/E1], DNA polymerase, [E2]UL42[/E2], and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "major DNA-binding protein", "entity_1_idx": [[238, 263]], "entity_1_idx_in_text_with_entity_marker": [242, 267], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p9", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding [E1]UL5[/E1], [E2]UL8[/E2], major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL8", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p10", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, [E1]UL8[/E1], major DNA-binding protein, DNA polymerase, UL42, and [E2]UL52[/E2]) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[291, 295]], "entity_2_idx_in_text_with_entity_marker": [304, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p11", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, [E1]UL8[/E1], major DNA-binding protein, DNA polymerase, [E2]UL42[/E2], and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL8", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p12", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding [E1]UL5[/E1], UL8, major DNA-binding protein, DNA polymerase, UL42, and [E2]UL52[/E2]) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[291, 295]], "entity_2_idx_in_text_with_entity_marker": [304, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p13", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding [E1]UL5[/E1], UL8, major DNA-binding protein, DNA polymerase, [E2]UL42[/E2], and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL5", "entity_1_idx": [[228, 231]], "entity_1_idx_in_text_with_entity_marker": [232, 235], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL42", "entity_2_idx": [[281, 285]], "entity_2_idx_in_text_with_entity_marker": [294, 298], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d760.s0_BioInfer.d760.s0.p14", "text": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, UL42, and UL52) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "text_with_entity_marker": "To characterize the AAV functions mediating this effect, cloned AAV type 2 wild-type or mutant genomes were transfected into simian virus 40 (SV40)-transformed hamster cells together with the six HSV replication genes (encoding UL5, UL8, major DNA-binding protein, DNA polymerase, [E1]UL42[/E1], and [E2]UL52[/E2]) which together are necessary and sufficient for the induction of SV40 DNA amplification (R. Heilbronn and H. zur Hausen, J. Virol. 63:3683-3692, 1989).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UL42", "entity_1_idx": [[281, 285]], "entity_1_idx_in_text_with_entity_marker": [285, 289], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "UL52", "entity_2_idx": [[291, 295]], "entity_2_idx_in_text_with_entity_marker": [304, 308], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d199.s0_BioInfer.d199.s0.p0", "text": "Exposure of the cells to tumor promoter did, however, result in a loss of actin and talin-rich cell surface elaborations that resemble focal contact precursor structures.", "text_with_entity_marker": "Exposure of the cells to tumor promoter did, however, result in a loss of [E1]actin[/E1] and [E2]talin[/E2]-rich cell surface elaborations that resemble focal contact precursor structures.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[74, 79]], "entity_1_idx_in_text_with_entity_marker": [78, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[84, 89]], "entity_2_idx_in_text_with_entity_marker": [97, 102], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p30", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), phosphoprotein (P), [E2]H[/E2], nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[152, 153], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [165, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p31", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), [E1]H[/E1], nucleocapsid (N) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[152, 153], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [156, 157], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p32", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] (P), [E2]H[/E2], nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "H", "entity_2_idx": [[152, 153], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [165, 166], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p33", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), phosphoprotein (P), H, nucleocapsid (N) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p34", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the [E1]fusion[/E1] (F), [E2]phosphoprotein[/E2] (P), H, nucleocapsid (N) and matrix (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[120, 126], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[132, 146], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [145, 159], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d574.s0_BioInfer.d574.s0.p35", "text": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), phosphoprotein (P), H, nucleocapsid (N) and matrix (M) proteins.", "text_with_entity_marker": "The analysis of the viral proteins by electrophoresis indicates molecular weight differences between CDV and PDV in the fusion (F), [E1]phosphoprotein[/E1] (P), H, nucleocapsid (N) and [E2]matrix[/E2] (M) proteins.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[132, 146], [187, 195]], "entity_1_idx_in_text_with_entity_marker": [136, 150], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "matrix", "entity_2_idx": [[176, 182], [187, 195]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p30", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], [E2]myosin light chain kinase[/E2], myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain kinase", "entity_2_idx": [[97, 122]], "entity_2_idx_in_text_with_entity_marker": [110, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p31", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, [E2]myosin regulatory light chain[/E2], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin regulatory light chain", "entity_2_idx": [[66, 95]], "entity_2_idx_in_text_with_entity_marker": [79, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p32", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], [E2]myosin regulatory light chain[/E2], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin regulatory light chain", "entity_2_idx": [[66, 95]], "entity_2_idx_in_text_with_entity_marker": [79, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p33", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included [E1]actin[/E1], tropomyosin, troponin I, [E2]myosin regulatory light chain[/E2], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[34, 39]], "entity_1_idx_in_text_with_entity_marker": [38, 43], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin regulatory light chain", "entity_2_idx": [[66, 95]], "entity_2_idx_in_text_with_entity_marker": [79, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p34", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, [E2]muscle LIM[/E2] protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle LIM", "entity_2_idx": [[207, 217]], "entity_2_idx_in_text_with_entity_marker": [220, 230], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p35", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, myosin heavy chain, calmodulin, [E2]calponin[/E2], calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "calponin", "entity_2_idx": [[156, 164]], "entity_2_idx_in_text_with_entity_marker": [169, 177], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p36", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and [E2]SH3-binding glutamate-rich protein[/E2], suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "SH3-binding glutamate-rich protein", "entity_2_idx": [[231, 265]], "entity_2_idx_in_text_with_entity_marker": [244, 278], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p37", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, troponin I, [E1]myosin regulatory light chain[/E1], myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, [E2]creatine kinase[/E2], muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin regulatory light chain", "entity_1_idx": [[66, 95]], "entity_1_idx_in_text_with_entity_marker": [70, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "creatine kinase", "entity_2_idx": [[190, 205]], "entity_2_idx_in_text_with_entity_marker": [203, 218], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p38", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, [E1]tropomyosin[/E1], troponin I, myosin regulatory light chain, [E2]myosin light chain kinase[/E2], myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "tropomyosin", "entity_1_idx": [[41, 52]], "entity_1_idx_in_text_with_entity_marker": [45, 56], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain kinase", "entity_2_idx": [[97, 122]], "entity_2_idx_in_text_with_entity_marker": [110, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d649.s0_BioInfer.d649.s0.p39", "text": "The muscle-related genes included actin, tropomyosin, troponin I, myosin regulatory light chain, myosin light chain kinase, myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "text_with_entity_marker": "The muscle-related genes included actin, tropomyosin, [E1]troponin I[/E1], myosin regulatory light chain, [E2]myosin light chain kinase[/E2], myosin heavy chain, calmodulin, calponin, calcium vector protein, creatine kinase, muscle LIM protein, and SH3-binding glutamate-rich protein, suggesting that vertebrate skeletal and smooth muscle-type genes are simultaneously expressed in the amphioxus notochord.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "troponin I", "entity_1_idx": [[54, 64]], "entity_1_idx_in_text_with_entity_marker": [58, 68], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin light chain kinase", "entity_2_idx": [[97, 122]], "entity_2_idx_in_text_with_entity_marker": [110, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p30", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p31", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p32", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p33", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and [E2]DUN1[/E2] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DUN1", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p34", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E1]DUN1[/E1] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DUN1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p35", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and [E1]DUN1[/E1] increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DUN1", "entity_1_idx": [[91, 95]], "entity_1_idx_in_text_with_entity_marker": [95, 99], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p36", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p37", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, [E1]PDS1[/E1], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PDS1", "entity_1_idx": [[81, 85]], "entity_1_idx_in_text_with_entity_marker": [85, 89], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p38", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E1]RAD9[/E1], [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p39", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p40", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p41", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, [E1]MEC1[/E1], DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC1", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p42", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae [E1]RFC5[/E1], DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RFC5", "entity_1_idx": [[38, 42]], "entity_1_idx_in_text_with_entity_marker": [42, 46], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p43", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 [E1]MEC3[/E1], RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E2]RAD9[/E2], RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MEC3", "entity_1_idx": [[62, 66]], "entity_1_idx_in_text_with_entity_marker": [66, 70], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD9", "entity_2_idx": [[176, 180]], "entity_2_idx_in_text_with_entity_marker": [189, 193], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p44", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E1]RAD9[/E1], RAD17, RAD24, [E2]BUB3[/E2], and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUB3", "entity_2_idx": [[196, 200]], "entity_2_idx_in_text_with_entity_marker": [209, 213], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p45", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in [E1]RAD9[/E1], RAD17, RAD24, BUB3, and [E2]MAD3[/E2] had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD9", "entity_1_idx": [[176, 180]], "entity_1_idx_in_text_with_entity_marker": [180, 184], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MAD3", "entity_2_idx": [[206, 210]], "entity_2_idx_in_text_with_entity_marker": [219, 223], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p46", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], [E2]PDS1[/E2], and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PDS1", "entity_2_idx": [[81, 85]], "entity_2_idx_in_text_with_entity_marker": [94, 98], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p47", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, [E1]CHK1[/E1], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, [E2]RAD17[/E2], RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CHK1", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD17", "entity_2_idx": [[182, 187]], "entity_2_idx_in_text_with_entity_marker": [195, 200], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p48", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, [E1]RAD53[/E1], [E2]CHK1[/E2], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD53", "entity_1_idx": [[68, 73]], "entity_1_idx_in_text_with_entity_marker": [72, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CHK1", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d446.s0_BioInfer.d446.s0.p49", "text": "Mutations in Saccharomyces cerevisiae RFC5, DPB11, MEC1, DDC2 MEC3, RAD53, CHK1, PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "text_with_entity_marker": "Mutations in Saccharomyces cerevisiae RFC5, [E1]DPB11[/E1], MEC1, DDC2 MEC3, RAD53, [E2]CHK1[/E2], PDS1, and DUN1 increased the rate of genome rearrangements up to 200-fold whereas mutations in RAD9, RAD17, RAD24, BUB3, and MAD3 had little effect.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DPB11", "entity_1_idx": [[44, 49]], "entity_1_idx_in_text_with_entity_marker": [48, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "CHK1", "entity_2_idx": [[75, 79]], "entity_2_idx_in_text_with_entity_marker": [88, 92], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d272.s0_BioInfer.d272.s0.p0", "text": "However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.", "text_with_entity_marker": "However, once initiated, the synthesis of [E1]muscle tropomyosin[/E1] mRNA continued in the presence of cycloheximide, while the expression of [E2]muscle[/E2] actin, myosin heavy chain, and myogenin mRNA was abolished.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "muscle tropomyosin", "entity_1_idx": [[42, 60]], "entity_1_idx_in_text_with_entity_marker": [46, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle", "entity_2_idx": [[134, 140], [148, 166]], "entity_2_idx_in_text_with_entity_marker": [147, 153], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d272.s0_BioInfer.d272.s0.p1", "text": "However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.", "text_with_entity_marker": "However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of [E1-E2]muscle[/E1-E2] actin, myosin heavy chain, and myogenin mRNA was abolished.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "muscle", "entity_1_idx": [[134, 140], [172, 180]], "entity_1_idx_in_text_with_entity_marker": [141, 147], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle", "entity_2_idx": [[134, 140], [148, 166]], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d272.s0_BioInfer.d272.s0.p2", "text": "However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.", "text_with_entity_marker": "However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of [E1-E2]muscle[/E1] actin[/E2], myosin heavy chain, and myogenin mRNA was abolished.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "muscle", "entity_1_idx": [[134, 140], [148, 166]], "entity_1_idx_in_text_with_entity_marker": [141, 147], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle[/E1] actin", "entity_2_idx": [[134, 146]], "entity_2_idx_in_text_with_entity_marker": [141, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d272.s0_BioInfer.d272.s0.p3", "text": "However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.", "text_with_entity_marker": "However, once initiated, the synthesis of [E1]muscle tropomyosin[/E1] mRNA continued in the presence of cycloheximide, while the expression of [E2]muscle[/E2] actin, myosin heavy chain, and myogenin mRNA was abolished.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "muscle tropomyosin", "entity_1_idx": [[42, 60]], "entity_1_idx_in_text_with_entity_marker": [46, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle", "entity_2_idx": [[134, 140], [172, 180]], "entity_2_idx_in_text_with_entity_marker": [147, 153], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d272.s0_BioInfer.d272.s0.p4", "text": "However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.", "text_with_entity_marker": "However, once initiated, the synthesis of [E1]muscle tropomyosin[/E1] mRNA continued in the presence of cycloheximide, while the expression of [E2]muscle actin[/E2], myosin heavy chain, and myogenin mRNA was abolished.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "muscle tropomyosin", "entity_1_idx": [[42, 60]], "entity_1_idx_in_text_with_entity_marker": [46, 64], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle actin", "entity_2_idx": [[134, 146]], "entity_2_idx_in_text_with_entity_marker": [147, 159], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d272.s0_BioInfer.d272.s0.p5", "text": "However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of muscle actin, myosin heavy chain, and myogenin mRNA was abolished.", "text_with_entity_marker": "However, once initiated, the synthesis of muscle tropomyosin mRNA continued in the presence of cycloheximide, while the expression of [E1-E2]muscle[/E1] actin[/E2], myosin heavy chain, and myogenin mRNA was abolished.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "muscle", "entity_1_idx": [[134, 140], [172, 180]], "entity_1_idx_in_text_with_entity_marker": [141, 147], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "muscle[/E1] actin", "entity_2_idx": [[134, 146]], "entity_2_idx_in_text_with_entity_marker": [141, 158], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s0_BioInfer.d28.s0.p0", "text": "After 24 or 48 hours of shear, staining for VE-cadherin, alpha-catenin, and beta-catenin was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "text_with_entity_marker": "After 24 or 48 hours of shear, staining for [E1]VE-cadherin[/E1], alpha-catenin, and [E2]beta-catenin[/E2] was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VE-cadherin", "entity_1_idx": [[44, 55]], "entity_1_idx_in_text_with_entity_marker": [48, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[76, 88]], "entity_2_idx_in_text_with_entity_marker": [89, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s0_BioInfer.d28.s0.p1", "text": "After 24 or 48 hours of shear, staining for VE-cadherin, alpha-catenin, and beta-catenin was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "text_with_entity_marker": "After 24 or 48 hours of shear, staining for VE-cadherin, [E1]alpha-catenin[/E1], and [E2]beta-catenin[/E2] was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[57, 70]], "entity_1_idx_in_text_with_entity_marker": [61, 74], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[76, 88]], "entity_2_idx_in_text_with_entity_marker": [89, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s0_BioInfer.d28.s0.p2", "text": "After 24 or 48 hours of shear, staining for VE-cadherin, alpha-catenin, and beta-catenin was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "text_with_entity_marker": "After 24 or 48 hours of shear, staining for [E1]VE-cadherin[/E1], [E2]alpha-catenin[/E2], and beta-catenin was intense and peripheral, forming a band of \"dashes\" (adherens plaques) that colocalized with the ends of stress fibers that inserted along the lateral membranes of cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "VE-cadherin", "entity_1_idx": [[44, 55]], "entity_1_idx_in_text_with_entity_marker": [48, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[57, 70]], "entity_2_idx_in_text_with_entity_marker": [70, 83], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p0", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to [E1]vascular endothelial[/E1] (VE) cadherin, alpha-catenin, [E2]beta-catenin[/E2], or plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vascular endothelial", "entity_1_idx": [[48, 68], [74, 82]], "entity_1_idx_in_text_with_entity_marker": [52, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p1", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to [E1]vascular endothelial[/E1] (VE) cadherin, [E2]alpha-catenin[/E2], beta-catenin, or plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vascular endothelial", "entity_1_idx": [[48, 68], [74, 82]], "entity_1_idx_in_text_with_entity_marker": [52, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[84, 97]], "entity_2_idx_in_text_with_entity_marker": [97, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p2", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to [E1]vascular endothelial[/E1] (VE) cadherin, alpha-catenin, beta-catenin, or [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vascular endothelial", "entity_1_idx": [[48, 68], [74, 82]], "entity_1_idx_in_text_with_entity_marker": [52, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p3", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], or plakoglobin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[84, 97]], "entity_1_idx_in_text_with_entity_marker": [88, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[99, 111]], "entity_2_idx_in_text_with_entity_marker": [112, 124], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p4", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, [E1]beta-catenin[/E1], or [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d28.s1_BioInfer.d28.s1.p5", "text": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, alpha-catenin, beta-catenin, or plakoglobin.", "text_with_entity_marker": "Cells were fixed and stained with antibodies to vascular endothelial (VE) cadherin, [E1]alpha-catenin[/E1], beta-catenin, or [E2]plakoglobin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[84, 97]], "entity_1_idx_in_text_with_entity_marker": [88, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[116, 127]], "entity_2_idx_in_text_with_entity_marker": [129, 140], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d30.s0_BioInfer.d30.s0.p0", "text": "After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.", "text_with_entity_marker": "After elution of the three actin-binding proteins, [E1]actin[/E1] and profilin were recovered from the [E2]DNase I[/E2] column with 2 M urea solution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNase I", "entity_2_idx": [[94, 101]], "entity_2_idx_in_text_with_entity_marker": [107, 114], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d30.s0_BioInfer.d30.s0.p1", "text": "After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.", "text_with_entity_marker": "After elution of the three [E1]actin-binding proteins[/E1], [E2]actin[/E2] and profilin were recovered from the DNase I column with 2 M urea solution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin-binding proteins", "entity_1_idx": [[27, 49]], "entity_1_idx_in_text_with_entity_marker": [31, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "actin", "entity_2_idx": [[51, 56]], "entity_2_idx_in_text_with_entity_marker": [64, 69], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d30.s0_BioInfer.d30.s0.p2", "text": "After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.", "text_with_entity_marker": "After elution of the three actin-binding proteins, [E1]actin[/E1] and [E2]profilin[/E2] were recovered from the DNase I column with 2 M urea solution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[51, 56]], "entity_1_idx_in_text_with_entity_marker": [55, 60], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d30.s0_BioInfer.d30.s0.p3", "text": "After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.", "text_with_entity_marker": "After elution of the three [E1]actin-binding proteins[/E1], actin and profilin were recovered from the [E2]DNase I[/E2] column with 2 M urea solution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin-binding proteins", "entity_1_idx": [[27, 49]], "entity_1_idx_in_text_with_entity_marker": [31, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNase I", "entity_2_idx": [[94, 101]], "entity_2_idx_in_text_with_entity_marker": [107, 114], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d30.s0_BioInfer.d30.s0.p4", "text": "After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.", "text_with_entity_marker": "After elution of the three actin-binding proteins, actin and [E1]profilin[/E1] were recovered from the [E2]DNase I[/E2] column with 2 M urea solution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[61, 69]], "entity_1_idx_in_text_with_entity_marker": [65, 73], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "DNase I", "entity_2_idx": [[94, 101]], "entity_2_idx_in_text_with_entity_marker": [107, 114], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d30.s0_BioInfer.d30.s0.p5", "text": "After elution of the three actin-binding proteins, actin and profilin were recovered from the DNase I column with 2 M urea solution.", "text_with_entity_marker": "After elution of the three [E1]actin-binding proteins[/E1], actin and [E2]profilin[/E2] were recovered from the DNase I column with 2 M urea solution.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin-binding proteins", "entity_1_idx": [[27, 49]], "entity_1_idx_in_text_with_entity_marker": [31, 53], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[61, 69]], "entity_2_idx_in_text_with_entity_marker": [74, 82], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s2_BioInfer.d643.s2.p0", "text": "With solutions of actin (2 microM) and thymosin-beta4 (2 or 4 microM), the barbed-end assembly rate rose with increasing profilin concentration (0.7-2 microM).", "text_with_entity_marker": "With solutions of actin (2 microM) and [E1]thymosin-beta4[/E1] (2 or 4 microM), the barbed-end assembly rate rose with increasing [E2]profilin[/E2] concentration (0.7-2 microM).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "thymosin-beta4", "entity_1_idx": [[39, 53]], "entity_1_idx_in_text_with_entity_marker": [43, 57], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[121, 129]], "entity_2_idx_in_text_with_entity_marker": [134, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s2_BioInfer.d643.s2.p1", "text": "With solutions of actin (2 microM) and thymosin-beta4 (2 or 4 microM), the barbed-end assembly rate rose with increasing profilin concentration (0.7-2 microM).", "text_with_entity_marker": "With solutions of [E1]actin[/E1] (2 microM) and [E2]thymosin-beta4[/E2] (2 or 4 microM), the barbed-end assembly rate rose with increasing profilin concentration (0.7-2 microM).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "thymosin-beta4", "entity_2_idx": [[39, 53]], "entity_2_idx_in_text_with_entity_marker": [52, 66], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d643.s2_BioInfer.d643.s2.p2", "text": "With solutions of actin (2 microM) and thymosin-beta4 (2 or 4 microM), the barbed-end assembly rate rose with increasing profilin concentration (0.7-2 microM).", "text_with_entity_marker": "With solutions of [E1]actin[/E1] (2 microM) and thymosin-beta4 (2 or 4 microM), the barbed-end assembly rate rose with increasing [E2]profilin[/E2] concentration (0.7-2 microM).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[121, 129]], "entity_2_idx_in_text_with_entity_marker": [134, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d241.s0_BioInfer.d241.s0.p0", "text": "Here, we describe proline-rich proteins involved in regulating actin polymerization and classify them according to their role in recruiting profilin to the membrane.", "text_with_entity_marker": "Here, we describe proline-rich proteins involved in regulating [E1]actin[/E1] polymerization and classify them according to their role in recruiting [E2]profilin[/E2] to the membrane.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[63, 68]], "entity_1_idx_in_text_with_entity_marker": [67, 72], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "profilin", "entity_2_idx": [[140, 148]], "entity_2_idx_in_text_with_entity_marker": [153, 161], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d801.s0_BioInfer.d801.s0.p0", "text": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain (MHC), actin, and mixed muscle proteins in nonfrail elders and younger women and men.", "text_with_entity_marker": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, [E1]myosin heavy chain[/E1] (MHC), [E2]actin[/E2], and mixed muscle proteins in nonfrail elders and younger women and men.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[121, 139]], "entity_1_idx_in_text_with_entity_marker": [125, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d801.s0_BioInfer.d801.s0.p1", "text": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain (MHC), actin, and mixed muscle proteins in nonfrail elders and younger women and men.", "text_with_entity_marker": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain ([E1]MHC[/E1]), [E2]actin[/E2], and mixed muscle proteins in nonfrail elders and younger women and men.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MHC", "entity_1_idx": [[141, 144]], "entity_1_idx_in_text_with_entity_marker": [145, 148], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[147, 152]], "entity_2_idx_in_text_with_entity_marker": [160, 165], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d801.s0_BioInfer.d801.s0.p2", "text": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, myosin heavy chain (MHC), actin, and mixed muscle proteins in nonfrail elders and younger women and men.", "text_with_entity_marker": "We determined whether short-term weight-lifting exercise increases the synthesis rate of the major contractile proteins, [E1]myosin heavy chain[/E1] ([E2]MHC[/E2]), actin, and mixed muscle proteins in nonfrail elders and younger women and men.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[121, 139]], "entity_1_idx_in_text_with_entity_marker": [125, 143], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "MHC", "entity_2_idx": [[141, 144]], "entity_2_idx_in_text_with_entity_marker": [154, 157], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d468.s0_BioInfer.d468.s0.p0", "text": "Opposite effects of cofilin and profilin from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.", "text_with_entity_marker": "Opposite effects of cofilin and [E1]profilin[/E1] from porcine brain on rate of exchange of [E2]actin[/E2]-bound adenosine 5'-triphosphate.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "profilin", "entity_1_idx": [[32, 40]], "entity_1_idx_in_text_with_entity_marker": [36, 44], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d468.s0_BioInfer.d468.s0.p1", "text": "Opposite effects of cofilin and profilin from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.", "text_with_entity_marker": "Opposite effects of [E1]cofilin[/E1] and [E2]profilin[/E2] from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "profilin", "entity_2_idx": [[32, 40]], "entity_2_idx_in_text_with_entity_marker": [45, 53], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d468.s0_BioInfer.d468.s0.p2", "text": "Opposite effects of cofilin and profilin from porcine brain on rate of exchange of actin-bound adenosine 5'-triphosphate.", "text_with_entity_marker": "Opposite effects of [E1]cofilin[/E1] and profilin from porcine brain on rate of exchange of [E2]actin[/E2]-bound adenosine 5'-triphosphate.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "cofilin", "entity_1_idx": [[20, 27]], "entity_1_idx_in_text_with_entity_marker": [24, 31], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "actin", "entity_2_idx": [[83, 88]], "entity_2_idx_in_text_with_entity_marker": [96, 101], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d172.s0_BioInfer.d172.s0.p0", "text": "Developmental changes in actin and myosin heavy chain isoform expression in smooth muscle.", "text_with_entity_marker": "Developmental changes in [E1]actin[/E1] and [E2]myosin heavy chain[/E2] isoform expression in smooth muscle.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[25, 30]], "entity_1_idx_in_text_with_entity_marker": [29, 34], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[35, 53]], "entity_2_idx_in_text_with_entity_marker": [48, 66], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d798.s0_BioInfer.d798.s0.p0", "text": "We conclude that germ-line involvement of MSH6 and MSH3 is rare and that other genes are likely to account for a majority of MSH2-, MLH1-mutation negative families with nonpolypotic colon cancer.", "text_with_entity_marker": "We conclude that germ-line involvement of [E1]MSH6[/E1] and MSH3 is rare and that other genes are likely to account for a majority of [E2]MSH2[/E2]-, MLH1-mutation negative families with nonpolypotic colon cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[125, 129]], "entity_2_idx_in_text_with_entity_marker": [138, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d798.s0_BioInfer.d798.s0.p1", "text": "We conclude that germ-line involvement of MSH6 and MSH3 is rare and that other genes are likely to account for a majority of MSH2-, MLH1-mutation negative families with nonpolypotic colon cancer.", "text_with_entity_marker": "We conclude that germ-line involvement of MSH6 and MSH3 is rare and that other genes are likely to account for a majority of [E1]MSH2[/E1]-, [E2]MLH1[/E2]-mutation negative families with nonpolypotic colon cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[125, 129]], "entity_1_idx_in_text_with_entity_marker": [129, 133], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MLH1", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d798.s0_BioInfer.d798.s0.p2", "text": "We conclude that germ-line involvement of MSH6 and MSH3 is rare and that other genes are likely to account for a majority of MSH2-, MLH1-mutation negative families with nonpolypotic colon cancer.", "text_with_entity_marker": "We conclude that germ-line involvement of MSH6 and [E1]MSH3[/E1] is rare and that other genes are likely to account for a majority of [E2]MSH2[/E2]-, MLH1-mutation negative families with nonpolypotic colon cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH2", "entity_2_idx": [[125, 129]], "entity_2_idx_in_text_with_entity_marker": [138, 142], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d798.s0_BioInfer.d798.s0.p3", "text": "We conclude that germ-line involvement of MSH6 and MSH3 is rare and that other genes are likely to account for a majority of MSH2-, MLH1-mutation negative families with nonpolypotic colon cancer.", "text_with_entity_marker": "We conclude that germ-line involvement of [E1]MSH6[/E1] and MSH3 is rare and that other genes are likely to account for a majority of MSH2-, [E2]MLH1[/E2]-mutation negative families with nonpolypotic colon cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MLH1", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d798.s0_BioInfer.d798.s0.p4", "text": "We conclude that germ-line involvement of MSH6 and MSH3 is rare and that other genes are likely to account for a majority of MSH2-, MLH1-mutation negative families with nonpolypotic colon cancer.", "text_with_entity_marker": "We conclude that germ-line involvement of [E1]MSH6[/E1] and [E2]MSH3[/E2] is rare and that other genes are likely to account for a majority of MSH2-, MLH1-mutation negative families with nonpolypotic colon cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[42, 46]], "entity_1_idx_in_text_with_entity_marker": [46, 50], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[51, 55]], "entity_2_idx_in_text_with_entity_marker": [64, 68], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d798.s0_BioInfer.d798.s0.p5", "text": "We conclude that germ-line involvement of MSH6 and MSH3 is rare and that other genes are likely to account for a majority of MSH2-, MLH1-mutation negative families with nonpolypotic colon cancer.", "text_with_entity_marker": "We conclude that germ-line involvement of MSH6 and [E1]MSH3[/E1] is rare and that other genes are likely to account for a majority of MSH2-, [E2]MLH1[/E2]-mutation negative families with nonpolypotic colon cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH3", "entity_1_idx": [[51, 55]], "entity_1_idx_in_text_with_entity_marker": [55, 59], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MLH1", "entity_2_idx": [[132, 136]], "entity_2_idx_in_text_with_entity_marker": [145, 149], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p10", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and [E2]vinculin[/E2] that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[161, 169]], "entity_2_idx_in_text_with_entity_marker": [174, 182], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p11", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, [E1]plakoglobin[/E1], [E2]p120[/E2], alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "plakoglobin", "entity_1_idx": [[124, 135]], "entity_1_idx_in_text_with_entity_marker": [128, 139], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p12", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, [E1]alpha-catenin[/E1], beta-catenin, [E2]plakoglobin[/E2], p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[95, 108]], "entity_1_idx_in_text_with_entity_marker": [99, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[124, 135]], "entity_2_idx_in_text_with_entity_marker": [137, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p13", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, [E1]beta-catenin[/E1], [E2]plakoglobin[/E2], p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[110, 122]], "entity_1_idx_in_text_with_entity_marker": [114, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[124, 135]], "entity_2_idx_in_text_with_entity_marker": [137, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p14", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], alpha-catenin, beta-catenin, [E2]plakoglobin[/E2], p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "plakoglobin", "entity_2_idx": [[124, 135]], "entity_2_idx_in_text_with_entity_marker": [137, 148], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p15", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, [E1]alpha-catenin[/E1], beta-catenin, plakoglobin, [E2]p120[/E2], alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[95, 108]], "entity_1_idx_in_text_with_entity_marker": [99, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p16", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, [E1]beta-catenin[/E1], plakoglobin, [E2]p120[/E2], alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[110, 122]], "entity_1_idx_in_text_with_entity_marker": [114, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p17", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], alpha-catenin, beta-catenin, plakoglobin, [E2]p120[/E2], alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[137, 141]], "entity_2_idx_in_text_with_entity_marker": [150, 154], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p18", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, [E1]alpha-catenin[/E1], [E2]beta-catenin[/E2], plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[95, 108]], "entity_1_idx_in_text_with_entity_marker": [99, 112], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[110, 122]], "entity_2_idx_in_text_with_entity_marker": [123, 135], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d227.s0_BioInfer.d227.s0.p19", "text": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of N-cadherin, alpha-catenin, beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "text_with_entity_marker": "Fusiform RPE, however, were not deficient in these proteins, expressing amounts of [E1]N-cadherin[/E1], [E2]alpha-catenin[/E2], beta-catenin, plakoglobin, p120, alpha-actinin and vinculin that were equivalent to epithelioid cells.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[83, 93]], "entity_1_idx_in_text_with_entity_marker": [87, 97], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[95, 108]], "entity_2_idx_in_text_with_entity_marker": [108, 121], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p0", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, [E1]MSH6[/E1], MLH1, and PMS2, but not [E2]MSH3[/E2], are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[63, 67]], "entity_1_idx_in_text_with_entity_marker": [67, 71], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p1", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, MSH6, [E1]MLH1[/E1], and PMS2, but not [E2]MSH3[/E2], are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p2", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, [E1]MSH2[/E1], MSH6, MLH1, and PMS2, but not [E2]MSH3[/E2], are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p3", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and [E1]PMS2[/E1], but not [E2]MSH3[/E2], are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "PMS2", "entity_1_idx": [[79, 83]], "entity_1_idx_in_text_with_entity_marker": [83, 87], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH3", "entity_2_idx": [[93, 97]], "entity_2_idx_in_text_with_entity_marker": [106, 110], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p4", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, [E1]MSH6[/E1], [E2]MLH1[/E2], and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[63, 67]], "entity_1_idx_in_text_with_entity_marker": [67, 71], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MLH1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p5", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, [E1]MSH2[/E1], [E2]MSH6[/E2], MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MSH6", "entity_2_idx": [[63, 67]], "entity_2_idx_in_text_with_entity_marker": [76, 80], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p6", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, [E1]MSH6[/E1], MLH1, and [E2]PMS2[/E2], but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH6", "entity_1_idx": [[63, 67]], "entity_1_idx_in_text_with_entity_marker": [67, 71], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS2", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p7", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, [E1]MSH2[/E1], MSH6, [E2]MLH1[/E2], and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MLH1", "entity_2_idx": [[69, 73]], "entity_2_idx_in_text_with_entity_marker": [82, 86], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p8", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, MSH2, MSH6, [E1]MLH1[/E1], and [E2]PMS2[/E2], but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MLH1", "entity_1_idx": [[69, 73]], "entity_1_idx_in_text_with_entity_marker": [73, 77], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS2", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d233.s0_BioInfer.d233.s0.p9", "text": "Germline mutations in several members of these families, MSH2, MSH6, MLH1, and PMS2, but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "text_with_entity_marker": "Germline mutations in several members of these families, [E1]MSH2[/E1], MSH6, MLH1, and [E2]PMS2[/E2], but not MSH3, are responsible for hereditary non-polyposis colorectal cancer.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MSH2", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "PMS2", "entity_2_idx": [[79, 83]], "entity_2_idx_in_text_with_entity_marker": [92, 96], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p80", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[96, 110], [130, 138]], "entity_1_idx_in_text_with_entity_marker": [100, 114], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p81", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p82", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[112, 113]], "entity_1_idx_in_text_with_entity_marker": [116, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p83", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P) and matrix (M) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p84", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E1]M[/E1]) proteins of MV and the H, [E2]F[/E2], NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[127, 128]], "entity_1_idx_in_text_with_entity_marker": [131, 132], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F", "entity_2_idx": [[156, 157], [168, 176]], "entity_2_idx_in_text_with_entity_marker": [169, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p85", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p86", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein ([E2]NP[/E2]), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[91, 93]], "entity_2_idx_in_text_with_entity_marker": [104, 106], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p87", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin ([E1]H[/E1]), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "H", "entity_1_idx": [[53, 54]], "entity_1_idx_in_text_with_entity_marker": [57, 58], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p88", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein ([E1]NP[/E1]), phosphoprotein ([E2]P[/E2]) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[91, 93]], "entity_1_idx_in_text_with_entity_marker": [95, 97], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[112, 113]], "entity_2_idx_in_text_with_entity_marker": [125, 126], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d480.s0_BioInfer.d480.s0.p89", "text": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein (P) and matrix (M) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "text_with_entity_marker": "Panels of six to 31 MAbs against the haemagglutinin (H), fusion (F), nucleocapsid protein (NP), phosphoprotein ([E1]P[/E1]) and matrix ([E2]M[/E2]) proteins of MV and the H, F, NP and P proteins of CDV were employed.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[112, 113]], "entity_1_idx_in_text_with_entity_marker": [116, 117], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[127, 128]], "entity_2_idx_in_text_with_entity_marker": [140, 141], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d201.s0_BioInfer.d201.s0.p0", "text": "Expression of actin and myosin heavy chain genes in skeletal, cardiac and uterine muscles of young and old rats.", "text_with_entity_marker": "Expression of [E1]actin[/E1] and [E2]myosin heavy chain[/E2] genes in skeletal, cardiac and uterine muscles of young and old rats.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[24, 42]], "entity_2_idx_in_text_with_entity_marker": [37, 55], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p10", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, [E1]TRAIL[/E1], TRADD, [E2]RIP[/E2], and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAIL", "entity_1_idx": [[219, 224]], "entity_1_idx_in_text_with_entity_marker": [223, 228], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[233, 236]], "entity_2_idx_in_text_with_entity_marker": [246, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p11", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, [E1]TNF-R1[/E1], [E2]TRAIL[/E2], TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R1", "entity_1_idx": [[211, 217]], "entity_1_idx_in_text_with_entity_marker": [215, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[219, 224]], "entity_2_idx_in_text_with_entity_marker": [232, 237], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p12", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], Fas ligand, TNF-R1, [E2]TRAIL[/E2], TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[219, 224]], "entity_2_idx_in_text_with_entity_marker": [232, 237], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p13", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, [E1]TRAIL[/E1], [E2]TRADD[/E2], RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAIL", "entity_1_idx": [[219, 224]], "entity_1_idx_in_text_with_entity_marker": [223, 228], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRADD", "entity_2_idx": [[226, 231]], "entity_2_idx_in_text_with_entity_marker": [239, 244], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p14", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, [E1]Fas ligand[/E1], TNF-R1, [E2]TRAIL[/E2], TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[199, 209]], "entity_1_idx_in_text_with_entity_marker": [203, 213], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "TRAIL", "entity_2_idx": [[219, 224]], "entity_2_idx_in_text_with_entity_marker": [232, 237], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p15", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, [E1]TRAIL[/E1], TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for [E2]FAF[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAIL", "entity_1_idx": [[219, 224]], "entity_1_idx_in_text_with_entity_marker": [223, 228], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[333, 336]], "entity_2_idx_in_text_with_entity_marker": [346, 349], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p16", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, [E1]TRAIL[/E1], TRADD, RIP, and caspase-8, and an up to twofold increase for [E2]FADD[/E2] and FAP, but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRAIL", "entity_1_idx": [[219, 224]], "entity_1_idx_in_text_with_entity_marker": [223, 228], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FADD", "entity_2_idx": [[287, 291]], "entity_2_idx_in_text_with_entity_marker": [300, 304], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p17", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, [E1]RIP[/E1], and caspase-8, and an up to twofold increase for FADD and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIP", "entity_1_idx": [[233, 236]], "entity_1_idx_in_text_with_entity_marker": [237, 240], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p18", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, [E1]TNF-R1[/E1], TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNF-R1", "entity_1_idx": [[211, 217]], "entity_1_idx_in_text_with_entity_marker": [215, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s0_BioInfer.d148.s0.p19", "text": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for Fas, Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and FAP, but there was little change for FAF.", "text_with_entity_marker": "Compared with control and contralateral kidneys, the ligated kidneys displayed a dynamic expression of mRNAs for many apoptosis-related molecules, which included an up to threefold increase for [E1]Fas[/E1], Fas ligand, TNF-R1, TRAIL, TRADD, RIP, and caspase-8, and an up to twofold increase for FADD and [E2]FAP[/E2], but there was little change for FAF.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[194, 197]], "entity_1_idx_in_text_with_entity_marker": [198, 201], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[296, 299]], "entity_2_idx_in_text_with_entity_marker": [309, 312], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p25", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], TRAIL, FADD, TRADD, RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p26", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, [E2]FAF[/E2], FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAF", "entity_2_idx": [[185, 188]], "entity_2_idx_in_text_with_entity_marker": [198, 201], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p27", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, [E1]TRADD[/E1], RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRADD", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p28", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, [E1]RIP[/E1], FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RIP", "entity_1_idx": [[180, 183]], "entity_1_idx_in_text_with_entity_marker": [184, 187], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p29", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, [E1]FAP[/E1], and [E2]caspase-8[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FAP", "entity_1_idx": [[190, 193]], "entity_1_idx_in_text_with_entity_marker": [194, 197], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "caspase-8", "entity_2_idx": [[199, 208]], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p30", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, [E1]FADD[/E1], TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "FADD", "entity_1_idx": [[167, 171]], "entity_1_idx_in_text_with_entity_marker": [171, 175], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p31", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, [E1]Fas ligand[/E1], TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas ligand", "entity_1_idx": [[140, 150]], "entity_1_idx_in_text_with_entity_marker": [144, 154], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p32", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, [E1]TNFR-1[/E1], TRAIL, FADD, TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TNFR-1", "entity_1_idx": [[152, 158]], "entity_1_idx_in_text_with_entity_marker": [156, 162], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p33", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for [E1]Fas[/E1], Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, [E2]FAP[/E2], and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Fas", "entity_1_idx": [[135, 138]], "entity_1_idx_in_text_with_entity_marker": [139, 142], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "FAP", "entity_2_idx": [[190, 193]], "entity_2_idx_in_text_with_entity_marker": [203, 206], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d148.s1_BioInfer.d148.s1.p34", "text": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, TRADD, RIP, FAF, FAP, and caspase-8.", "text_with_entity_marker": "To detect the expression of apoptosis-related molecules, ribonuclease protection assay was used with specific antisense RNA probes for Fas, Fas ligand, TNFR-1, TRAIL, FADD, [E1]TRADD[/E1], [E2]RIP[/E2], FAF, FAP, and caspase-8.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "TRADD", "entity_1_idx": [[173, 178]], "entity_1_idx_in_text_with_entity_marker": [177, 182], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RIP", "entity_2_idx": [[180, 183]], "entity_2_idx_in_text_with_entity_marker": [193, 196], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d776.s0_BioInfer.d776.s0.p0", "text": "Treatment of cells with gamma linolenic acid (GLA) increased alpha catenin expression in most cell lines, while beta catenin levels were reduced, and gamma catenin expression was unchanged.", "text_with_entity_marker": "Treatment of cells with gamma linolenic acid (GLA) increased alpha catenin expression in most cell lines, while [E1]beta catenin[/E1] levels were reduced, and [E2]gamma catenin[/E2] expression was unchanged.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta catenin", "entity_1_idx": [[112, 124]], "entity_1_idx_in_text_with_entity_marker": [116, 128], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma catenin", "entity_2_idx": [[150, 163]], "entity_2_idx_in_text_with_entity_marker": [163, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d776.s0_BioInfer.d776.s0.p1", "text": "Treatment of cells with gamma linolenic acid (GLA) increased alpha catenin expression in most cell lines, while beta catenin levels were reduced, and gamma catenin expression was unchanged.", "text_with_entity_marker": "Treatment of cells with gamma linolenic acid (GLA) increased [E1]alpha catenin[/E1] expression in most cell lines, while [E2]beta catenin[/E2] levels were reduced, and gamma catenin expression was unchanged.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha catenin", "entity_1_idx": [[61, 74]], "entity_1_idx_in_text_with_entity_marker": [65, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta catenin", "entity_2_idx": [[112, 124]], "entity_2_idx_in_text_with_entity_marker": [125, 137], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d776.s0_BioInfer.d776.s0.p2", "text": "Treatment of cells with gamma linolenic acid (GLA) increased alpha catenin expression in most cell lines, while beta catenin levels were reduced, and gamma catenin expression was unchanged.", "text_with_entity_marker": "Treatment of cells with gamma linolenic acid (GLA) increased [E1]alpha catenin[/E1] expression in most cell lines, while beta catenin levels were reduced, and [E2]gamma catenin[/E2] expression was unchanged.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha catenin", "entity_1_idx": [[61, 74]], "entity_1_idx_in_text_with_entity_marker": [65, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "gamma catenin", "entity_2_idx": [[150, 163]], "entity_2_idx_in_text_with_entity_marker": [163, 176], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p0", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of [E1]N-cadherin[/E1], beta-catenin, [E2]alpha-catenin[/E2] and p120, by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[73, 86]], "entity_2_idx_in_text_with_entity_marker": [86, 99], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p1", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of [E1]N-cadherin[/E1], [E2]beta-catenin[/E2], alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "beta-catenin", "entity_2_idx": [[59, 71]], "entity_2_idx_in_text_with_entity_marker": [72, 84], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p2", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of [E1]N-cadherin[/E1], beta-catenin, alpha-catenin and [E2]p120[/E2], by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N-cadherin", "entity_1_idx": [[47, 57]], "entity_1_idx_in_text_with_entity_marker": [51, 61], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p3", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of N-cadherin, [E1]beta-catenin[/E1], [E2]alpha-catenin[/E2] and p120, by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[59, 71]], "entity_1_idx_in_text_with_entity_marker": [63, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[73, 86]], "entity_2_idx_in_text_with_entity_marker": [86, 99], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p4", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, [E1]alpha-catenin[/E1] and [E2]p120[/E2], by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[73, 86]], "entity_1_idx_in_text_with_entity_marker": [77, 90], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d112.s0_BioInfer.d112.s0.p5", "text": "Both types of beads induced the recruitment of N-cadherin, beta-catenin, alpha-catenin and p120, by lateral mobilization of preexisting cell membrane complexes.", "text_with_entity_marker": "Both types of beads induced the recruitment of N-cadherin, [E1]beta-catenin[/E1], alpha-catenin and [E2]p120[/E2], by lateral mobilization of preexisting cell membrane complexes.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[59, 71]], "entity_1_idx_in_text_with_entity_marker": [63, 75], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "p120", "entity_2_idx": [[91, 95]], "entity_2_idx_in_text_with_entity_marker": [104, 108], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p20", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, [E2]sarcomeric actin[/E2], Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "sarcomeric actin", "entity_2_idx": [[156, 172]], "entity_2_idx_in_text_with_entity_marker": [169, 185], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p21", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, [E1]nestin[/E1], myosin heavy chain, sarcomeric actin, [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nestin", "entity_1_idx": [[128, 134]], "entity_1_idx_in_text_with_entity_marker": [132, 138], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p22", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, [E1]myosin heavy chain[/E1], sarcomeric actin, [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "myosin heavy chain", "entity_1_idx": [[136, 154]], "entity_1_idx_in_text_with_entity_marker": [140, 158], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p23", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p24", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], nestin, myosin heavy chain, sarcomeric actin, [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p25", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, [E2]Myf-5[/E2], MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "Myf-5", "entity_2_idx": [[174, 179]], "entity_2_idx_in_text_with_entity_marker": [187, 192], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p26", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, [E1]nestin[/E1], [E2]myosin heavy chain[/E2], sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nestin", "entity_1_idx": [[128, 134]], "entity_1_idx_in_text_with_entity_marker": [132, 138], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[136, 154]], "entity_2_idx_in_text_with_entity_marker": [149, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p27", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, [E2]nestin[/E2], myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nestin", "entity_2_idx": [[128, 134]], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p28", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], [E2]nestin[/E2], myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nestin", "entity_2_idx": [[128, 134]], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p29", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, [E2]nestin[/E2], myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "nestin", "entity_2_idx": [[128, 134]], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p30", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with desmin, nestin, [E2]myosin heavy chain[/E2], sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[136, 154]], "entity_2_idx_in_text_with_entity_marker": [149, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p31", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with [E1]desmin[/E1], nestin, [E2]myosin heavy chain[/E2], sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[120, 126]], "entity_1_idx_in_text_with_entity_marker": [124, 130], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[136, 154]], "entity_2_idx_in_text_with_entity_marker": [149, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p32", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with desmin, nestin, [E2]myosin heavy chain[/E2], sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "myosin heavy chain", "entity_2_idx": [[136, 154]], "entity_2_idx_in_text_with_entity_marker": [149, 167], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p33", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned Myf-5 and [E1]MyoD[/E1] mutant embryos with antibodies reactive with [E2]desmin[/E2], nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "MyoD", "entity_1_idx": [[70, 74]], "entity_1_idx_in_text_with_entity_marker": [74, 78], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[120, 126]], "entity_2_idx_in_text_with_entity_marker": [133, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p34", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and [E2]MyoD[/E2] mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "MyoD", "entity_2_idx": [[70, 74]], "entity_2_idx_in_text_with_entity_marker": [83, 87], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d316.s0_BioInfer.d316.s0.p35", "text": "In addition, we performed immunohistochemistry on sectioned Myf-5 and MyoD mutant embryos with antibodies reactive with desmin, nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "text_with_entity_marker": "In addition, we performed immunohistochemistry on sectioned [E1]Myf-5[/E1] and MyoD mutant embryos with antibodies reactive with [E2]desmin[/E2], nestin, myosin heavy chain, sarcomeric actin, Myf-5, MyoD and myogenin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Myf-5", "entity_1_idx": [[60, 65]], "entity_1_idx_in_text_with_entity_marker": [64, 69], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "desmin", "entity_2_idx": [[120, 126]], "entity_2_idx_in_text_with_entity_marker": [133, 139], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p0", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "[E1]p53[/E1]-mediated cell injury exhibited proteolysis of the [E2]caspase[/E2] protein substrate lamin B without appreciable breakdown of TnI.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "caspase", "entity_2_idx": [[54, 61]], "entity_2_idx_in_text_with_entity_marker": [67, 74], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p1", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "[E1]p53[/E1]-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of [E2]TnI[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p2", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "[E1]p53[/E1]-mediated cell injury exhibited proteolysis of the caspase protein substrate [E2]lamin B[/E2] without appreciable breakdown of TnI.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p53", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "lamin B", "entity_2_idx": [[80, 87]], "entity_2_idx_in_text_with_entity_marker": [93, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p3", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "p53-mediated cell injury exhibited proteolysis of the [E1]caspase[/E1] protein substrate lamin B without appreciable breakdown of [E2]TnI[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "caspase", "entity_1_idx": [[54, 61]], "entity_1_idx_in_text_with_entity_marker": [58, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p4", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "p53-mediated cell injury exhibited proteolysis of the [E1]caspase[/E1] protein substrate [E2]lamin B[/E2] without appreciable breakdown of TnI.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "caspase", "entity_1_idx": [[54, 61]], "entity_1_idx_in_text_with_entity_marker": [58, 65], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "lamin B", "entity_2_idx": [[80, 87]], "entity_2_idx_in_text_with_entity_marker": [93, 100], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d470.s0_BioInfer.d470.s0.p5", "text": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate lamin B without appreciable breakdown of TnI.", "text_with_entity_marker": "p53-mediated cell injury exhibited proteolysis of the caspase protein substrate [E1]lamin B[/E1] without appreciable breakdown of [E2]TnI[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "lamin B", "entity_1_idx": [[80, 87]], "entity_1_idx_in_text_with_entity_marker": [84, 91], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "TnI", "entity_2_idx": [[121, 124]], "entity_2_idx_in_text_with_entity_marker": [134, 137], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p0", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, [E2]P[/E2] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[228, 229]], "entity_2_idx_in_text_with_entity_marker": [241, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p1", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p2", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and [E1]phosphoprotein[/E1] (P) gene sequences; another, [E2]P[/E2] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[184, 198]], "entity_1_idx_in_text_with_entity_marker": [188, 202], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[228, 229]], "entity_2_idx_in_text_with_entity_marker": [241, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p3", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein ([E1]NP[/E1]) and phosphoprotein (P) gene sequences; another, [E2]P[/E2] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[176, 178]], "entity_1_idx_in_text_with_entity_marker": [180, 182], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[228, 229]], "entity_2_idx_in_text_with_entity_marker": [241, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p4", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p5", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p6", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein ([E1]P[/E1]) gene sequences; another, [E2]P[/E2] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[200, 201]], "entity_1_idx_in_text_with_entity_marker": [204, 205], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[228, 229]], "entity_2_idx_in_text_with_entity_marker": [241, 242], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p7", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and [E2]membrane protein[/E2] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "membrane protein", "entity_2_idx": [[234, 250]], "entity_2_idx_in_text_with_entity_marker": [247, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p8", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p9", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, M and [E2]fusion protein[/E2] (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fusion protein", "entity_2_idx": [[286, 300]], "entity_2_idx_in_text_with_entity_marker": [299, 313], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p10", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein ([E2]HN[/E2]) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HN", "entity_2_idx": [[379, 381]], "entity_2_idx_in_text_with_entity_marker": [392, 394], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p11", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, [E1]P[/E1] and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and [E2]hemagglutinin-neuraminidase protein[/E2] (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[228, 229]], "entity_1_idx_in_text_with_entity_marker": [232, 233], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "hemagglutinin-neuraminidase protein", "entity_2_idx": [[342, 377]], "entity_2_idx_in_text_with_entity_marker": [355, 390], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p12", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, [E2]M[/E2] and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[280, 281]], "entity_2_idx_in_text_with_entity_marker": [293, 294], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p13", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and [E2]phosphoprotein[/E2] (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "phosphoprotein", "entity_2_idx": [[184, 198]], "entity_2_idx_in_text_with_entity_marker": [197, 211], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p14", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] ([E2]NP[/E2]) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "NP", "entity_2_idx": [[176, 178]], "entity_2_idx_in_text_with_entity_marker": [189, 191], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p15", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, [E2]F0[/E2] and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[335, 337]], "entity_2_idx_in_text_with_entity_marker": [348, 350], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p16", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein ([E2]M[/E2]) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "M", "entity_2_idx": [[252, 253]], "entity_2_idx_in_text_with_entity_marker": [265, 266], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p17", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein ([E2]P[/E2]) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "P", "entity_2_idx": [[200, 201]], "entity_2_idx_in_text_with_entity_marker": [213, 214], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p18", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and [E2]membrane protein[/E2] (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "membrane protein", "entity_2_idx": [[234, 250]], "entity_2_idx_in_text_with_entity_marker": [247, 263], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d121.s0_BioInfer.d121.s0.p19", "text": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains nucleocapsid protein (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein (F0) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "text_with_entity_marker": "By this method, it was shown that four of these large RNA species are polycistronic transcripts containing sequences from two genes: one species contains [E1]nucleocapsid protein[/E1] (NP) and phosphoprotein (P) gene sequences; another, P and membrane protein (M) gene sequences; another, M and fusion protein ([E2]F0[/E2]) gene sequences; and another, F0 and hemagglutinin-neuraminidase protein (HN) gene sequences.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[154, 174]], "entity_1_idx_in_text_with_entity_marker": [158, 178], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "F0", "entity_2_idx": [[302, 304]], "entity_2_idx_in_text_with_entity_marker": [315, 317], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p30", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein ([E1]P[/E1]), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p31", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p32", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion ([E1]F[/E1]), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[86, 87]], "entity_1_idx_in_text_with_entity_marker": [90, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p33", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p34", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p35", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p36", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and [E1]large protein[/E1] (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large protein", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p37", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p38", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E1]N[/E1]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, [E2]L[/E2]: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[245, 246]], "entity_1_idx_in_text_with_entity_marker": [249, 250], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[301, 302]], "entity_2_idx_in_text_with_entity_marker": [314, 315], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p39", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E1]L[/E1]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, [E2]M[/E2]: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[109, 110]], "entity_1_idx_in_text_with_entity_marker": [113, 114], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "M", "entity_2_idx": [[273, 274]], "entity_2_idx_in_text_with_entity_marker": [286, 287], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p40", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), [E1]fusion[/E1] (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "fusion", "entity_1_idx": [[78, 84], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [82, 88], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p41", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein ([E1]P[/E1]), matrix (M), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[62, 63]], "entity_1_idx_in_text_with_entity_marker": [66, 67], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p42", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid ([E1]N[/E1]), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[42, 43]], "entity_1_idx_in_text_with_entity_marker": [46, 47], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p43", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion ([E1]F[/E1]), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "F", "entity_1_idx": [[86, 87]], "entity_1_idx_in_text_with_entity_marker": [90, 91], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p44", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of [E1]nucleocapsid[/E1] (N), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid", "entity_1_idx": [[28, 40], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [32, 44], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p45", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), [E1]matrix[/E1] (M), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "matrix", "entity_1_idx": [[66, 72], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [70, 76], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p46", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), [E1]phosphoprotein[/E1] (P), matrix (M), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[46, 60], [100, 107]], "entity_1_idx_in_text_with_entity_marker": [50, 64], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p47", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and [E1]large protein[/E1] ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "large protein", "entity_1_idx": [[94, 107]], "entity_1_idx_in_text_with_entity_marker": [98, 111], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p48", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix ([E1]M[/E1]), fusion (F), and large protein ([E2]L[/E2]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "M", "entity_1_idx": [[74, 75]], "entity_1_idx_in_text_with_entity_marker": [78, 79], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "L", "entity_2_idx": [[109, 110]], "entity_2_idx_in_text_with_entity_marker": [122, 123], "entity_2_type": "Gene", "entity_2_type_id": 3}], "directed": false, "reverse": false}
{"id": "BioInfer.d653.s0_BioInfer.d653.s0.p49", "text": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein (L) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position N: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "text_with_entity_marker": "The nucleotide sequences of nucleocapsid (N), phosphoprotein (P), matrix (M), fusion (F), and large protein ([E1]L[/E1]) genes were partly determined for 19 wild strains of measles virus (MV) isolated over the past 10 years in Japan (nucleotide position [E2]N[/E2]: 1301-1700, P: 1751-2190, M: 3571-4057, F: 6621-7210, L: 10381-11133) and also for a MV strain obtained from a patient with subacute sclerosing panencephalitis (SSPE) who had natural measles in 1980.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "L", "entity_1_idx": [[109, 110]], "entity_1_idx_in_text_with_entity_marker": [113, 114], "entity_1_type": "Gene", "entity_1_type_id": 3, "entity_2": "N", "entity_2_idx": [[245, 246]], "entity_2_idx_in_text_with_entity_marker": [258, 259], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d443.s0_BioInfer.d443.s0.p0", "text": "Mutations in BUD3, BUD4, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "text_with_entity_marker": "Mutations in BUD3, [E1]BUD4[/E1], and [E2]AXL1[/E2] cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BUD4", "entity_1_idx": [[19, 23]], "entity_1_idx_in_text_with_entity_marker": [23, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "AXL1", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d443.s0_BioInfer.d443.s0.p1", "text": "Mutations in BUD3, BUD4, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "text_with_entity_marker": "Mutations in [E1]BUD3[/E1], [E2]BUD4[/E2], and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BUD3", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "BUD4", "entity_2_idx": [[19, 23]], "entity_2_idx_in_text_with_entity_marker": [32, 36], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d443.s0_BioInfer.d443.s0.p2", "text": "Mutations in BUD3, BUD4, and AXL1 cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "text_with_entity_marker": "Mutations in [E1]BUD3[/E1], BUD4, and [E2]AXL1[/E2] cause a and alpha cells to exhibit the bipolar pattern, indicating that these genes are necessary to specify the axial budding pattern (Chant, J., and I. Herskowitz. 1991. Cell. 65:1203-1212; Fujita, A., C. Oka, Y. Arikawa, T. Katagi, A. Tonouchi, S. Kuhara, and Y. Misumi. 1994. Nature (Lond.). 372:567-570).", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "BUD3", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "AXL1", "entity_2_idx": [[29, 33]], "entity_2_idx_in_text_with_entity_marker": [42, 46], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d145.s0_BioInfer.d145.s0.p0", "text": "cDNA clones of the N, P, and L genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "text_with_entity_marker": "cDNA clones of the [E1]N[/E1], [E2]P[/E2], and L genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[19, 20]], "entity_1_idx_in_text_with_entity_marker": [23, 24], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "P", "entity_2_idx": [[22, 23]], "entity_2_idx_in_text_with_entity_marker": [35, 36], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d145.s0_BioInfer.d145.s0.p1", "text": "cDNA clones of the N, P, and L genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "text_with_entity_marker": "cDNA clones of the N, [E1]P[/E1], and [E2]L[/E2] genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "P", "entity_1_idx": [[22, 23]], "entity_1_idx_in_text_with_entity_marker": [26, 27], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[29, 30]], "entity_2_idx_in_text_with_entity_marker": [42, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d145.s0_BioInfer.d145.s0.p2", "text": "cDNA clones of the N, P, and L genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "text_with_entity_marker": "cDNA clones of the [E1]N[/E1], P, and [E2]L[/E2] genes were constructed in pGEM-based expression plasmids and shown to direct expression of the appropriate polypeptides.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "N", "entity_1_idx": [[19, 20]], "entity_1_idx_in_text_with_entity_marker": [23, 24], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "L", "entity_2_idx": [[29, 30]], "entity_2_idx_in_text_with_entity_marker": [42, 43], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d365.s0_BioInfer.d365.s0.p20", "text": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, beta-catenin, and gamma-catenin, but not with antibodies to P-cadherin, alpha-catenin, or with pan-desmocollin and pan-desmoglein antibodies.", "text_with_entity_marker": "In the basal layer, patches of brightly labeled cells were detected with antibodies to E-cadherin, [E1]beta-catenin[/E1], and gamma-catenin, but not with antibodies to P-cadherin, [E2]alpha-catenin[/E2], or with pan-desmocollin and pan-desmoglein antibodies.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[99, 111]], "entity_1_idx_in_text_with_entity_marker": [103, 115], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-catenin", "entity_2_idx": [[171, 184]], "entity_2_idx_in_text_with_entity_marker": [184, 197], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p0", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), [E1]phosphoprotein[/E1] (P), [E2]V protein[/E2], matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phosphoprotein", "entity_1_idx": [[71, 85]], "entity_1_idx_in_text_with_entity_marker": [75, 89], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V protein", "entity_2_idx": [[91, 100]], "entity_2_idx_in_text_with_entity_marker": [104, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p1", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), [E2]fusion protein[/E2] (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "fusion protein", "entity_2_idx": [[122, 136]], "entity_2_idx_in_text_with_entity_marker": [135, 149], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p2", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), fusion protein (F), [E2]small hydrophobic[/E2] (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "small hydrophobic", "entity_2_idx": [[142, 159], [165, 172]], "entity_2_idx_in_text_with_entity_marker": [155, 172], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p3", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, [E1]nucleocapsid protein[/E1] (NP), phosphoprotein (P), [E2]V protein[/E2], matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "nucleocapsid protein", "entity_1_idx": [[44, 64]], "entity_1_idx_in_text_with_entity_marker": [48, 68], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V protein", "entity_2_idx": [[91, 100]], "entity_2_idx_in_text_with_entity_marker": [104, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p4", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and [E2]large[/E2] (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "large", "entity_2_idx": [[220, 225], [230, 237]], "entity_2_idx_in_text_with_entity_marker": [233, 238], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p5", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein ([E2]M[/E2]), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "M", "entity_2_idx": [[118, 119]], "entity_2_idx_in_text_with_entity_marker": [131, 132], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p6", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase ([E2]HN[/E2]) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "HN", "entity_2_idx": [[204, 206]], "entity_2_idx_in_text_with_entity_marker": [217, 219], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p7", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein ([E1]NP[/E1]), phosphoprotein (P), [E2]V protein[/E2], matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NP", "entity_1_idx": [[66, 68]], "entity_1_idx_in_text_with_entity_marker": [70, 72], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "V protein", "entity_2_idx": [[91, 100]], "entity_2_idx_in_text_with_entity_marker": [104, 113], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p8", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], [E2]matrix protein[/E2] (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "matrix protein", "entity_2_idx": [[102, 116]], "entity_2_idx_in_text_with_entity_marker": [115, 129], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d560.s0_BioInfer.d560.s0.p9", "text": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), V protein, matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, haemagglutinin-neuraminidase (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "text_with_entity_marker": "The 16236 nt genome encodes eight proteins, nucleocapsid protein (NP), phosphoprotein (P), [E1]V protein[/E1], matrix protein (M), fusion protein (F), small hydrophobic (SH) protein, [E2]haemagglutinin-neuraminidase[/E2] (HN) protein and large (L) protein, which are flanked by a 55 nt leader sequence and a 54 nt trailer sequence.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "V protein", "entity_1_idx": [[91, 100]], "entity_1_idx_in_text_with_entity_marker": [95, 104], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "haemagglutinin-neuraminidase", "entity_2_idx": [[174, 202], [208, 215]], "entity_2_idx_in_text_with_entity_marker": [187, 215], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p0", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of [E1]E-cadherin[/E1] (E-Cad), alpha-catenin (A-Cat) and [E2]beta-catenin[/E2] (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[65, 75]], "entity_1_idx_in_text_with_entity_marker": [69, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[111, 123]], "entity_2_idx_in_text_with_entity_marker": [124, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p1", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin ([E1]A-Cat[/E1]) and [E2]beta-catenin[/E2] (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "A-Cat", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[111, 123]], "entity_2_idx_in_text_with_entity_marker": [124, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p2", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), [E1]alpha-catenin[/E1] (A-Cat) and [E2]beta-catenin[/E2] (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[85, 98]], "entity_1_idx_in_text_with_entity_marker": [89, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[111, 123]], "entity_2_idx_in_text_with_entity_marker": [124, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p3", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and [E1]beta-catenin[/E1] ([E2]B-Cat[/E2]) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "beta-catenin", "entity_1_idx": [[111, 123]], "entity_1_idx_in_text_with_entity_marker": [115, 127], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "B-Cat", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p4", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin ([E1]E-Cad[/E1]), alpha-catenin (A-Cat) and [E2]beta-catenin[/E2] (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-Cad", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "beta-catenin", "entity_2_idx": [[111, 123]], "entity_2_idx_in_text_with_entity_marker": [124, 136], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p5", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of [E1]E-cadherin[/E1] (E-Cad), alpha-catenin ([E2]A-Cat[/E2]) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[65, 75]], "entity_1_idx_in_text_with_entity_marker": [69, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-Cat", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p6", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of [E1]E-cadherin[/E1] (E-Cad), [E2]alpha-catenin[/E2] (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[65, 75]], "entity_1_idx_in_text_with_entity_marker": [69, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[85, 98]], "entity_2_idx_in_text_with_entity_marker": [98, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p7", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of [E1]E-cadherin[/E1] (E-Cad), alpha-catenin (A-Cat) and beta-catenin ([E2]B-Cat[/E2]) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[65, 75]], "entity_1_idx_in_text_with_entity_marker": [69, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "B-Cat", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p8", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of [E1]E-cadherin[/E1] ([E2]E-Cad[/E2]), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-cadherin", "entity_1_idx": [[65, 75]], "entity_1_idx_in_text_with_entity_marker": [69, 79], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "E-Cad", "entity_2_idx": [[77, 82]], "entity_2_idx_in_text_with_entity_marker": [90, 95], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p9", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), [E1]alpha-catenin[/E1] ([E2]A-Cat[/E2]) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[85, 98]], "entity_1_idx_in_text_with_entity_marker": [89, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-Cat", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p10", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin ([E1]A-Cat[/E1]) and beta-catenin ([E2]B-Cat[/E2]) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "A-Cat", "entity_1_idx": [[100, 105]], "entity_1_idx_in_text_with_entity_marker": [104, 109], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "B-Cat", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p11", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin ([E1]E-Cad[/E1]), alpha-catenin ([E2]A-Cat[/E2]) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-Cad", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "A-Cat", "entity_2_idx": [[100, 105]], "entity_2_idx_in_text_with_entity_marker": [113, 118], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p12", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), [E1]alpha-catenin[/E1] (A-Cat) and beta-catenin ([E2]B-Cat[/E2]) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-catenin", "entity_1_idx": [[85, 98]], "entity_1_idx_in_text_with_entity_marker": [89, 102], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "B-Cat", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p13", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin ([E1]E-Cad[/E1]), [E2]alpha-catenin[/E2] (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-Cad", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "alpha-catenin", "entity_2_idx": [[85, 98]], "entity_2_idx_in_text_with_entity_marker": [98, 111], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d424.s0_BioInfer.d424.s0.p14", "text": "METHODS: We immunohistochemically investigated the expression of E-cadherin (E-Cad), alpha-catenin (A-Cat) and beta-catenin (B-Cat) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "text_with_entity_marker": "METHODS: We immunohistochemically investigated the expression of E-cadherin ([E1]E-Cad[/E1]), alpha-catenin (A-Cat) and beta-catenin ([E2]B-Cat[/E2]) during human intrahepatic bile duct development, using 31 fetal livers of various gestational ages.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "E-Cad", "entity_1_idx": [[77, 82]], "entity_1_idx_in_text_with_entity_marker": [81, 86], "entity_1_type": "Individual_protein", "entity_1_type_id": 0, "entity_2": "B-Cat", "entity_2_idx": [[125, 130]], "entity_2_idx_in_text_with_entity_marker": [138, 143], "entity_2_type": "Individual_protein", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "BioInfer.d153.s0_BioInfer.d153.s0.p0", "text": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins vinculin and talin.", "text_with_entity_marker": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in [E1]actin[/E1] cytoarchitecture and the distribution of focal contact proteins vinculin and [E2]talin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[194, 199]], "entity_1_idx_in_text_with_entity_marker": [198, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[277, 282]], "entity_2_idx_in_text_with_entity_marker": [290, 295], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d153.s0_BioInfer.d153.s0.p1", "text": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins vinculin and talin.", "text_with_entity_marker": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in [E1]actin[/E1] cytoarchitecture and the distribution of focal contact proteins [E2]vinculin[/E2] and talin.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[194, 199]], "entity_1_idx_in_text_with_entity_marker": [198, 203], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[264, 272]], "entity_2_idx_in_text_with_entity_marker": [277, 285], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d153.s0_BioInfer.d153.s0.p2", "text": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins vinculin and talin.", "text_with_entity_marker": "Confluent calf pulmonary artery endothelial monolayers exposed to 95% oxygen for 1, 2, or 3 days exhibit a time-dependent increase in adherence to substratum, which closely parallels changes in actin cytoarchitecture and the distribution of focal contact proteins [E1]vinculin[/E1] and [E2]talin[/E2].", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[264, 272]], "entity_1_idx_in_text_with_entity_marker": [268, 276], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[277, 282]], "entity_2_idx_in_text_with_entity_marker": [290, 295], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d207.s0_BioInfer.d207.s0.p0", "text": "Features studied were actin, microtubules, vinculin, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "text_with_entity_marker": "Features studied were [E1]actin[/E1], microtubules, vinculin, and [E2]talin[/E2], using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d207.s0_BioInfer.d207.s0.p1", "text": "Features studied were actin, microtubules, vinculin, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "text_with_entity_marker": "Features studied were actin, microtubules, [E1]vinculin[/E1], and [E2]talin[/E2], using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vinculin", "entity_1_idx": [[43, 51]], "entity_1_idx_in_text_with_entity_marker": [47, 55], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "talin", "entity_2_idx": [[57, 62]], "entity_2_idx_in_text_with_entity_marker": [70, 75], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d207.s0_BioInfer.d207.s0.p2", "text": "Features studied were actin, microtubules, vinculin, and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "text_with_entity_marker": "Features studied were [E1]actin[/E1], microtubules, [E2]vinculin[/E2], and talin, using immunofluorescence, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and immunoblotting; permeability of the cell sheet; wound healing; and phagocytic capacity.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "actin", "entity_1_idx": [[22, 27]], "entity_1_idx_in_text_with_entity_marker": [26, 31], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "vinculin", "entity_2_idx": [[43, 51]], "entity_2_idx_in_text_with_entity_marker": [56, 64], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p10", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p11", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, [E1]alpha-smooth muscle actin[/E1] and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "alpha-smooth muscle actin", "entity_1_idx": [[63, 88]], "entity_1_idx_in_text_with_entity_marker": [67, 92], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p12", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, [E1]Factor-XIIIa[/E1], alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Factor-XIIIa", "entity_1_idx": [[49, 61]], "entity_1_idx_in_text_with_entity_marker": [53, 65], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p13", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for [E1]desmin[/E1], calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmin", "entity_1_idx": [[116, 122]], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p14", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and [E1]CD34[/E1], but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "CD34", "entity_1_idx": [[93, 97]], "entity_1_idx_in_text_with_entity_marker": [97, 101], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p15", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, [E1]high molecular weight caldesmon[/E1], smooth muscle myosin heavy chain, collagen type IV, laminin and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "high molecular weight caldesmon", "entity_1_idx": [[134, 165]], "entity_1_idx_in_text_with_entity_marker": [138, 169], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p16", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, [E1]calponin[/E1], high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "calponin", "entity_1_idx": [[124, 132]], "entity_1_idx_in_text_with_entity_marker": [128, 136], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p17", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, [E1]collagen type IV[/E1], laminin and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "collagen type IV", "entity_1_idx": [[201, 217]], "entity_1_idx_in_text_with_entity_marker": [205, 221], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p18", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, [E1]laminin[/E1] and [E2]S-100[/E2] protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "laminin", "entity_1_idx": [[219, 226]], "entity_1_idx_in_text_with_entity_marker": [223, 230], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "S-100", "entity_2_idx": [[231, 236]], "entity_2_idx_in_text_with_entity_marker": [244, 249], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d651.s0_BioInfer.d651.s0.p19", "text": "The neoplastic cells were positive for vimentin, Factor-XIIIa, alpha-smooth muscle actin and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "text_with_entity_marker": "The neoplastic cells were positive for [E1]vimentin[/E1], Factor-XIIIa, [E2]alpha-smooth muscle actin[/E2] and CD34, but negative for desmin, calponin, high molecular weight caldesmon, smooth muscle myosin heavy chain, collagen type IV, laminin and S-100 protein.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "vimentin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "alpha-smooth muscle actin", "entity_2_idx": [[63, 88]], "entity_2_idx_in_text_with_entity_marker": [76, 101], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "BioInfer.d492.s0_BioInfer.d492.s0.p0", "text": "Previously, we have shown that in the absence of RAD52, repair is nearly absent and diploid cells lose the broken chromosome; however, in cells lacking RAD51, gene conversion is absent but cells can repair the DSB by BIR.", "text_with_entity_marker": "Previously, we have shown that in the absence of [E1]RAD52[/E1], repair is nearly absent and diploid cells lose the broken chromosome; however, in cells lacking [E2]RAD51[/E2], gene conversion is absent but cells can repair the DSB by BIR.", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "RAD52", "entity_1_idx": [[49, 54]], "entity_1_idx_in_text_with_entity_marker": [53, 58], "entity_1_type": "Gene/protein/RNA", "entity_1_type_id": 2, "entity_2": "RAD51", "entity_2_idx": [[152, 157]], "entity_2_idx_in_text_with_entity_marker": [165, 170], "entity_2_type": "Gene/protein/RNA", "entity_2_type_id": 2}], "directed": false, "reverse": false}
{"id": "HPRD50.d13.s1_HPRD50.d13.s1.p0", "text": "Overexpression of CLIP-170 results in a zinc finger-dependent localization of a phospho-LIS1 isoform and dynactin to MT bundles, raising the possibility that CLIP-170 and LIS1 regulate dynein/dynactin binding to MTs", "text_with_entity_marker": "Overexpression of [E1]CLIP-170[/E1] results in a zinc finger-dependent localization of a [E2]phospho-LIS1[/E2] isoform and dynactin to MT bundles, raising the possibility that CLIP-170 and LIS1 regulate dynein/dynactin binding to MTs", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "CLIP-170", "entity_1_idx": [[18, 26]], "entity_1_idx_in_text_with_entity_marker": [22, 30], "entity_1_type": "pm0124985", "entity_1_type_id": 43, "entity_2": "phospho-LIS1", "entity_2_idx": [[80, 92]], "entity_2_idx_in_text_with_entity_marker": [93, 105], "entity_2_type": "phospho-pm0110467", "entity_2_type_id": 45}], "directed": false, "reverse": false}
{"id": "HPRD50.d13.s2_HPRD50.d13.s2.p0", "text": "This work suggests that LIS1 is a regulated adapter between CLIP-170 and cytoplasmic dynein at sites involved in cargo-MT loading, and/or in the control of MT dynamics", "text_with_entity_marker": "This work suggests that [E1]LIS1[/E1] is a regulated adapter between [E2]CLIP-170[/E2] and cytoplasmic dynein at sites involved in cargo-MT loading, and/or in the control of MT dynamics", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "LIS1", "entity_1_idx": [[24, 28]], "entity_1_idx_in_text_with_entity_marker": [28, 32], "entity_1_type": "pm0110467", "entity_1_type_id": 44, "entity_2": "CLIP-170", "entity_2_idx": [[60, 68]], "entity_2_idx_in_text_with_entity_marker": [73, 81], "entity_2_type": "pm0124985", "entity_2_type_id": 43}], "directed": false, "reverse": false}
{"id": "HPRD50.d10.s0_HPRD50.d10.s0.p0", "text": "Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1)", "text_with_entity_marker": "Cutting edge: [E1]CD43[/E1] functions as a T cell counterreceptor for the macrophage adhesion receptor [E2]sialoadhesin[/E2] (Siglec-1)", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "CD43", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "pm0122945", "entity_1_type_id": 36, "entity_2": "sialoadhesin", "entity_2_idx": [[94, 106]], "entity_2_idx_in_text_with_entity_marker": [107, 119], "entity_2_type": "pm0108007", "entity_2_type_id": 37}], "directed": false, "reverse": false}
{"id": "HPRD50.d10.s0_HPRD50.d10.s0.p1", "text": "Cutting edge: CD43 functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin (Siglec-1)", "text_with_entity_marker": "Cutting edge: [E1]CD43[/E1] functions as a T cell counterreceptor for the macrophage adhesion receptor sialoadhesin ([E2]Siglec-1[/E2])", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "CD43", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "pm0122945", "entity_1_type_id": 36, "entity_2": "Siglec-1", "entity_2_idx": [[108, 116]], "entity_2_idx_in_text_with_entity_marker": [121, 129], "entity_2_type": "pm0108007", "entity_2_type_id": 37}], "directed": false, "reverse": false}
{"id": "HPRD50.d10.s2_HPRD50.d10.s2.p0", "text": "CD43 expressed in COS cells supported increased binding to immobilized sialoadhesin", "text_with_entity_marker": "[E1]CD43[/E1] expressed in COS cells supported increased binding to immobilized [E2]sialoadhesin[/E2]", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "CD43", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "pm0122945", "entity_1_type_id": 36, "entity_2": "sialoadhesin", "entity_2_idx": [[71, 83]], "entity_2_idx_in_text_with_entity_marker": [84, 96], "entity_2_type": "pm0108007", "entity_2_type_id": 37}], "directed": false, "reverse": false}
{"id": "HPRD50.d10.s3_HPRD50.d10.s3.p0", "text": "Finally, sialoadhesin bound different glycoforms of CD43 expressed in Chinese hamster ovary cells, including unbranched (core 1) and branched (core 2) O:-linked glycans, that are normally found on CD43 in resting and activated T cells, respectively", "text_with_entity_marker": "Finally, [E1]sialoadhesin[/E1] bound different glycoforms of [E2]CD43[/E2] expressed in Chinese hamster ovary cells, including unbranched (core 1) and branched (core 2) O:-linked glycans, that are normally found on CD43 in resting and activated T cells, respectively", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "sialoadhesin", "entity_1_idx": [[9, 21]], "entity_1_idx_in_text_with_entity_marker": [13, 25], "entity_1_type": "pm0108007", "entity_1_type_id": 37, "entity_2": "CD43", "entity_2_idx": [[52, 56]], "entity_2_idx_in_text_with_entity_marker": [65, 69], "entity_2_type": "pm0122945", "entity_2_type_id": 36}], "directed": false, "reverse": false}
{"id": "HPRD50.d10.s4_HPRD50.d10.s4.p0", "text": "These results identify CD43 as a T cell counterreceptor for sialoadhesin and suggest that in addition to its anti-adhesive role CD43 may promote cell-cell interactions", "text_with_entity_marker": "These results identify [E1]CD43[/E1] as a T cell counterreceptor for [E2]sialoadhesin[/E2] and suggest that in addition to its anti-adhesive role CD43 may promote cell-cell interactions", "relation": [{"relation_type": "structural", "relation_id": 1, "entity_1": "CD43", "entity_1_idx": [[23, 27]], "entity_1_idx_in_text_with_entity_marker": [27, 31], "entity_1_type": "pm0122945", "entity_1_type_id": 36, "entity_2": "sialoadhesin", "entity_2_idx": [[60, 72]], "entity_2_idx_in_text_with_entity_marker": [73, 85], "entity_2_type": "pm0108007", "entity_2_type_id": 37}], "directed": false, "reverse": false}
{"id": "HPRD50.d40.s0_HPRD50.d40.s0.p0", "text": "Transient expression of the full-length E2-2 without RSRS in U1240MG glioblastoma cells resulted in repression of FGF-1.B promoter activity", "text_with_entity_marker": "Transient expression of the full-length [E1]E2-2[/E1] without RSRS in U1240MG glioblastoma cells resulted in repression of [E2]FGF-1.B[/E2] promoter activity", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "E2-2", "entity_1_idx": [[40, 44]], "entity_1_idx_in_text_with_entity_marker": [44, 48], "entity_1_type": "pm0110165", "entity_1_type_id": 148, "entity_2": "FGF-1.B", "entity_2_idx": [[114, 121]], "entity_2_idx_in_text_with_entity_marker": [127, 134], "entity_2_type": "pm0124654-1.B", "entity_2_type_id": 149}], "directed": false, "reverse": false}
{"id": "HPRD50.d40.s1_HPRD50.d40.s1.p0", "text": "These results suggest that the relative abundance of the two splice variants of E2-2 in brain could be an important determinant for the expression of FGF-1", "text_with_entity_marker": "These results suggest that the relative abundance of the two splice variants of [E1]E2-2[/E1] in brain could be an important determinant for the expression of [E2]FGF-1[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "E2-2", "entity_1_idx": [[80, 84]], "entity_1_idx_in_text_with_entity_marker": [84, 88], "entity_1_type": "pm0110165", "entity_1_type_id": 148, "entity_2": "FGF-1", "entity_2_idx": [[150, 155]], "entity_2_idx_in_text_with_entity_marker": [163, 168], "entity_2_type": "pm0124654", "entity_2_type_id": 16}], "directed": false, "reverse": false}
{"id": "HPRD50.d38.s1_HPRD50.d38.s1.p0", "text": "Specific glutamines or lysines of involucrin were used to cross-link the different proteins, such as glutamines 495 and 496 to desmoplakin, glutamine 288 to keratins, and lysines 468, 485, and 508 and glutamines 465 and 489 for interchain involucrin cross-links", "text_with_entity_marker": "Specific glutamines or lysines of [E1]involucrin[/E1] were used to cross-link the different proteins, such as glutamines 495 and 496 to [E2]desmoplakin[/E2], glutamine 288 to keratins, and lysines 468, 485, and 508 and glutamines 465 and 489 for interchain involucrin cross-links", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "involucrin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "pm0104308", "entity_1_type_id": 139, "entity_2": "desmoplakin", "entity_2_idx": [[127, 138]], "entity_2_idx_in_text_with_entity_marker": [140, 151], "entity_2_type": "pm0110549", "entity_2_type_id": 141}], "directed": false, "reverse": false}
{"id": "HPRD50.d38.s1_HPRD50.d38.s1.p1", "text": "Specific glutamines or lysines of involucrin were used to cross-link the different proteins, such as glutamines 495 and 496 to desmoplakin, glutamine 288 to keratins, and lysines 468, 485, and 508 and glutamines 465 and 489 for interchain involucrin cross-links", "text_with_entity_marker": "Specific glutamines or lysines of [E1]involucrin[/E1] were used to cross-link the different proteins, such as glutamines 495 and 496 to desmoplakin, glutamine 288 to keratins, and lysines 468, 485, and 508 and glutamines 465 and 489 for interchain [E2]involucrin[/E2] cross-links", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "involucrin", "entity_1_idx": [[34, 44]], "entity_1_idx_in_text_with_entity_marker": [38, 48], "entity_1_type": "pm0104308", "entity_1_type_id": 139, "entity_2": "involucrin", "entity_2_idx": [[239, 249]], "entity_2_idx_in_text_with_entity_marker": [252, 262], "entity_2_type": "pm0104308", "entity_2_type_id": 139}], "directed": false, "reverse": false}
{"id": "HPRD50.d38.s1_HPRD50.d38.s1.p2", "text": "Specific glutamines or lysines of involucrin were used to cross-link the different proteins, such as glutamines 495 and 496 to desmoplakin, glutamine 288 to keratins, and lysines 468, 485, and 508 and glutamines 465 and 489 for interchain involucrin cross-links", "text_with_entity_marker": "Specific glutamines or lysines of involucrin were used to cross-link the different proteins, such as glutamines 495 and 496 to [E1]desmoplakin[/E1], glutamine 288 to keratins, and lysines 468, 485, and 508 and glutamines 465 and 489 for interchain [E2]involucrin[/E2] cross-links", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "desmoplakin", "entity_1_idx": [[127, 138]], "entity_1_idx_in_text_with_entity_marker": [131, 142], "entity_1_type": "pm0110549", "entity_1_type_id": 141, "entity_2": "involucrin", "entity_2_idx": [[239, 249]], "entity_2_idx_in_text_with_entity_marker": [252, 262], "entity_2_type": "pm0104308", "entity_2_type_id": 139}], "directed": false, "reverse": false}
{"id": "HPRD50.d18.s1_HPRD50.d18.s1.p0", "text": "The receptor-like protein tyrosine phosphatase DEP1, also known as CD148, is expressed predominantly in epithelial cells, in a variety of tumor cell lines, and in lymphocytes", "text_with_entity_marker": "The [E1]receptor-like protein tyrosine phosphatase[/E1] [E2]DEP1[/E2], also known as CD148, is expressed predominantly in epithelial cells, in a variety of tumor cell lines, and in lymphocytes", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "receptor-like protein tyrosine phosphatase", "entity_1_idx": [[4, 46]], "entity_1_idx_in_text_with_entity_marker": [8, 50], "entity_1_type": "pm0104157", "entity_1_type_id": 58, "entity_2": "DEP1", "entity_2_idx": [[47, 51]], "entity_2_idx_in_text_with_entity_marker": [60, 64], "entity_2_type": "pm0115917", "entity_2_type_id": 59}], "directed": false, "reverse": false}
{"id": "HPRD50.d18.s1_HPRD50.d18.s1.p1", "text": "The receptor-like protein tyrosine phosphatase DEP1, also known as CD148, is expressed predominantly in epithelial cells, in a variety of tumor cell lines, and in lymphocytes", "text_with_entity_marker": "The [E1]receptor-like protein tyrosine phosphatase[/E1] DEP1, also known as [E2]CD148[/E2], is expressed predominantly in epithelial cells, in a variety of tumor cell lines, and in lymphocytes", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "receptor-like protein tyrosine phosphatase", "entity_1_idx": [[4, 46]], "entity_1_idx_in_text_with_entity_marker": [8, 50], "entity_1_type": "pm0104157", "entity_1_type_id": 58, "entity_2": "CD148", "entity_2_idx": [[67, 72]], "entity_2_idx_in_text_with_entity_marker": [80, 85], "entity_2_type": "pm0115917", "entity_2_type_id": 59}], "directed": false, "reverse": false}
{"id": "HPRD50.d18.s1_HPRD50.d18.s1.p2", "text": "The receptor-like protein tyrosine phosphatase DEP1, also known as CD148, is expressed predominantly in epithelial cells, in a variety of tumor cell lines, and in lymphocytes", "text_with_entity_marker": "The receptor-like protein tyrosine phosphatase [E1]DEP1[/E1], also known as [E2]CD148[/E2], is expressed predominantly in epithelial cells, in a variety of tumor cell lines, and in lymphocytes", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "DEP1", "entity_1_idx": [[47, 51]], "entity_1_idx_in_text_with_entity_marker": [51, 55], "entity_1_type": "pm0115917", "entity_1_type_id": 59, "entity_2": "CD148", "entity_2_idx": [[67, 72]], "entity_2_idx_in_text_with_entity_marker": [80, 85], "entity_2_type": "pm0115917", "entity_2_type_id": 59}], "directed": false, "reverse": false}
{"id": "HPRD50.d18.s3_HPRD50.d18.s3.p0", "text": "The interaction with p120(ctn) is likely to be direct, as the interaction occurs in K562 cells lacking functional adherens junctions and E-cadherin expression", "text_with_entity_marker": "The interaction with [E1]p120(ctn)[/E1] is likely to be direct, as the interaction occurs in K562 cells lacking functional adherens junctions and [E2]E-cadherin[/E2] expression", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "p120(ctn)", "entity_1_idx": [[21, 30]], "entity_1_idx_in_text_with_entity_marker": [25, 34], "entity_1_type": "pm0101886", "entity_1_type_id": 60, "entity_2": "E-cadherin", "entity_2_idx": [[137, 147]], "entity_2_idx_in_text_with_entity_marker": [150, 160], "entity_2_type": "pm0115783", "entity_2_type_id": 62}], "directed": false, "reverse": false}
{"id": "HPRD50.d35.s0_HPRD50.d35.s0.p0", "text": "Assignment of Etfdh, Etfb, and Etfa to chromosomes 3, 7, and 13: the mouse homologs of genes responsible for glutaric acidemia type II in human", "text_with_entity_marker": "Assignment of [E1]Etfdh[/E1], [E2]Etfb[/E2], and Etfa to chromosomes 3, 7, and 13: the mouse homologs of genes responsible for glutaric acidemia type II in human", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Etfdh", "entity_1_idx": [[14, 19]], "entity_1_idx_in_text_with_entity_marker": [18, 23], "entity_1_type": "pm0103481", "entity_1_type_id": 133, "entity_2": "Etfb", "entity_2_idx": [[21, 25]], "entity_2_idx_in_text_with_entity_marker": [34, 38], "entity_2_type": "pm0110405", "entity_2_type_id": 134}], "directed": false, "reverse": false}
{"id": "HPRD50.d35.s1_HPRD50.d35.s1.p0", "text": "We used cDNA probes for the Etfdh, Etfb, and Etfa genes to determine localization of these mouse genes to chromosomes 3, 7, and 13", "text_with_entity_marker": "We used cDNA probes for the [E1]Etfdh[/E1], [E2]Etfb[/E2], and Etfa genes to determine localization of these mouse genes to chromosomes 3, 7, and 13", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "Etfdh", "entity_1_idx": [[28, 33]], "entity_1_idx_in_text_with_entity_marker": [32, 37], "entity_1_type": "pm0103481", "entity_1_type_id": 133, "entity_2": "Etfb", "entity_2_idx": [[35, 39]], "entity_2_idx_in_text_with_entity_marker": [48, 52], "entity_2_type": "pm0110405", "entity_2_type_id": 134}], "directed": false, "reverse": false}
{"id": "IEPA.d159.s382_IEPA.d159.s382.p0", "text": "In the fasting state UCP-2 expression correlated inversely with body mass index (r = -0.45; P = 0.026), percent body fat (r = -0.41; P = 0.05), plasma insulin (r = -0.47; P = 0.02), epigastric venous fatty acids (r = -0.45; P = 0.04), and leptin (r = -0.50; P = 0.018)", "text_with_entity_marker": "In the fasting state [E1]UCP-2[/E1] expression correlated inversely with body mass index (r = -0.45; P = 0.026), percent body fat (r = -0.41; P = 0.05), plasma insulin (r = -0.47; P = 0.02), epigastric venous fatty acids (r = -0.45; P = 0.04), and [E2]leptin[/E2] (r = -0.50; P = 0.018)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP-2", "entity_1_idx": [[21, 26]], "entity_1_idx_in_text_with_entity_marker": [25, 30], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[239, 245]], "entity_2_idx_in_text_with_entity_marker": [252, 258], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d159.s383_IEPA.d159.s383.p0", "text": "UCP-2 expression remained inversely related with plasma leptin after controlling for percent body (r = -0.45; P = 0.038)", "text_with_entity_marker": "[E1]UCP-2[/E1] expression remained inversely related with plasma [E2]leptin[/E2] after controlling for percent body (r = -0.45; P = 0.038)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP-2", "entity_1_idx": [[0, 5]], "entity_1_idx_in_text_with_entity_marker": [4, 9], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[56, 62]], "entity_2_idx_in_text_with_entity_marker": [69, 75], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d159.s384_IEPA.d159.s384.p0", "text": "In conclusion, 1) UCP-2 messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma leptin levels; and 2) UCP-2 expression is not acutely regulated by food intake, insulin, or fatty acids", "text_with_entity_marker": "In conclusion, 1) [E1]UCP-2[/E1] messenger ribonucleic acid expression in sc adipose tissue is inversely related to adiposity and independently linked to local plasma [E2]leptin[/E2] levels; and 2) UCP-2 expression is not acutely regulated by food intake, insulin, or fatty acids", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP-2", "entity_1_idx": [[18, 23]], "entity_1_idx_in_text_with_entity_marker": [22, 27], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[158, 164]], "entity_2_idx_in_text_with_entity_marker": [171, 177], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d67.s167_IEPA.d67.s167.p2", "text": "Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for PLCgamma in metabolic signaling by insulin", "text_with_entity_marker": "Association of the insulin receptor with phospholipase C-gamma (PLCgamma) in 3T3-L1 adipocytes suggests a role for [E1]PLCgamma[/E1] in metabolic signaling by [E2]insulin[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PLCgamma", "entity_1_idx": [[115, 123]], "entity_1_idx_in_text_with_entity_marker": [119, 127], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[150, 157]], "entity_2_idx_in_text_with_entity_marker": [163, 170], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s251_IEPA.d108.s251.p0", "text": "Long-term changes in gastrin, cholecystokinin and insulin in response to oxytocin treatment", "text_with_entity_marker": "Long-term changes in gastrin, cholecystokinin and [E1]insulin[/E1] in response to [E2]oxytocin[/E2] treatment", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[50, 57]], "entity_1_idx_in_text_with_entity_marker": [54, 61], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[73, 81]], "entity_2_idx_in_text_with_entity_marker": [86, 94], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s252_IEPA.d108.s252.p0", "text": "The present study was designed to investigate how repeated injections of oxytocin influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), insulin and somatostatin, as well as of endogenous oxytocin and glucose", "text_with_entity_marker": "The present study was designed to investigate how repeated injections of [E1]oxytocin[/E1] influence plasma levels of vagally controlled hormones such as gastrin, cholecystokinin (CCK), [E2]insulin[/E2] and somatostatin, as well as of endogenous oxytocin and glucose", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[73, 81]], "entity_1_idx_in_text_with_entity_marker": [77, 85], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[177, 184]], "entity_2_idx_in_text_with_entity_marker": [190, 197], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s253_IEPA.d108.s253.p0", "text": "In addition, both insulin and CCK levels were decreased in response to the oxytocin treatment when measured 3 and 10 days after the last injection (ANOVA; insulin p < 0.01, CCK p < 0.05)", "text_with_entity_marker": "In addition, both [E1]insulin[/E1] and CCK levels were decreased in response to the [E2]oxytocin[/E2] treatment when measured 3 and 10 days after the last injection (ANOVA; insulin p < 0.01, CCK p < 0.05)", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "insulin", "entity_1_idx": [[18, 25]], "entity_1_idx_in_text_with_entity_marker": [22, 29], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[75, 83]], "entity_2_idx_in_text_with_entity_marker": [88, 96], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d108.s255_IEPA.d108.s255.p0", "text": "In conclusion, these results show that oxytocin induces long-lasting changes in plasma levels of gastrin, CCK and insulin, without affecting somatostatin or glucose levels", "text_with_entity_marker": "In conclusion, these results show that [E1]oxytocin[/E1] induces long-lasting changes in plasma levels of gastrin, CCK and [E2]insulin[/E2], without affecting somatostatin or glucose levels", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "oxytocin", "entity_1_idx": [[39, 47]], "entity_1_idx_in_text_with_entity_marker": [43, 51], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[114, 121]], "entity_2_idx_in_text_with_entity_marker": [127, 134], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d80.s191_IEPA.d80.s191.p0", "text": "A single i.c.v. injection of leptin decreased cumulative food intake and body weight gain, and increased UCP-1 mRNA expression during 3 h at the onset of the dark phase", "text_with_entity_marker": "A single i.c.v. injection of [E1]leptin[/E1] decreased cumulative food intake and body weight gain, and increased [E2]UCP-1[/E2] mRNA expression during 3 h at the onset of the dark phase", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[29, 35]], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-1", "entity_2_idx": [[105, 110]], "entity_2_idx_in_text_with_entity_marker": [118, 123], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d80.s192_IEPA.d80.s192.p0", "text": "Co-injection of SHU9119 also inhibited completely the leptin-induced increase in UCP-1 mRNA expression in the BAT", "text_with_entity_marker": "Co-injection of SHU9119 also inhibited completely the [E1]leptin[/E1]-induced increase in [E2]UCP-1[/E2] mRNA expression in the BAT", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[54, 60]], "entity_1_idx_in_text_with_entity_marker": [58, 64], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-1", "entity_2_idx": [[81, 86]], "entity_2_idx_in_text_with_entity_marker": [94, 99], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d10.s22_IEPA.d10.s22.p0", "text": "Amyloid beta protein disruption of cholinergic and growth factor phospholipase C signals could underlie cognitive and neurodegerative aspects of Alzheimer's disease", "text_with_entity_marker": "[E1]Amyloid[/E1] beta protein disruption of cholinergic and growth factor [E2]phospholipase C[/E2] signals could underlie cognitive and neurodegerative aspects of Alzheimer's disease", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Amyloid", "entity_1_idx": [[0, 7]], "entity_1_idx_in_text_with_entity_marker": [4, 11], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[65, 80]], "entity_2_idx_in_text_with_entity_marker": [78, 93], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d141.s338_IEPA.d141.s338.p0", "text": "Tolbutamide and diazoxide modulate phospholipase C-linked Ca(2+) signaling and insulin secretion in beta-cells", "text_with_entity_marker": "Tolbutamide and diazoxide modulate [E1]phospholipase C[/E1]-linked Ca(2+) signaling and [E2]insulin[/E2] secretion in beta-cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "phospholipase C", "entity_1_idx": [[35, 50]], "entity_1_idx_in_text_with_entity_marker": [39, 54], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[79, 86]], "entity_2_idx_in_text_with_entity_marker": [92, 99], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d141.s339_IEPA.d141.s339.p2", "text": "We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PLC-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with PLC-linked insulin secretion from HIT-T15 cells", "text_with_entity_marker": "We examined whether tolbutamide and diazoxide, which close or open ATP-sensitive K(+) channels (K(ATP) channels), respectively, interact with PLC-linked Ca(2+) signals in HIT-T15 and mouse beta-cells and with [E1]PLC[/E1]-linked [E2]insulin[/E2] secretion from HIT-T15 cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[209, 212]], "entity_1_idx_in_text_with_entity_marker": [213, 216], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[220, 227]], "entity_2_idx_in_text_with_entity_marker": [233, 240], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d141.s340_IEPA.d141.s340.p0", "text": "Thus tolbutamide and diazoxide regulate both PLC-linked Ca(2+) signaling and insulin secretion from pancreatic beta-cells by modulating K(ATP) channels, thereby determining voltage-sensitive Ca(2+) influx", "text_with_entity_marker": "Thus tolbutamide and diazoxide regulate both [E1]PLC[/E1]-linked Ca(2+) signaling and [E2]insulin[/E2] secretion from pancreatic beta-cells by modulating K(ATP) channels, thereby determining voltage-sensitive Ca(2+) influx", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PLC", "entity_1_idx": [[45, 48]], "entity_1_idx_in_text_with_entity_marker": [49, 52], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[77, 84]], "entity_2_idx_in_text_with_entity_marker": [90, 97], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d78.s187_IEPA.d78.s187.p0", "text": "To assess the possible involvement of PKC in AVP and IL-1 action in Leydig cells, the PKC inhibitor Calphostin C was tested", "text_with_entity_marker": "To assess the possible involvement of [E1]PKC[/E1] in [E2]AVP[/E2] and IL-1 action in Leydig cells, the PKC inhibitor Calphostin C was tested", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[38, 41]], "entity_1_idx_in_text_with_entity_marker": [42, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[45, 48]], "entity_2_idx_in_text_with_entity_marker": [58, 61], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d78.s188_IEPA.d78.s188.p0", "text": "These results confirm that AVP and PMA activate PKC and indicate that IL-1 likely does not activate PKC in Leydig cells", "text_with_entity_marker": "These results confirm that [E1]AVP[/E1] and PMA activate [E2]PKC[/E2] and indicate that IL-1 likely does not activate PKC in Leydig cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[27, 30]], "entity_1_idx_in_text_with_entity_marker": [31, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[48, 51]], "entity_2_idx_in_text_with_entity_marker": [61, 64], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s256_IEPA.d109.s256.p0", "text": "Fasting and leptin modulate adipose and muscle uncoupling protein: divergent effects between messenger ribonucleic acid and protein expression", "text_with_entity_marker": "Fasting and [E1]leptin[/E1] modulate adipose and muscle [E2]uncoupling protein[/E2]: divergent effects between messenger ribonucleic acid and protein expression", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[12, 18]], "entity_1_idx_in_text_with_entity_marker": [16, 22], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "uncoupling protein", "entity_2_idx": [[47, 65]], "entity_2_idx_in_text_with_entity_marker": [60, 78], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s259_IEPA.d109.s259.p1", "text": "Fasting significantly decreased BAT UCP-1 and UCP-3 mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of leptin to fasted rats", "text_with_entity_marker": "Fasting significantly decreased BAT [E1]UCP-1[/E1] and UCP-3 mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of [E2]leptin[/E2] to fasted rats", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP-1", "entity_1_idx": [[36, 41]], "entity_1_idx_in_text_with_entity_marker": [40, 45], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[176, 182]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s259_IEPA.d109.s259.p2", "text": "Fasting significantly decreased BAT UCP-1 and UCP-3 mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of leptin to fasted rats", "text_with_entity_marker": "Fasting significantly decreased BAT UCP-1 and [E1]UCP-3[/E1] mRNA expression, to 31% and 30% of ad libitum fed controls, respectively, effects which were prevented by administration of [E2]leptin[/E2] to fasted rats", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP-3", "entity_1_idx": [[46, 51]], "entity_1_idx_in_text_with_entity_marker": [50, 55], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[176, 182]], "entity_2_idx_in_text_with_entity_marker": [189, 195], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s261_IEPA.d109.s261.p5", "text": "Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, leptin administration to ad libitum fed rats significantly increased BAT UCP-2 mRNA, to 138% of control", "text_with_entity_marker": "Fasting, with or without leptin administration, did not affect BAT UCP-2 mRNA; however, [E1]leptin[/E1] administration to ad libitum fed rats significantly increased BAT [E2]UCP-2[/E2] mRNA, to 138% of control", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "leptin", "entity_1_idx": [[88, 94]], "entity_1_idx_in_text_with_entity_marker": [92, 98], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP-2", "entity_2_idx": [[161, 166]], "entity_2_idx_in_text_with_entity_marker": [174, 179], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d109.s263_IEPA.d109.s263.p0", "text": "In summary, UCP subtype mRNA and protein are regulated in tissue- and subtype-specific fashion by leptin and food restriction", "text_with_entity_marker": "In summary, [E1]UCP[/E1] subtype mRNA and protein are regulated in tissue- and subtype-specific fashion by [E2]leptin[/E2] and food restriction", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "UCP", "entity_1_idx": [[12, 15]], "entity_1_idx_in_text_with_entity_marker": [16, 19], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[98, 104]], "entity_2_idx_in_text_with_entity_marker": [111, 117], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d140.s335_IEPA.d140.s335.p0", "text": "Arginine vasopressin (AVP) and lysophosphatidic acid (LPA) have been shown to stimulate protein kinase C (PKC) and mitogen-activated protein (MAP) kinases and the proliferation of vascular smooth muscle cells", "text_with_entity_marker": "[E1]Arginine vasopressin[/E1] (AVP) and lysophosphatidic acid (LPA) have been shown to stimulate [E2]protein kinase C[/E2] (PKC) and mitogen-activated protein (MAP) kinases and the proliferation of vascular smooth muscle cells", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Arginine vasopressin", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase C", "entity_2_idx": [[88, 104]], "entity_2_idx_in_text_with_entity_marker": [101, 117], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d140.s336_IEPA.d140.s336.p0", "text": "However, AVP-induced activation of RSK2, a downstream substrate of ERK1 and ERK2, was PKC-dependent and PI 3-kinase-independent", "text_with_entity_marker": "However, [E1]AVP[/E1]-induced activation of RSK2, a downstream substrate of ERK1 and ERK2, was [E2]PKC[/E2]-dependent and PI 3-kinase-independent", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "AVP", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "PKC", "entity_2_idx": [[86, 89]], "entity_2_idx_in_text_with_entity_marker": [99, 102], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d140.s337_IEPA.d140.s337.p0", "text": "PKC was necessary in AVP- but not in LPA-induced activation of p70 S6K", "text_with_entity_marker": "[E1]PKC[/E1] was necessary in [E2]AVP[/E2]- but not in LPA-induced activation of p70 S6K", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PKC", "entity_1_idx": [[0, 3]], "entity_1_idx_in_text_with_entity_marker": [4, 7], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "AVP", "entity_2_idx": [[21, 24]], "entity_2_idx_in_text_with_entity_marker": [34, 37], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d22.s46_IEPA.d22.s46.p9", "text": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a prion protein-specific kinase", "text_with_entity_marker": "Once the abnormally phosphorylated abnormal prion protein isoform agent is initiated, any stress event ensuing in adult life induces a nerve growth factor-mediated synthesis of normal cellular prion protein isoform that aggregates to abnormally phosphorylated abnormal prion protein isoform, thereby becoming 'infected'/transformed into the same; due to the vicious circle of positive feedback invoked by the blocking of a [E1]prion protein[/E1]-specific [E2]kinase[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "prion protein", "entity_1_idx": [[423, 436]], "entity_1_idx_in_text_with_entity_marker": [427, 440], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "kinase", "entity_2_idx": [[446, 452]], "entity_2_idx_in_text_with_entity_marker": [459, 465], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d15.s32_IEPA.d15.s32.p0", "text": "The beta amyloid protein fragments had diverse effects on phosphoinositide-specific phospholipase C (PI-PLC) as assayed in rat cortical membranes", "text_with_entity_marker": "The beta [E1]amyloid[/E1] protein fragments had diverse effects on phosphoinositide-specific [E2]phospholipase C[/E2] (PI-PLC) as assayed in rat cortical membranes", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "amyloid", "entity_1_idx": [[9, 16]], "entity_1_idx_in_text_with_entity_marker": [13, 20], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "phospholipase C", "entity_2_idx": [[84, 99]], "entity_2_idx_in_text_with_entity_marker": [97, 112], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d197.s478_IEPA.d197.s478.p0", "text": "Bovine prion protein as a modulator of protein kinase CK2", "text_with_entity_marker": "[E1]Bovine prion protein[/E1] as a modulator of [E2]protein kinase CK2[/E2]", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "Bovine prion protein", "entity_1_idx": [[0, 20]], "entity_1_idx_in_text_with_entity_marker": [4, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase CK2", "entity_2_idx": [[39, 57]], "entity_2_idx_in_text_with_entity_marker": [52, 70], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d197.s479_IEPA.d197.s479.p0", "text": "On the basis of far-Western blot and plasmon resonance (BIAcore) experiments, we show here that recombinant bovine prion protein (bPrP) (25-242) strongly interacts with the catalytic alpha/alpha' subunits of protein kinase CK2 (also termed 'casein kinase 2')", "text_with_entity_marker": "On the basis of far-Western blot and plasmon resonance (BIAcore) experiments, we show here that recombinant [E1]bovine prion protein[/E1] (bPrP) (25-242) strongly interacts with the catalytic alpha/alpha' subunits of [E2]protein kinase CK2[/E2] (also termed 'casein kinase 2')", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "bovine prion protein", "entity_1_idx": [[108, 128]], "entity_1_idx_in_text_with_entity_marker": [112, 132], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "protein kinase CK2", "entity_2_idx": [[208, 226]], "entity_2_idx_in_text_with_entity_marker": [221, 239], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d197.s481_IEPA.d197.s481.p0", "text": "A truncated form of bPrP encompassing the C-terminal domain (residues 105-242) interacts with CK2 but does not affect its catalytic activity", "text_with_entity_marker": "A truncated form of [E1]bPrP[/E1] encompassing the C-terminal domain (residues 105-242) interacts with [E2]CK2[/E2] but does not affect its catalytic activity", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "bPrP", "entity_1_idx": [[20, 24]], "entity_1_idx_in_text_with_entity_marker": [24, 28], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "CK2", "entity_2_idx": [[94, 97]], "entity_2_idx_in_text_with_entity_marker": [107, 110], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d197.s482_IEPA.d197.s482.p0", "text": "These results disclose the potential of the PrP to modulate the activity of CK2, a pleiotropic protein kinase that is particularly abundant in the brain", "text_with_entity_marker": "These results disclose the potential of the [E1]PrP[/E1] to modulate the activity of [E2]CK2[/E2], a pleiotropic protein kinase that is particularly abundant in the brain", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "PrP", "entity_1_idx": [[44, 47]], "entity_1_idx_in_text_with_entity_marker": [48, 51], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "CK2", "entity_2_idx": [[76, 79]], "entity_2_idx_in_text_with_entity_marker": [89, 92], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d19.s41_IEPA.d19.s41.p0", "text": "Granulosa cells were isolated from bovine preovulatory follicles and cultured for 3 days with or without OT in medium supplemented with either insulin (1 microgram/ml) + 1% fetal calf serum (FCS), which maintains basal estradiol secretion, or low doses of FSH (1 and 2 ng/ml) + 1% FCS, a culture condition that maximizes effects of FSH on estradiol secretion", "text_with_entity_marker": "Granulosa cells were isolated from bovine preovulatory follicles and cultured for 3 days with or without [E1]OT[/E1] in medium supplemented with either [E2]insulin[/E2] (1 microgram/ml) + 1% fetal calf serum (FCS), which maintains basal estradiol secretion, or low doses of FSH (1 and 2 ng/ml) + 1% FCS, a culture condition that maximizes effects of FSH on estradiol secretion", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "OT", "entity_1_idx": [[105, 107]], "entity_1_idx_in_text_with_entity_marker": [109, 111], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[143, 150]], "entity_2_idx_in_text_with_entity_marker": [156, 163], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d69.s170_IEPA.d69.s170.p0", "text": "During wk 6, milk yield and dry matter intake (DMI) were recorded daily, and plasma concentrations of glucose, nonesterified fatty acids, urea, protein, growth hormone, insulin, insulin-like growth factor I, oxytocin, and prolactin were determined", "text_with_entity_marker": "During wk 6, milk yield and dry matter intake (DMI) were recorded daily, and plasma concentrations of glucose, nonesterified fatty acids, urea, protein, growth hormone, [E1]insulin[/E1], insulin-like growth factor I, [E2]oxytocin[/E2], and prolactin were determined", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[169, 176]], "entity_1_idx_in_text_with_entity_marker": [173, 180], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[208, 216]], "entity_2_idx_in_text_with_entity_marker": [221, 229], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d164.s396_IEPA.d164.s396.p0", "text": "The aims of this study were: (1) to assess the effects of maternal undernutrition during pregnancy on adult offspring with regard to growth, body composition and plasma levels of glucose, insulin and corticosterone, and (2) to investigate whether oxytocin treatment early in life could ameliorate the adverse effects of food restriction in utero", "text_with_entity_marker": "The aims of this study were: (1) to assess the effects of maternal undernutrition during pregnancy on adult offspring with regard to growth, body composition and plasma levels of glucose, [E1]insulin[/E1] and corticosterone, and (2) to investigate whether [E2]oxytocin[/E2] treatment early in life could ameliorate the adverse effects of food restriction in utero", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[188, 195]], "entity_1_idx_in_text_with_entity_marker": [192, 199], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "oxytocin", "entity_2_idx": [[247, 255]], "entity_2_idx_in_text_with_entity_marker": [260, 268], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d154.s371_IEPA.d154.s371.p0", "text": "Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific phospholipase C, it was not released upon insulin treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to insulin-stimulated release", "text_with_entity_marker": "Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific [E1]phospholipase C[/E1], it was not released upon [E2]insulin[/E2] treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to insulin-stimulated release", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phospholipase C", "entity_1_idx": [[148, 163]], "entity_1_idx_in_text_with_entity_marker": [152, 167], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[190, 197]], "entity_2_idx_in_text_with_entity_marker": [203, 210], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d154.s371_IEPA.d154.s371.p1", "text": "Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific phospholipase C, it was not released upon insulin treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to insulin-stimulated release", "text_with_entity_marker": "Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific [E1]phospholipase C[/E1], it was not released upon insulin treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to [E2]insulin[/E2]-stimulated release", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "phospholipase C", "entity_1_idx": [[148, 163]], "entity_1_idx_in_text_with_entity_marker": [152, 167], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[300, 307]], "entity_2_idx_in_text_with_entity_marker": [313, 320], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d154.s371_IEPA.d154.s371.p2", "text": "Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific phospholipase C, it was not released upon insulin treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to insulin-stimulated release", "text_with_entity_marker": "Although X-Pro aminopeptidase (EC 3.4.11.9) is GPI-anchored in 3T3-L1 adipocytes as shown by digestion with bacterial phosphatidylinositol-specific phospholipase C, it was not released upon [E1]insulin[/E1] treatment of the cells, indicating that only a subset of the GPI-anchored proteins are susceptible to [E2]insulin[/E2]-stimulated release", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "insulin", "entity_1_idx": [[190, 197]], "entity_1_idx_in_text_with_entity_marker": [194, 201], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[300, 307]], "entity_2_idx_in_text_with_entity_marker": [313, 320], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s292_IEPA.d122.s292.p0", "text": "To study if leptin also has direct peripherally mediated effects on these processes, this hormone (1 mg/day) or its vehicle was infused i.v. for 4 days to lean rats and insulin-stimulated glucose utilization in skeletal muscle and adipose tissue as well as the expression of UCP messenger RNAs (mRNAs) in brown adipose tissue were measured", "text_with_entity_marker": "To study if [E1]leptin[/E1] also has direct peripherally mediated effects on these processes, this hormone (1 mg/day) or its vehicle was infused i.v. for 4 days to lean rats and insulin-stimulated glucose utilization in skeletal muscle and adipose tissue as well as the expression of [E2]UCP[/E2] messenger RNAs (mRNAs) in brown adipose tissue were measured", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[12, 18]], "entity_1_idx_in_text_with_entity_marker": [16, 22], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP", "entity_2_idx": [[275, 278]], "entity_2_idx_in_text_with_entity_marker": [288, 291], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p0", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative [E1]UCP[/E1] expression levels were 100, 104, and 33 for [E2]UCP1[/E2], 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP1", "entity_2_idx": [[57, 61]], "entity_2_idx_in_text_with_entity_marker": [70, 74], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p1", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative [E1]UCP[/E1] expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for [E2]UCP2[/E2] and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p2", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative [E1]UCP[/E1] expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for [E2]UCP3[/E2] in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p3", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative [E1]UCP[/E1] expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in [E2]leptin[/E2]-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP", "entity_1_idx": [[9, 12]], "entity_1_idx_in_text_with_entity_marker": [13, 16], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[155, 161]], "entity_2_idx_in_text_with_entity_marker": [168, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p4", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for [E1]UCP1[/E1], 100, 191, and 125 for [E2]UCP2[/E2] and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP1", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP2", "entity_2_idx": [[85, 89]], "entity_2_idx_in_text_with_entity_marker": [98, 102], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p5", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for [E1]UCP1[/E1], 100, 191, and 125 for UCP2 and 100, 107, and 29 for [E2]UCP3[/E2] in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP1", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p6", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for [E1]UCP1[/E1], 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in [E2]leptin[/E2]-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP1", "entity_1_idx": [[57, 61]], "entity_1_idx_in_text_with_entity_marker": [61, 65], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[155, 161]], "entity_2_idx_in_text_with_entity_marker": [168, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p7", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for [E1]UCP2[/E1] and 100, 107, and 29 for [E2]UCP3[/E2] in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP2", "entity_1_idx": [[85, 89]], "entity_1_idx_in_text_with_entity_marker": [89, 93], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "UCP3", "entity_2_idx": [[115, 119]], "entity_2_idx_in_text_with_entity_marker": [128, 132], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p8", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for [E1]UCP2[/E1] and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in [E2]leptin[/E2]-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP2", "entity_1_idx": [[85, 89]], "entity_1_idx_in_text_with_entity_marker": [89, 93], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[155, 161]], "entity_2_idx_in_text_with_entity_marker": [168, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d122.s294_IEPA.d122.s294.p9", "text": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for UCP3 in ad libitum fed control rats, in leptin-treated rats and in pair-fed control rats, respectively", "text_with_entity_marker": "Relative UCP expression levels were 100, 104, and 33 for UCP1, 100, 191, and 125 for UCP2 and 100, 107, and 29 for [E1]UCP3[/E1] in ad libitum fed control rats, in [E2]leptin[/E2]-treated rats and in pair-fed control rats, respectively", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "UCP3", "entity_1_idx": [[115, 119]], "entity_1_idx_in_text_with_entity_marker": [119, 123], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[155, 161]], "entity_2_idx_in_text_with_entity_marker": [168, 174], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d152.s368_IEPA.d152.s368.p0", "text": "We examined for the first time in young men effects of intravenous injections of NPY (4x50 or 100 microg, n = 9 and 11, respectively, at 22.00, 23.00, 24.00 and 01.00 compared to saline) on the sleep electroencephalogram (EEG; recorded from 23.00 to 07.00) and nocturnal secretion of adrenocorticotrophic hormone (ACTH), cortisol, growth hormone (GH), prolactin and leptin", "text_with_entity_marker": "We examined for the first time in young men effects of intravenous injections of [E1]NPY[/E1] (4x50 or 100 microg, n = 9 and 11, respectively, at 22.00, 23.00, 24.00 and 01.00 compared to saline) on the sleep electroencephalogram (EEG; recorded from 23.00 to 07.00) and nocturnal secretion of adrenocorticotrophic hormone (ACTH), cortisol, growth hormone (GH), prolactin and [E2]leptin[/E2]", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "NPY", "entity_1_idx": [[81, 84]], "entity_1_idx_in_text_with_entity_marker": [85, 88], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[366, 372]], "entity_2_idx_in_text_with_entity_marker": [379, 385], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d84.s202_IEPA.d84.s202.p0", "text": "Blood samples for OT assay were taken just before the rapid injection of insulin (time 0) and at time 15, 30, 45 and 60 min", "text_with_entity_marker": "Blood samples for [E1]OT[/E1] assay were taken just before the rapid injection of [E2]insulin[/E2] (time 0) and at time 15, 30, 45 and 60 min", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "OT", "entity_1_idx": [[18, 20]], "entity_1_idx_in_text_with_entity_marker": [22, 24], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "insulin", "entity_2_idx": [[73, 80]], "entity_2_idx_in_text_with_entity_marker": [86, 93], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d177.s428_IEPA.d177.s428.p0", "text": "These results demonstrate that chronic central infusion to produce a persistent elevation of the cytokine at pathophysiological levels (a situation that may normally manifest during infection, injury and inflammation) produced severe anorexia and weight loss in conjunction with reduction in both serum leptin concentrations and hypothalamic NPY gene expression", "text_with_entity_marker": "These results demonstrate that chronic central infusion to produce a persistent elevation of the cytokine at pathophysiological levels (a situation that may normally manifest during infection, injury and inflammation) produced severe anorexia and weight loss in conjunction with reduction in both serum [E1]leptin[/E1] concentrations and hypothalamic [E2]NPY[/E2] gene expression", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[303, 309]], "entity_1_idx_in_text_with_entity_marker": [307, 313], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[342, 345]], "entity_2_idx_in_text_with_entity_marker": [355, 358], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d170.s410_IEPA.d170.s410.p0", "text": "Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels", "text_with_entity_marker": "Influence of obesity and menopausal status on serum [E1]leptin[/E1], cholecystokinin, galanin and [E2]neuropeptide Y[/E2] levels", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[52, 58]], "entity_1_idx_in_text_with_entity_marker": [56, 62], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "neuropeptide Y", "entity_2_idx": [[89, 103]], "entity_2_idx_in_text_with_entity_marker": [102, 116], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d170.s411_IEPA.d170.s411.p0", "text": "Obesity occurs in 60% of women after menopause and is characterized by an excess of adipose tissue that depends on several orexigenic (neuropeptide Y (NPY) stimulates carbohydrate ingestion, galanin stimulates fat intake) and anorectic (leptin, cholecystokinin (CCK)) factors", "text_with_entity_marker": "Obesity occurs in 60% of women after menopause and is characterized by an excess of adipose tissue that depends on several orexigenic ([E1]neuropeptide Y[/E1] (NPY) stimulates carbohydrate ingestion, galanin stimulates fat intake) and anorectic ([E2]leptin[/E2], cholecystokinin (CCK)) factors", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "neuropeptide Y", "entity_1_idx": [[135, 149]], "entity_1_idx_in_text_with_entity_marker": [139, 153], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "leptin", "entity_2_idx": [[237, 243]], "entity_2_idx_in_text_with_entity_marker": [250, 256], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d170.s413_IEPA.d170.s413.p0", "text": "We investigated basal levels of serum leptin, CCK, galanin and NPY in 16 non-obese premenopausal women, in 15 obese premenopausal women (body mass index (BMI) 34.6 +/- 1.3 SD) and in ten obese postmenopausal women (BMI 34.7 +/- 1.5 SD) to determine the relationship between obesity, menopause and these neuropeptides", "text_with_entity_marker": "We investigated basal levels of serum [E1]leptin[/E1], CCK, galanin and [E2]NPY[/E2] in 16 non-obese premenopausal women, in 15 obese premenopausal women (body mass index (BMI) 34.6 +/- 1.3 SD) and in ten obese postmenopausal women (BMI 34.7 +/- 1.5 SD) to determine the relationship between obesity, menopause and these neuropeptides", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[38, 44]], "entity_1_idx_in_text_with_entity_marker": [42, 48], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[63, 66]], "entity_2_idx_in_text_with_entity_marker": [76, 79], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "IEPA.d170.s414_IEPA.d170.s414.p0", "text": "Significantly increased leptin and galanin levels in postmenopausal obese women coupled with decreased NPY levels revealed some changes in the neuropeptides regulating eating behavior, which may be the reason for the onset of postmenopausal obesity", "text_with_entity_marker": "Significantly increased [E1]leptin[/E1] and galanin levels in postmenopausal obese women coupled with decreased [E2]NPY[/E2] levels revealed some changes in the neuropeptides regulating eating behavior, which may be the reason for the onset of postmenopausal obesity", "relation": [{"relation_type": "negative", "relation_id": 2, "entity_1": "leptin", "entity_1_idx": [[24, 30]], "entity_1_idx_in_text_with_entity_marker": [28, 34], "entity_1_type": "no-type", "entity_1_type_id": 0, "entity_2": "NPY", "entity_2_idx": [[103, 106]], "entity_2_idx_in_text_with_entity_marker": [116, 119], "entity_2_type": "no-type", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d5.s0_LLL.d5.s0.p0", "text": "In the shaA mutant, sigma(H)-dependent expression of spo0A and spoVG at an early stage of sporulation was sensitive to external NaCl.", "text_with_entity_marker": "In the shaA mutant, [E1]sigma(H)[/E1]-dependent expression of [E2]spo0A[/E2] and spoVG at an early stage of sporulation was sensitive to external NaCl.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigma(H)", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "spo0A", "entity_2_idx": [[53, 58]], "entity_2_idx_in_text_with_entity_marker": [66, 71], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d5.s0_LLL.d5.s0.p1", "text": "In the shaA mutant, sigma(H)-dependent expression of spo0A and spoVG at an early stage of sporulation was sensitive to external NaCl.", "text_with_entity_marker": "In the shaA mutant, [E1]sigma(H)[/E1]-dependent expression of spo0A and [E2]spoVG[/E2] at an early stage of sporulation was sensitive to external NaCl.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sigma(H)", "entity_1_idx": [[20, 28]], "entity_1_idx_in_text_with_entity_marker": [24, 32], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "spoVG", "entity_2_idx": [[63, 68]], "entity_2_idx_in_text_with_entity_marker": [76, 81], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d32.s0_LLL.d32.s0.p0", "text": "Transcriptional studies demonstrated that the expression from the araE promoter is induced by L-arabinose, repressed by glucose, and negatively regulated by AraR.", "text_with_entity_marker": "Transcriptional studies demonstrated that the expression from the [E1]araE[/E1] promoter is induced by L-arabinose, repressed by glucose, and negatively regulated by [E2]AraR[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "araE", "entity_1_idx": [[66, 70]], "entity_1_idx_in_text_with_entity_marker": [70, 74], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "AraR", "entity_2_idx": [[157, 161]], "entity_2_idx_in_text_with_entity_marker": [170, 174], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d3.s0_LLL.d3.s0.p1", "text": "Analysis of the expression of a translational ywhE-lacZ fusion showed that ywhE expression is sporulation-specific, and is controlled predominantly by the forespore-specific sigma factor sigma(F), and to a lesser extent by sigma(G).", "text_with_entity_marker": "Analysis of the expression of a translational ywhE-lacZ fusion showed that [E1]ywhE[/E1] expression is sporulation-specific, and is controlled predominantly by the forespore-specific sigma factor [E2]sigma(F)[/E2], and to a lesser extent by sigma(G).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ywhE", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(F)", "entity_2_idx": [[187, 195]], "entity_2_idx_in_text_with_entity_marker": [200, 208], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d3.s0_LLL.d3.s0.p2", "text": "Analysis of the expression of a translational ywhE-lacZ fusion showed that ywhE expression is sporulation-specific, and is controlled predominantly by the forespore-specific sigma factor sigma(F), and to a lesser extent by sigma(G).", "text_with_entity_marker": "Analysis of the expression of a translational ywhE-lacZ fusion showed that [E1]ywhE[/E1] expression is sporulation-specific, and is controlled predominantly by the forespore-specific sigma factor sigma(F), and to a lesser extent by [E2]sigma(G)[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ywhE", "entity_1_idx": [[75, 79]], "entity_1_idx_in_text_with_entity_marker": [79, 83], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigma(G)", "entity_2_idx": [[223, 231]], "entity_2_idx_in_text_with_entity_marker": [236, 244], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d43.s0_LLL.d43.s0.p2", "text": "The sspH and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, sigmaG; the sspN-tlp operon is recognized equally well by sigmaG and the other forespore-specific sigma factor, sigmaF.", "text_with_entity_marker": "The [E1]sspH[/E1] and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, [E2]sigmaG[/E2]; the sspN-tlp operon is recognized equally well by sigmaG and the other forespore-specific sigma factor, sigmaF.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sspH", "entity_1_idx": [[4, 8]], "entity_1_idx_in_text_with_entity_marker": [8, 12], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaG", "entity_2_idx": [[108, 114]], "entity_2_idx_in_text_with_entity_marker": [121, 127], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d43.s0_LLL.d43.s0.p4", "text": "The sspH and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, sigmaG; the sspN-tlp operon is recognized equally well by sigmaG and the other forespore-specific sigma factor, sigmaF.", "text_with_entity_marker": "The sspH and [E1]sspL[/E1] genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, [E2]sigmaG[/E2]; the sspN-tlp operon is recognized equally well by sigmaG and the other forespore-specific sigma factor, sigmaF.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sspL", "entity_1_idx": [[13, 17]], "entity_1_idx_in_text_with_entity_marker": [17, 21], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaG", "entity_2_idx": [[108, 114]], "entity_2_idx_in_text_with_entity_marker": [121, 127], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d43.s0_LLL.d43.s0.p8", "text": "The sspH and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, sigmaG; the sspN-tlp operon is recognized equally well by sigmaG and the other forespore-specific sigma factor, sigmaF.", "text_with_entity_marker": "The sspH and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, sigmaG; the [E1]sspN[/E1]-tlp operon is recognized equally well by [E2]sigmaG[/E2] and the other forespore-specific sigma factor, sigmaF.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sspN", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaG", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d43.s0_LLL.d43.s0.p10", "text": "The sspH and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, sigmaG; the sspN-tlp operon is recognized equally well by sigmaG and the other forespore-specific sigma factor, sigmaF.", "text_with_entity_marker": "The sspH and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, sigmaG; the sspN-[E1]tlp[/E1] operon is recognized equally well by [E2]sigmaG[/E2] and the other forespore-specific sigma factor, sigmaF.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "tlp", "entity_1_idx": [[125, 128]], "entity_1_idx_in_text_with_entity_marker": [129, 132], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaG", "entity_2_idx": [[166, 172]], "entity_2_idx_in_text_with_entity_marker": [179, 185], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d43.s0_LLL.d43.s0.p12", "text": "The sspH and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, sigmaG; the sspN-tlp operon is recognized equally well by sigmaG and the other forespore-specific sigma factor, sigmaF.", "text_with_entity_marker": "The sspH and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, sigmaG; the [E1]sspN[/E1]-tlp operon is recognized equally well by sigmaG and the other forespore-specific sigma factor, [E2]sigmaF[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "sspN", "entity_1_idx": [[120, 124]], "entity_1_idx_in_text_with_entity_marker": [124, 128], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaF", "entity_2_idx": [[220, 226]], "entity_2_idx_in_text_with_entity_marker": [233, 239], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d43.s0_LLL.d43.s0.p14", "text": "The sspH and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, sigmaG; the sspN-tlp operon is recognized equally well by sigmaG and the other forespore-specific sigma factor, sigmaF.", "text_with_entity_marker": "The sspH and sspL genes are recognized primarily by the forespore-specific sigma factor for RNA polymerase, sigmaG; the sspN-[E1]tlp[/E1] operon is recognized equally well by sigmaG and the other forespore-specific sigma factor, [E2]sigmaF[/E2].", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "tlp", "entity_1_idx": [[125, 128]], "entity_1_idx_in_text_with_entity_marker": [129, 132], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "sigmaF", "entity_2_idx": [[220, 226]], "entity_2_idx_in_text_with_entity_marker": [233, 239], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d2.s0_LLL.d2.s0.p0", "text": "Transcription of ydhD was dependent on SigE, and the mRNA was detectable from 2 h after the cessation of logarithmic growth (T2 of sporulation).", "text_with_entity_marker": "Transcription of [E1]ydhD[/E1] was dependent on [E2]SigE[/E2], and the mRNA was detectable from 2 h after the cessation of logarithmic growth (T2 of sporulation).", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ydhD", "entity_1_idx": [[17, 21]], "entity_1_idx_in_text_with_entity_marker": [21, 25], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SigE", "entity_2_idx": [[39, 43]], "entity_2_idx_in_text_with_entity_marker": [52, 56], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d2.s1_LLL.d2.s1.p0", "text": "ykuD was transcribed by SigK RNA polymerase from T4 of sporulation.", "text_with_entity_marker": "[E1]ykuD[/E1] was transcribed by [E2]SigK[/E2] RNA polymerase from T4 of sporulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "ykuD", "entity_1_idx": [[0, 4]], "entity_1_idx_in_text_with_entity_marker": [4, 8], "entity_1_type": "target", "entity_1_type_id": 1, "entity_2": "SigK", "entity_2_idx": [[24, 28]], "entity_2_idx_in_text_with_entity_marker": [37, 41], "entity_2_type": "agent", "entity_2_type_id": 0}], "directed": false, "reverse": false}
{"id": "LLL.d2.s2_LLL.d2.s2.p1", "text": "Both SigK and GerE were essential for ykvP expression, and this gene was transcribed from T5 of sporulation.", "text_with_entity_marker": "Both [E1]SigK[/E1] and GerE were essential for [E2]ykvP[/E2] expression, and this gene was transcribed from T5 of sporulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "SigK", "entity_1_idx": [[5, 9]], "entity_1_idx_in_text_with_entity_marker": [9, 13], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "ykvP", "entity_2_idx": [[38, 42]], "entity_2_idx_in_text_with_entity_marker": [51, 55], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
{"id": "LLL.d2.s2_LLL.d2.s2.p2", "text": "Both SigK and GerE were essential for ykvP expression, and this gene was transcribed from T5 of sporulation.", "text_with_entity_marker": "Both SigK and [E1]GerE[/E1] were essential for [E2]ykvP[/E2] expression, and this gene was transcribed from T5 of sporulation.", "relation": [{"relation_type": "enzyme", "relation_id": 0, "entity_1": "GerE", "entity_1_idx": [[14, 18]], "entity_1_idx_in_text_with_entity_marker": [18, 22], "entity_1_type": "agent", "entity_1_type_id": 0, "entity_2": "ykvP", "entity_2_idx": [[38, 42]], "entity_2_idx_in_text_with_entity_marker": [51, 55], "entity_2_type": "target", "entity_2_type_id": 1}], "directed": false, "reverse": false}
